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Inflammatory Breast Carcinoma:
an Alternative Mechanism
for Its Clinical Manifestation
To the editors.—Inflammatory carci
noma o f the breast is a diagnosis applied
to those carcinomas in which the patient
presents with increasing breast size, pain,
warmth, edem a and skin redness
associated with dermal lymphatic car
cinomatosis.1 The appearance may be
clinically indistinguishable from cellulitis;
however, an inflammatory response is
rarely seen on microscopy.
The underlying mechanism for the skin
appearance has been attributed to
obstruction o f the dermal lymphatics by
neoplastic cells.2'5 Certainly this explains
the edema, but does it also fully explain
the telangiectasia that is the most distinc
tive feature?
We had occasion to review a case of
inflammatory carcinoma in which we
found both dermal lymphatic and blood
vessel involvement by malignant cells
(Fig. 1).
We would like to draw attention to the
blood-vessel involvement in this case and

The Canadian Journal of
Surgery
Le journal canadien de
chirurgie
( 613)

731-9331

The Canadian Journal o f Surgery is pub
lished by the Canadian Medical Association
and sponsored by the Royal College of Phy
sicians and Surgeons o f Canada. The estab
lishm ent o f e d ito ria l p o lic y is the
responsibility of the Royal College. The
objectives o f the Journal, endorsed by the
Council of the College, are: (1) to contribute
to the effective continuing education of
Canadian surgical specialists, using innova
tive techniques when feasible and (2) to pro
vide Canadian surgeons with an effective
vehicle for the dissemination of their obser
vations in the area o f clinical research.

Published every 2 months by the Canadian
Medical Association, PO Box 8650, Ottawa,
Ont. K1G 0G8. Printed by Harpell's Press

suggest that it may play an important role
in causing the clinical features o f the con
dition, although the emphasis in previous
reports has been on lymphatic obstruction
as the underlying mechanism.2'5 Perhaps
hematogenous involvement also provides
an explanation for the rapid downhill
course o f patients with this aggressive
lesion.

Roger Byard, md
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md, frcpc

Department of Laboratory Medicine,
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FIG. 1—Two dermal vessels lined by single
layer of endothelium in which there are both
neoplastic cells and erythrocytes, suggesting
that they are blood, not lymphatic, capillaries
(hematoxylin and eosin, original magnification

x 30).
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Pilonidal Disease
To the editors.—My experience with
pilonidal disease caused me to respond to
Dr. Eugene Salvati. The treatment he out
lined in his paper (Can J Surg 1985; 28:
225-6) appears much outdated.
As most surgeons will attest, any inci
sion in the midline, with or without
removal of skin, takes much too long to
heal. In my opinion and experience, an
incision should never be made in the
midline.
A slightly curved incision lateral to the
midline will expose the affected area and
allow excellent drainage and excision.
Moreover, the small “ pits” in the mid
line can be excised individually with re
moval of a small “ diamond-shaped”
amount of skin surrounding the sinus
openings, which can be closed easily with
one or two small 6-0 silk sutures.
I have not had to hospitalize any
patient over the past 15 years, and I hope
that such major procedures as marsupi
alization, split-thickness grafting and Zplasty will be relegated to the past.
M.J. F urman , md , frcsc , facs
960 East Green St.,
Pasadena, CA 91106
USA

To the editors.—I agree wholeheartedly
with Dr. Furman that most patients with
pilonidal disease can be treated in the
office and of course this was the main
thrust of my article. However, I strongly
disagree that an incision should “never
be made in the midline” . I frequently see
patients who have had lateral incisions
made over the point of maximum fluctu
ation and in almost all cases the sinus
recurs.
Excision of the pits and primary closure
with lateral drainage appears surgically
sound but what if a midline pit cannot be
demonstrated? How would Dr. Furman
treat a large, dirty, recurrent pilonidal
cyst with a 2-cm “ midline pit” ? Could
this be excised and closed primarily and
would it remain closed?
Obviously there are different types of
pilonidal disease and no one method is
applicable to them all. A simple unin
fected cyst with one or two midline pits
should respond well to lateral incision and
midline-pit excision with primary closure;
however, the application of this method
to complicated or recurrent pilonidal dis
ease or to cysts without visible pits
appears to be of doubtful value.
E ugene P. Salvati, md , facs
1010 Park Ave.,
Plainfield, NJ 07060
USA
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Role of Lymphoscintigraphy
in Breast Cancer
To the editors.—In the November 1983
issue of this journal (pages 507-9), we
reported our results of axillary and inter
nal mammary lymphoscintigraphy in 89
patients with benign and malignant breast
disease. An additional 41 women with
breast cancer have been added, totalling
86 women whose cancer has now been
prospectively staged preoperatively by
internal mammary lymphoscintigraphy
using technetium-99m antimony sulfide
colloid complemented by axillary lymphadenectomy. Forty of the 86 patients
had axillary nodal involvement histolog
ically. In 17 the scan identified the cancer
(positive scans); 23 had false-negative
scans. Of the 46 patients with no axillary
node involvement, 38 had negative scans
and 8 a false-positive scan. The sensitiv
ity, specificity and accuracy of the axil
lary lymphoscintigram, therefore, was
42.5%, 83% and 64% respectively.
Correlation of internal mammary lymphoscintigrams with histologic findings
was not possible because in only two
patients was biopsy of internal mammary
nodes done. Comparison of internal
mammary scans with the histologic fea
tures of the axillary nodes, in an attempt
to assess the predictive value of the scan,

improved the sensitivity to 45%, the
specificity to 96% and the accuracy to
72%. If positive internal mammary lymphoscintigrams in patients with negative
axillary nodes represent those with true
nodal disease, long-term follow-up should
show some differences over the group
with negative internal mammary scans, as
has previously been suggested by Ege and
Clark.1
As current therapy of breast cancer
depends, in part, on axillary nodal sta
tus, we have attempted to find a noninvasive means of assessing the axilla (i.e.,
lymphoscintigraphy) by comparing the
findings of this preoperative assessment
with those of the accepted gold standard
(i.e., axillary dissection). The results indi
cate that the test is neither sensitive nor
accurate enough to be of clinical use.

a

D.I. SOUTTER, MD, FRCSC
L.J. Mahoney , md , frcsc
-4
Department of Surgery,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
M5B 1W8
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SESAP IV Question
4
255. Which of the following most accurately reflects current theories about
the effectiveness of adjuvant chemotherapy for the treatment of cancer?
(A)

The last cancer cell must be killed or sterilized by the drugs

(B)

Combinations of drugs are used to improve the chance of
finding a single drug that is effective

(C)

Continuous administration gives the best hope for cure
when an effective drug is found

(D)

Combinations of drugs with different mechanisms of action
are most likely to be effective

(E)

Timing is less important than finding the single most effec
tive drug

M

■—*

A

i

■ A

For the question above select the best answer of the five given.
- ' i

(Reproduced by permission from SESAP IV Syllabus; Surgical Education and
Self-Assessment Program No. 4. For enrolment in the Surgical Education and
Self-Assessment Program No. 4, please apply to the American College of Sur
geons, 55 East Erie St., Chicago, IL 60611.)
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W hat's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Preventing and Handling the Unexpected
Unexpected findings at laparotomy —
what to do when you find more than
you’re looking for — was the theme of
a symposium presented in Vancouver at
the 54th annual meeting of the Royal Col
lege of Physicians and Surgeons of
Canada, and the turnout of about 250,
representing about 50% more participants
than were expected, was a pleasant sur
prise for the surgeons who organized the
symposium.
The 2-hour session was the first of what
promises to be a long series of annual
events sponsored jointly by the RCPSC
and the Canadian Association of General
Surgeons (CAGS); it brought together a
panel of six experts and two moderators
to present possible surprises in abdomi
nal operations and ways of avoiding or
dealing with them.
The members of the audience received
a booklet that spelled out the problems
and listed several options for treatment.
The panel members showed slides,
expanded on the information in the book
let and outlined what they believed was
the most appropriate procedure, given the
available literature and their personal
experience.
For example, T. Keith Scobie, FACS,
FRCSC, who is a specialist in vascular
surgery and a professor at the University
of Ottawa, posed several questions about
repairing abdominal aortic aneurysm. In
brief, one of the questions was: If you
were operating to repair a 6-cm abdomi
nal aortic aneurysm that was not causing
symptoms in a 66-year-old man and you
discovered a distended, inflamed gallblad
der filled with small stones, would you (a)
repair the aneurysm and, some weeks

later, perform a cholecystectomy; (b) per
form a cholecystectomy and, some weeks
later, repair the aneurysm; (c) perform
both procedures at once; (d) perform
combined cholecystostomy and repair of
the aneurysm; or (e) perform a chole
cystectomy, ligate the aorta above and
below the aneurysm, and reconstruct the
aorta with an axillobifemoral graft?
Scobie, citing his own series of more than
900 aortic grafts and retrospective studies
of more than 1500 other cases, concluded
that a surgeon facing this dilemma should
perform a cholecystectomy at the time
and repair the aneurysm later. “ Would
you recommend the same treatment if the
aneurysm were 8 or 9 cm in diameter?”
was the question from the listeners. His
response, again supported by the litera
ture, was that the risk of rupture would
then justify a combined procedure.
Don’t find yourself in that predicament
was the message from panel member
Peter Cooperberg, FRCPC, a specialist
in diagnostic radiology, who heads the
Department of Ultrasound at Vancouver
General Hospital. In an interview with
CJS after the symposium, Cooperberg
said, “ I tried to point out that the role
of the radiologist is to prevent the sur
geons’ getting into that trouble in the first

Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

Repair of abdominal aortic aneurysms was one
of the hypothetical problems dealt with at
RCPSC/CAGS symposium on unexpected
findings at laparotomy.

place. If they had done ultrasound imag
ing on the patient with an aortic
aneurysm, they would have known that
the patient had cholecystitis. But if they’re
going to operate without doing the proper
investigations, then they are bound to get
into surprises. These days people hardly
ever operate without knowing exactly
what they are going to find.”
The strong turnout at the symposium
suggests otherwise and so does Scobie.
Although Cooperberg’s comments may
apply to the hypothetical problem in
which the aneurysmectomy was an elec
tive procedure, says Scobie, “ Quite often
surgeons have urgent operations and do
not have the time or the facilities for
thorough investigative procedures.”
He went on to say that radiologists are
normally removed from actual patient
care so they have a different perspective.
Cooperberg acknowledged the differ
ence in the roles: “ The other people on
the panel were surgical subspecialists —
urology, GI — and their thing was ‘what
if you operate on a patient for — let’s say
— the aortic aneurysm and you find that
the patient has cholecystitis?’; well, this
approach doesn’t apply to radiology as
much; you don’t get in there and find a
surprise that a radiologist is going to be
called up to the OR to help w ith.”
Cooperberg’s presentations at the sympo
sium echoed this difference, showing, for
example, cases in which there were dis
crepancies in the results obtained from
different imaging techniques. Said
Cooperberg, “ The point was that when
you have two different x-ray studies that
disagree with one another you have to
figure out why. What went w rong.”
Charles Scudamore, FRCSC, assistant
professor of surgery, University o f Brit
ish Columbia, reviewed hepatobiliary
problems that might be found at
laparotomy — such as an unexpected
tumour of the small bowel or o f the pan
creas, or a previously undetected case of
cirrhosis of the liver.
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Scudamore spoke briefly with CJS and
noted that the symposium was modelled
on a teaching method used by the Ameri
can College of Surgeons, although the
Canadian version did not yet have the
audience-response buttons that allow an
immediate assessment of the listeners’
familiarity with the problems.
That just happens to be one of the
changes planned for future symposia, said
Marvin Wexler, FACS, FRCSC, of the
Royal Victoria Hospital in Montreal, who
serves as the secretary for the CAGS.
“ The evaluations from the members of
the audience were unanimously suppor
tive,” Wexler commented, “ but we
learned a lot from this trial. We tried to

do too much in too little time; we asked
too many questions. Next time we’ll pro
ceed more slowly, allow for more dis
cussion.”

F.N. Gurd Receives Duncan
Graham Award From RCPSC

All the participants who took time to
speak with CJS agreed. The event was
successful and the only weakness was the
constraint on questions and exchanges
among the panel members and with the
audience.
Said Cooperberg, “ There wasn’t any
banter among the panel members. I think
the moderators could have said, ‘Well,
Dr. So-and-so, what do you think about
that?’ They did that with the audience but
never to the panel.”

4

Two Retired Surgeons Become Honorary Members, CAGS

H. Rocke Robertson and Allan D.
McKenzie became honorary members of
the Canadian Association of General Sur
geons during its annual meeting in Sep
tember.
The tw o surgeons, now retired,
received the honours in the city where
they had strongly influenced surgical care
for a total of nearly two decades, with
Robertson serving as chief of surgery at
the Vancouver General Hospital from
1950 to 1959 and McKenzie (who headed
the department at the University of Brit
ish Columbia) holding the position from
1959 to 1965.
Both spent some years of their medi
cal training at McGill, and Robertson
returned there to chair the Department of
Surgery from 1959 to 1962 and eventu

ally to become the principal and vice
chancellor of the university.
As well as being ex-members of the
Board of Regents of the American Col
lege of Surgeons, both held offices in
several medical societies. For example,
McKenzie served as president of the PanPacific Surgical Association and vicepresident of the James IV Association of
Surgeons. Robertson was president of the
Traffic Injury Research Foundation of
Canada from 1967 to 1973, a position
that drew on his special expertise and
interest in caring for penetrating wounds
(expertise that appears on the pages of
such authoritative works as “ Encyclopae
dia Britannica” and “ Christopher’s Text
book of Surgery” ).

4

F.N. Gurd, FACS, FRCSC

Fraser N. Gurd, former associate secre
tary for the Royal College, gained recog
nition recently for his contributions to
improved medical education in Canada
by accepting the Duncan Graham award
at the College’s annual meeting.
Gurd, a graduate of McGill University
and later chairman of the department of
surgery there, became professor emeritus
in 1980. He was instrumental in setting
up the current framework for the certifi
cation examinations of the Royal College,
serving from 1955 onward in some capac
ity for that organization. He drafted the
“ grey book” , which summarizes the
objectives, standards and conduct of
accreditation activities, and he revised and
expanded the detailed accreditation ques
tionnaires for all the specialties,
Gurd is the 15th physician to receive the
award, which is reserved for individuals
of international renown in the field of
medical education.

Blanchard Heads Surgery
at Manitoba

H .R. Robertson, FRCSC, FRCS(Edin)
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A.D. McKenzie, FACS, FRCSC

R obert J.W . Blanchard recently
became professor and head of surgery at
the University of Manitoba. He has been
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with the university since 1970 and has
proved popular with the house staff, who
elected him staff person of the year for
1981-1982. He took leave in 1984 to
become a visiting associate professor of
surgery and community health at Aga
Khan University, Karachi, Pakistan, an
appointment that grew out of his earlier
work as medical superintendent, Bach
Christian Hospital, Pakistan.
Blanchard is a member of the editorial
advisory board of the Canadian Journal
o f Surgery, a former examiner for the
Royal College and an instructor for the
American College of Surgeons’ training
program in life support for victims of
advanced trauma.
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Medical Council of Canada
Begins Revamping
Surgical Examinations
As part of its commitment to assessing
the clinical competence of physicians
practising in Canada, this fall the Medi
cal Council of Canada appointed Rudy
Danzinger, FACS, FRCSC, St. Boniface
Hospital, Winnipeg, to chair its subcom
mittee on surgery, which has the mandate
to define the objectives of undergraduate
education in the specialty.
An outline of what undergraduates
need to know in pediatrics has been
drafted and much of the task has been
done for obstetrics and gynecology.
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Endometriosis
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Endometriosis is related to retrograde
menstruation or coelomic metaplasia and
depends on the presence of estrogen. It
Is a consequence of menstruation into an
area that has no outlet for menstrual
blood. As a result, antigenic substances
are released, causing an inflammatory
response and the formation of
prostaglandins. Subsequent inflammatory
repair distorts pelvic anatomy and the
prostaglandins affect ovarian, tubal and
uterine function. Symptoms are not
specific, so definitive diagnosis depends
on laparoscopy or laparotomy for confir
mation.
Medical therapy is aimed at reducing
the estrogen on which the endometriotic
lesions depend. Danazol, a testosterone
derivative, does this by interfering with
ovarian follicular development, and often
results in both symptomatic and objec
tive improvement. When therapy is with
drawn, the renewed estrogen stimulus
may cause the lesions to recur.
Conservative surgical therapy (the
excision of endometriotic nodules and
the restoration of pelvic anatomy while
leaving a reproductive potential) is
equally successful. Radical surgery
(abdominal hysterectomy and bilateral
salpingo-oophorectomy) is definitive,
removing both the stimulus for
endometriotic growth and the source of
renewal.

*
*

►

>-

L'origine de I'endometriose est reliee aux
menstruations retrogrades ou a la
metaplasie coelomique et depend de la
presence d'oestrogenes. Les lesions
endometriotiques sont une consequence
des menstruations dans une aire oil il n'y

From the Department o f Obstetrics and
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McGill University, Montreal, PQ
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a pas de possibility de sortie pour le
sang menstruel. II se produit alors
comme resultat une emission de sub
stances antigeniques qui en retour
causent a la fois une reaction inflammatoire et la formation de prostaglandines. La reparation inflammatoire subsequente deforme I'anatomie pelvienne,
I'effet prostaglandin a la fois ovarien et
tubaire et la fonction uterine. Les symptomes ne sont pas specifiques et le
diagnostic definitif depend de la confir
mation de laparoscopie ou de laparotomie.
La therapie medicale a pour
but de reduire I'oestrogene dont depen
dent les lesions endometriotiques. Le
Danazol, un derive du testosterone,
produit cet effet en entravant le
developpement folliculaire ovarien. Le
resultat d'une telle therapie est qu'il se
produit souvent une amelioration a la
fois symptomatique et objective. Les
lesions peuvent reapparaitre a la fin de la
therapie avec la reprise du stimulus oestrogenique. Une therapie chirurgicale
conservatrice (excision des nodules
endometriotiques et restauration de
I'anatomie pelvienne tout en gardant une
possibility de reproduction) peut etre
egalement couronnee de succes. Une
therapie chirurgicale radicale (hysterectomie abdominale et salpingooophorectomie bilaterale) represente une
therapie definitive puisqu'elle elimine a la
fois le stimulus du developpement
endometriotique et leur source de renouvellement.

General surgeons are interested in
endometriosis because it is found at 15To
to 20% of all laparotomies performed for
gynecologic problems and because it is
interesting in itself.1There is no counter
part in medicine for this disconcerting dis
order that often appears to have the
characteristics of a malignant disease,
albeit of low grade, but results from
defects in the immunologic system that
allow it to spread.2 Histologically, it
shows inflammatory changes and there is
good evidence it may be the result of a

genetic disorder.3 With this assortment
of causes and pathogenesis, one might
expect symptoms to be confusing, the
treatment controversial and the results of
such treatment ambiguous. These expec
tations are fulfilled. Moreover, confusion
over treatment is further compounded by
the need to adjust for the patient’s age,
her desire for children and her particular
symptoms.
In order to understand the disease and
the rationale of treatment, I shall first
trace the development of the disease
process and then discuss both local and
systemic reactions to the process.
Development
Only two of a number of hypotheses
explaining the development of endometri
osis correlate well with the clinical picture.
The first is that of retrograde menstrua
tion and the second coelomic metaplasia.
Retrograde menstruation of viable
endometrial cells is an attractive simple
hypothesis, not only because it occurs but
also because it explains the distribution
of endometriotic implants close to the
ends of the fallopian tubes.4 Experimen
tal evidence for this theory is far from
conclusive.5 Endometriosis is not
produced by injecting menstrual blood
into the peritoneal cavity and, although
retrograde menstruation is a near-normal
phenomenon, endometriosis is not.
Another explanation is that endometriotic
lesions result from the reappearance and
differentiation of embryonic coelomic
cells capable of forming endometrium
that are laid down during embryonic
development.6 The stimulus for their
development and maintenance is estro
gen. Endometriosis, therefore, appears
only after puberty and is more common
when estrogen stimulation is prolonged,
as when childbearing is delayed. As with
so many other confident pronouncements
about endometriosis, there are excep
tions: the development of endometriosis
in men and its development in post
menopausal women.7,8
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The lesion is uterine endometrium at an
ectopic site. Its response to reproductive
hormones is delayed and weak,9 but
both estrogen and progesterone receptors
are present.10 The tissue menstruates into
itself and menstruation is central to the
lesion’s development. With no outlet for
the blood, pressure is exerted on the glan
dular secreting walls, which become
attenuated, and finally a thick concen
trated fluid oozes forth. The developing
lesion causes pelvic pain because of
peritoneal distension and irritation of the
surrounding nerves. The lesion is sealed
by the adherence of surrounding struc
tures in a way that often pulls the uterus
backward and the rectum forward, with
the ovaries becoming attached to the back
of the broad ligament.
Further effects stem from the break
down of endometrium. The release of an
antigenic substance stimulates an immune
response in adjacent tissues,11 resulting
in accentuation of local inflammation,
increased endoperoxide and prostagland
ing synthesis12 and the deposit of com
plem ent on th e norm al uterine
endometrium.11 The fibrosis resulting
from the antigenic tissue effect and the
release of free iron is so intense that the
blood supply to the lesion becomes lim
ited, and the growth of individual le
sions is thus contained. The synthesis of
prostaglandin F2a accounts for the
patient’s dysmenorrhea and interferes
with both ovum release and tubal move
ment.12,13 Conception is difficult because
not only are tubal and ovarian function
interfered with but sperm are destroyed
in excessive numbers.14 If, in spite of
these difficulties, fertilization and implan
tation do occur, an unusually high
proportion of early pregnancies are
rejected because of the complement
deposit on the endometrium.15
Pelvic structures are affected by
endometriosis in a distinct fashion. The
rectal lesion develops inward from the
serosal surface, directly opposite to that
of rectal neoplasia. Reactive fibrosis
causes the rectal wall to thicken and may
constrict the lumen, but rarely to the
point of obstruction. Implants appear to
have a ureteric predilection and may
obstruct the ureter.16 However, distor
tion is more common, causing the ureter
to be retracted towards the cervix where
injury during surgery is more likely. The
small intestine is rarely involved with
endometriosis but the peritoneum over
the dome of the bladder is frequently
involved.
Diagnosis

The principal symptoms of endometri
osis are infertility, secondary dysmenor
rhea and dyspareunia, but it is impossi
ble to predict which will be present or
472

predominate. Minimal lesions can cause
disabling symptoms, whereas obvious
gross disease may not cause a single com
plaint. The usual physical findings are a
retroverted uterus and one or more tender
nodules on the uterosacral ligaments in
the cul de sac; the ovaries are commonly
enlarged. Since both symptoms and pel
vic findings are nonspecific, diagnosis
must be confirmed by laparoscopy or
laparotomy before decisions as to treat
ment and prognosis can be made. Biopsy
is rarely necessary and can be misleading;
therefore, diagnosis usually depends on
the gross findings.
Therapy

Medical
Medical therapy is based on the
hypothesis that both symptoms and
lesions of endometriosis are caused by
menstruation in an unusual location. It
follows, therefore, that cessation of men
struation should relieve symptoms and
allow healing. This is achieved by the tem
porary withdrawal of estrogen stimula
tion of the endometrium. Following med
ical therapy, estrogen stim ulation
followed by menstruation will resume
(both in the uterus and in the ectopic foci
of endometrium). Thus, symptoms even
tually will recur. In the meantime, the
patient may have complete relief of symp
toms and may become pregnant.
Current medical therapy is essentially
limited to the use of Danazol,17 a deriva
tive of testosterone, which has widespread
effects on the reproductive system. Prin
cipally, it prevents the surge of luteiniz
ing hormone essential to follicular
development in the ovary. This is most
important since the largest component of
estradiol secretion is derived from the
ovarian follicle. Danazol also decreases
the biologic response to estrogen, and its
effect on testosterone metabolism causes
a mild anabolic and androgenic state.18
With estrogen decrease, both the size
and vascularity of the endometriotic foci
wane, especially in small noninvasive
ovarian lesions. The majority of patients
obtain both symptomatic and objective
improvement.19 Almost 50% of patients
who wish to conceive following cessation
of therapy do so, and 50% of those who
fail will have recurrent disease within 2
years.20 Usually no treatment is neces
sary when lesions are minimal.21
Surgery
Surgery remains the definitive therapy
in certain cases of endometriosis. The
operative procedure will depend on the
patient’s complaints and the need to
preserve her fertility. Since endometrio
sis is not a malignant disease, radical sur

gery (i.e., the removal of reproductive
potential) should not be performed
without profound and thoughtful consul
tation with the patient.
-»

Conservative Surgery
The aim is to restore the pelvic anat
omy without damaging reproductive
potential. This can be achieved by
removal of the endometriotic lesions and
lysis of adhesions. Excision of implants,
both ovarian and peritoneal, is best done
by sharp dissection. The surgery may be
more difficult than first envisaged.
Meticulous attention must be paid to
hemostasis and efforts made to achieve
reperitonealization, because if not done,
adhesions following surgery may them
selves cause infertility. In dissecting
endometrial cysts from the ovary, every
effort should be made to preserve a via
ble portion. If invasion is such that the
hilum of the ovary is involved, preserva
tion of the ovarian blood supply becomes
difficult and the remaining ovarian tissue
may be nonviable.
Other arbitrary surgical measures that
may be performed at this time include
dilatation and curettage, correction of the
retroverted uterus and presacral neurec
tomy. Dilatation of the cervix and short
ening of the round ligaments to correct
retroversion, although unproven as ther
apeutic measures, seem in this instance to
be harmless. Presacral neurectomy on the
other hand is a major procedure, bring
ing with it both immediate and long-term
complications and its use should be care
fully considered, especially in view of the
success of prostaglandin synthetase inhi
bitors for treating dysmenorrhea. Patient
selection makes it difficult to compare
conservative surgery and medical thera
py. The results vary with the age of the
patient and stage of the disease.22
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Radical Surgery
Radical surgery (total abdominal hys
terectom y and b ilateral salpingooophorectomy) is indicated in an older
women whose family is complete and
whose symptoms are unacceptable. The
most worrisome gynecologic surgery is
that done for endometriosis. Not only is
there annoying capillary bleeding, but
also the distortion of pelvic anatomy puts
all pelvic organs and the vascular struc
ture at risk. It demands considerable tech
nical skill and wise selection of the
appropriate surgical procedure.
First, anatomy must be restored; the
ovaries are mobilized from the back of
the broad ligaments by blunt dissection.
The rectum is separated from the back of
the uterus by sharp dissection. This is best
achieved by traction on the uterus, with
sutures through the fundus, and counter-
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ing upward traction on the rectosigmoid,
both of which help display the operative
area. The risk o f injury to the rectum is
always present because o f absent tissue
planes and difficult hemostasis. Dissec
tion should leave uterine muscle attached
to the rectum rather than the reverse. It
may be judicious to discontinue the dis
section and perform an incomplete hys
terectomy, leaving the cervix in place.
Resection of endometrial lesions of the
rectum are best delayed until the results
o f gynecologic surgery can be observed.
At a later date when the full effect of hor
mone deprivation is seen, the need for
bowel surgery can be appraised. If neces
sary, appropriate resection may be done
when the bowel is prepared and the pelvis
quiescent.
Since the ureters are at special risk, the
prudent surgeon will dissect them from
the brim of the pelvis to the point at
which they pass beneath the uterine arter
ies. If renal function is satisfactory,
implantation for incomplete ureteric
obstruction should be delayed until the
results o f gynecologic surgery are
observed. In extreme cases the choice of
surgery is easily understood. But in others
the choice is less obvious. A woman in her
thirties, whose family is complete and

who is suffering disabling menstrual com
plaints and pelvic pain, may wish to retain
her ovarian function. Hysterectomy with
retention o f her ovaries would render her
asymptomatic and may be the operation
of choice. Another enigma of endometri
osis is that so few of these patients require
pelvic surgery at a later date.23
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Technique for Banding Vertical Gastroplasties
The a u th o r describes a n e w tech niq u e
fo r banding vertical gastro p la sties, using
p o ly te tra flu o ro e th y le n e , in 1 7 7 pa tien ts.
This m aterial has several advantages
over M arlex as a re in fo rc in g m aterial. It
is in e rt, has no te n de n cy to m igrate and
c o n n e c tiv e tissue invades its m icropores
holding it in place. P o ly te tra flu o ro e th y l
ene 6 m m in diam eter assum es an oval
c o n fig u ra tio n and w h e n placed around
th e stom a does n o t kink, collapse or
im pinge on the lum en. The leakage rate
w a s o nly 1 % and sto m a l n a rro w in g
o ccurred in only 1 .7 % o f th e patients.
F ollo w -u p film s in d icate th a t sto m a l size
has rem ained stable in th e p a tie n ts fo l
lo w e d up fo r 2 years.
The tech niq u e has m uch to recom 
m end it fro m the p o in ts o f vie w o f sim 
p lic ity , econom y and lack o f co m p lica 
tio n s associated w ith th e g ra ftin g
m aterial.

2 ans ont indique que I'o u v e rtu re du
stom a etait dem euree stable.
Par sa sim p licity, son econom ie et
I'absence de co m p lica tio n s associees au
m ateriel g re ffe , ce tte te ch niq u e vaut
d 'e tre recom m andee.

Our experience at the University o f
Alberta has shown that horizontal gas
troplasty using a reinforced stoma1 is
unsatisfactory for long-term weight loss.
Vertical gastroplasty with a banded stoma
has produced much better early
results.2,3
Mason4 described a technique for ver
tical gastroplasty, using a circular stapler
together with a vertical staple line to form
a lesser curvature pouch o f reasonable
size. A Marlex mesh band has been used
to restrict expansion o f the stoma and
ensure that it stays approximately the
same size as at surgery. The circular

FIG . 1— Staples are removed from 03 and
04 positions o f staple cartridge to leave aper
ture at lesser curvature. Pouch is designed to
incorporate as little greater curvature as pos
sible.

Fig. 2a

Fig. 2b

L 'a u te u r d e c rit une nouvelle te ch niq u e de
baguage des gastroplasties ve rtica le s a
I'aid e de p o ly te tra flu o ro e th yle n e , te c h n i
que q u 'il a utilisee chez 1 7 7 pa tien ts. Ce
m ateriel possede plusieurs avantages sur
la fib re M arlex com m e tis s u de renforcem ent. II e st inerte, ne te n d pas a m igrer
e t le tissu c o n jo n c tif e n v a h it ses m icro 
pores pour le m aintenir en place. Le p o ly 
te tra flu o ro e th y le n e de 6 m m de diam etre
prend une c o n fig u ra tio n ovale et, place
a u to u r du stom a, il ne s 'e n to rtille pas, il
ne s 'a ffa is s e pas e t n 'o b s tru e pas la
lumi&re. On n'a observe que 1% de fu ite
de 1 .7 % de retre cisse m e n t du stom a
chez les patients. Les radiographies de
c o n tro le chez les p a tie n ts ve rifie s apres
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FIG. 2— (a) Segment o f polytetrafluoroethylene is stitched into place as shown using no.
1 Prolene, passing through staple lines, (b) A fte r portion o f graft has been eased snugly into
position, excess nylon is cut just above knot. Segment o f graft 5.5 cm long divides nondistensible cuff that is 6 mm wide.
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doughnut removed from the gastric wall
provides easy access for applying the band
but requires several extra steps in the
procedure and has reportedly been
associated with leaks at the intersection
of circular and vertical staple lines in
4.7% of patients.5
The purpose of this communication is
to describe a simpler technique for stomal
banding that is less expensive, less timeconsuming and is associated with an
extremely small risk of complication.
Procedure
Gastroplasty is performed without
mobilizing the greater curvature and with
the creation of a tunnel beneath the
cardia.
Three staples are removed from the
short row and four from the long row of
the TA90 stapler (United States Surgical
Corp., Stamford, Conn.) magazine at the
end distal to the pin slot. Two applica
tions of the stapler are made to create a
pouch with a capacity of 20 to 25 mL. A
nasogastric tube is passed into the distal
pouch.
Figures 1 and 2 show the technique of
applying a band of polytetrafluoroethylene (PTFE) graft (6 mm in diameter) at
the stoma site. The graft used is 5.5 cm
long. A small amount is lost by setting the
sutures a few millimetres back into the
graft substance.

Results
The banding procedure has been used
in 177 patients. Two (1%) have had leaks
at the staple line or involving the nylon
sutures. In both, the stomas were
debanded, all PTFE and nylon was
removed and the operative site was
drained. They have done well.
Three others (1.7%) had their stomas
debanded because of narrowing, which
caused nausea and emesis. They also have
done well, but the resulting stoma size in
two is undesirably larger and both have
failed to achieve an acceptable weight
loss. The third has maintained a small
stoma despite debanding.
Upper gastrointestinal series performed
on patients at day 60 and at 1 year after
gastroplasty show a mean stoma size of
4.9 mm and 5.6 mm respectively, rang
ing from 3 mm to 8 mm.

it less than ideal. Stomal obstruction of
5% has been reported in one large ser
ies.5 The PTFE, when placed around the
stoma, tends to assume a natural oval
configuration with no tendency to kink,
collapse or impinge on the lumen. Roentgenographic studies indicate that it pro
vides lasting support to stomas, maintain
ing their original size during follow-up.
No patient has died as a result o f leak
age. The only death (0.6%) was due to
pulmonary embolism.
Conclusion
Polytetrafluoroethylene vascular graft,
6 mm in diameter, has proved to be a
good banding material for gastroplasty
stomas, with characteristics in its appli
cation superior to Marlex and other rein
forcing materials.
References

Discussion
Polytetrafluoroethylene vascular grafts
of 6-mm diameter appealed to me as a
banding material following extensive
experience with the material in vascular
surgery. The graft appears basically inert
and has shown little tendency to migrate.
Connective tissue invades its micropores
and keeps it firmly fixed. Marlex, on the
other hand, tends to erode through the
gastric wall and its elastic qualities make
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A c h a l le n g e t o y o u r a n a l y t i c s k i l l s . . .
As a surgeon, you face tests of your ability every
day... but none are more important than the tests
you undertake yourself. The responsibilities placed
in your hands require a lifelong commitment to
continued enhancement of your surgical skills.
Thafs why the American College of Surgeons can
claim more than 65,000 enrollments in the Surgical
Education and Self-Assessment Program (SESAP).
SESAP V the newest in this distinguished series, is the
result of three years' intensive review and research
by 47 nationally-recognized surgical authorities.
Challenging in content and comprehensive in
scope, the flexible SESAP V format provides:
• highly individualized self-assessment, with hun
dreds of probing questions in 17 major surgical
categories
• detailed rationales, including references, for
each preferred answer
• an invaluable preparation for recertification
• a chance to determine confidentially your
standing among other participating colleagues
• 85 hours of Category 1 CME credit
For more information about SESAP V or to enroll,
call or write to the American College of Surgeons.
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The Royal College of Physicians and Surgeons of Canada
Le College Royal des Medecins et Chirurgiens du Canada

Director, Office of Fellowship Affairs
Applications are invited for the position of Director,
Office of Fellowship Affairs, of The Royal College of
Physicians and Surgeons of Canada, situated in
Ottawa.
The post will become vacant in August 1986 on the
retirement of the present Director.
This senior post in the College secretariat was
established in 1976. Reporting to the Executive
Director, the Director of Fellowship Affairs is
responsible for the planning, organization, co
ordination, direction and control of all activities
pertaining to the Office of Fellowship Affairs in order
to achieve the short and long-term objectives of the
College as determined by the Executive Committee and
the Council.
The Director’s main areas of responsibility consist
of: developing and maintaining good relations with the
national specialty societies in areas of mutal interest
such as continuing medical education (CME) and
specialist medical manpower; administering and
developing programs of CME for the Fellows, including
the scientific program of the annual meeting, and the
national and regional CME awards programs; visiting
twice yearly the five regional advisory committees;
acting as the resource person for the standing
committees on Biomedical Ethics, Fellowship Affairs,
Manpower and Maintenance of Competence.
The Director is expected to initiate policies in CME
for the consideration of standing committees and the
Council. These will include methods of identifying the
educational needs of the Fellowship and evaluating the
effectiveness of existing programs. Ele/she will also co
ordinate the College’s maintenance of competence
activities with those of the Canadian medical schools,
national specialty societies, medical associations and
provincial medical licensing authorities.
Employment with the College offers a stimulating
environment and an attractive compensation package.
An applicant must be a Fellow of the College. Fie/she
should have had experience in medical education and be
skilled in management methods. Fluency in both
official languages is an important asset.
Applications with a career resume should be directed
to:
The Executive Director
The Royal College of Physicians and Surgeons
of Canada
74 Stanley Avenue
Ottawa, Canada
K 1M 1P4
before February 28, 1986

Directeur,
Bureau des affaires des Associes
Le College recevra a compter de maintenant les
candidatures au poste de Directeur du Bureau des
affaires des Associes du College Royal des Medecins et
Chirurgiens du Canada, situe a Ottawa.
Le poste deviendra vacant en aout 1986 avec la
retraite du present directeur.
Ce poste de direction au secretariat du College a ete
cree en 1976. Faisant rapport au Directeur general, le
Directeur des affaires des Associes est responsable de la
planification, de l’organisation, de la coordination, de la
direction et du controle de toutes les activites relevant
du Bureau des affaires des Associes, en vue de realiser
les objectifs a court et a long terme du College tels que
definis par le Bureau du College et le Conseil.
Les principales responsabilites du Directeur sont:
l’etablissement et le maintien de bonnes relations avec
les societes nationales de specialistes, dans les domaines
d’jnteret mutuel, comme l’education medicale continue
(EMC) et la main-d’oeuvre medicale specialisee;
l’administration et le developpement de programmes
d’EMC a l’intention des Associes, y compris le
programme scientifique de l’assemblee annuelle et les
programmes de prix et bourses nationaux et regionaux
en EMC; la visite deux fois par annee des cinq comites
consultatifs regionaux; le role de personne
coordonnatrice pour les comites permanents: affaires
des Associes, ethique biomedicale, main-d’oeuvre
medicale et maintien de la competence.
On s’attend a ce que le Directeur propose des
politiques en matiere d’EMC pour etude par les comites
permanents et par le Conseil, politiques qui englobent
les methodes de detection des besoins educatifs des
Associes et de 1’evaluation des programmes existants. II
(elle) coordonne aussi les activites du College reliees au
maintien de la competence avec celles des facultes de
medecine canadiennes, des societes nationales de
specialistes, des associations medicales et des autorites
provinciates habilitees a accorder le droit d’exercice.
Le travail au College offre un environnement
stimulant associe a un ensemble attrayant de benefices
d’appoint. Pour etre candidat a ce poste, il faut etre un
Associe du College, posseder de l’experience en
education medicale et des connaissances etendues en
methodes de gestion. La maitrise des deux langues
officielles est un atout important.
Les candidatures accompagnees d’un resume de
carriere doivent parvenir avant le 28 fevrier 1986 au:
Directeur general
Le College Royal des Medecins et Chirurgiens
du Canada
74, Stanley
Ottawa, Canada
KIM 1P4

ROYAL COLLEGE SYMPOSIUM
Symposium on the Organization of Trauma Care
J. A l e x H a l l e r , j r ., m d , f a c s ; J a m e s B u c k , m d

1. Does a Trauma-Management System Improve Outcome
for Children With Life-Threatening Injuries?
V-
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The authors describe the management
system at their statewide pediatric
trauma centre. The system includes
nonoperative management of liver and
splenic injuries, allowing more aggressive
treatm ent of head injuries. The large
volume of injuries treated, combined
w ith weekly morbidity and mortality con
ferences and the establishment of a
registry that records injury severity
scores, aids the development and evalua
tion of new techniques in pediatric
trauma care.
Les auteurs decrivent le systeme de traitem ent qui prevaut dans leur centre
pediatrique d'Etat pour traumatises. Ce
systeme comprend les soins non operatoires des blessures hepatiques et spleniques. ce qui permet un traitem ent plus
agressif des traumatismes craniens. Le
grand nombre de blessures traitees, des
entretiens hebdomadaires portant sur la
morbidity et la mortality et la mise sur
pied d'un registre permettant de consi
gner une cote de gravite des blessures,
facilitent le developpement et revalua
tion de nouvelles techniques de soins
des traumatismes pediatriques.

I
V

v-

From the Department o f Pediatric Surgery,
Johns Hopkins Hospital, Baltimore, Md.
Presented as part o f a symposium on the
organization o f trauma care at the 53rd
annual meeting o f the Royal College of
Physicians and Surgeons o f Canada by the
Royal College in cooperation with the
Trauma Association o f Canada, the Cana
dian Association o f General Surgeons, the
Canadian Orthopaedic Association and the
Canadian Association o f Plastic Surgeons,
Montreal, PQ, Sept. 11, 1984
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The State of Maryland has a population
of 7 million. During 1982, 267 children
(approximately 5 each week) with lifethreatening injuries were admitted to the
state regional pediatric trauma centre at
the Johns Hopkins Children’s Center in
Baltimore. Of these, 195 (73%) arrived
directly from the injury scene; 47% were
brought by helicopter and 50% by
ambulance. Injuries were caused by
motor vehicle or bicycle accidents (54%),
falls (25%), assaults (9%) and sports and
other injuries (10.5%). In 62% of motor
vehicle accidents, the child was a pedes
trian. Fifty-four percent of injuries were
to a single organ system, 27% involved
two systems and 11% involved three or
more systems. Remarkably, the death rate
of 6.5% was not affected by the num
ber of organ systems involved, but was
directly related to the presence or absence
of head injury. Fourteen of 17 deaths
resulted from cerebrospinal injuries.
Eighty percent of documented liver and
spleen injuries were managed nonoperatively. This plan of management aided the
optimal treatment of head injuries. The
high frequency of head injury has neces
sitated a more aggressive approach to the
management of brain trauma, including
early intracranial monitoring.
Since 1975, more than 1000 children
with life-threatening injuries have been
preferentially transported by helicopter or
city ambulance to our statewide regional
pediatric trauma centre. Initial care at the
scene is provided by emergency medical
technicians with special instruction in the
handling of pediatric trauma.
We have learned that this system allows
excellent stabilization and airway control
at the injury site and initiates rapid radiodirected transport to the trauma centre
where in-hospital m anagem ent is
provided by pediatric and surgical person
nel experienced in the treatment of all
aspects of childhood trauma. We have

organized weekly trauma morbidity and
mortality conferences and have estab
lished a trauma registry that records
injury severity scores.
Between January 1976 and December
1979, 49 children with coma lasting longer
than 24 hours were treated in the pediatric
intensive care unit. The death rate was
still high (38%), but with the use of
intracranial monitoring and aggressive
control of brain edema, 88% of the sur
vivors had a good recovery without major
motor or intellectual deficit.
Pelvic fractures from blunt traum a
were associated with a death rate of 1.4%
in our series of 267 children, the lowest
rate of any reported.
In addition to improved individual
patient management, the large volume of
children’s trauma cases allows us to
develop and evaluate new techniques in
traum a care. This centre also provides
invaluable experience for the training of
general surgical residents, pediatricians
and emergency physicians.
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2. The Comprehensive Burn Unit
A burn unit is only as good as its staff.
Trained, experienced nurses, therapists
and surgeons accustomed to dealing
with large open wounds are a major req
uisite for the care of burned patients, who
have a multisystem disease. Equipment
needs include monitors, hydrotherapy
tank, ready access to the operating room
and comprehensive rehabilitation facili
ties. Skilled anesthesia, consultative sup
port in nephrology, respirology, pedi
atrics and infectious diseases, a blood
bank, access to human allograft and
good microbiology support are neces
sary. Ventilatory support for associated
smoke inhalation injury may be provided
on the unit or in a separate ventilatory
intensive care unit with isolation capabil
ity. In 1982, 29.9 Canadians per 100
0 0 0 were hospitalized for burn care
(approximately 20% to 25% in burn
units). Burn care requires a high staff-topatient ratio and a hospital budget to
support this is mandatory.
La quality d'une unite de soins pour
grand brules depend de la qualite de son
personnel. Des infirmieres, therapeutes
et chirurgiens specialement formes,
experim ents et habitues a traiter de lar
ges plaies ouvertes sont absolument
necessaire aux soins des brules souffrant
d'atteintes plurifonctionnelles. Les equipements necessaires comprennent moniteurs, reservoirs d'hydrotherapie, acces
immediat au bloc operatoire et equipements complets de readaptation. Un ser-

vice d'anesthesie qualifie, la consultation
des services de nephrologie, respirologie,
pediatrie et maladies infectieuses, une
banque de sang, la disponibilite d’allogreffes humaines et un bon soutien
microbiologique sont necessaires. Des
equipements de respiration assistee doivent etre la en cas de lesions dues a
I'inhalation de fumee ou doivent etre
offerts dans une u n it separee de soins
respiratoires intensifs permettant I'isolement du malade. En 1982, 29.9 Canadiens par 100 000 habitants ont e t hos
pitalises pour brulure (environ 20% a 25%
dans des unites pour bruits). Le soin aux
brules exigent un rapport du nombre
d'employes/nombre de patients eleve et
le budget alloug par I'hopital a cette fin
doit 6tre en consequence.

The objectives of treatment of a patient
with a burn injury are resuscitation, resur
facing of the wound and rehabilitation.
To achieve these goals, a skilled, dedi
cated staff, good equipment and a large
operating budget are essential in the com
prehensive burn unit.
In 1982, the most recent year for which
final, complete Canadian statistics are
available, 7255 people (30 per 100 000
population) were hospitalized with a
primary diagnosis of burn, and the mean
hospital stay was 14.2 days per patient
(Table I1-2).
The Burn Unit

The Role o f Medical S ta ff
From the Burn Unit, Vancouver General
Hospital, Vancouver, BC
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Burn physicians must be prepared to
manage both resuscitation and the

wound. Smoke inhalation, with or
without deep flame burns to the face, can
quickly produce upper airway occlusion
(12% of burn patients treated in 1984 at
the Vancouver General Hospital required
intubation and ventilation). Such patients
may be treated in the burn unit, while in
many hospitals, such as the Vancouver
General Hospital, they are treated in a
separate isolated ventilatory intensive care
unit until extubated. This ventilation
phase may last from 5 to 30 days. Plasma
losses must be replaced immediately.
There is continued controversy as to the
volume that should be given, the concen
tration of sodium ion to be used and, in
particular, inclusion or exclusion of albu
min during the first 24 hours after injury.
The end point is monitored in most
patients by measuring hourly urine out
put. Across Canada, plastic surgeons are
actively involved in initial resuscitation of
burned patients, primary wound manage
ment and subsequent reconstruction.
Resuscitation may require consultation
with intensivists, respirologists, cardiol
ogists and nephrologists.
Initially, the wounds are cleansed and
covered with topical antibacterials, with
or without daily dressings. Wound depth
may not be clearly defined for 5 to 7 days.
Debridement of eschar and harvesting
and application of skin grafts require the
skills of the plastic surgeon and enough
surgical assistants to minimize the dura
tion of surgery. The anesthetist manag
ing a burned patient who is undergoing
excision must be skilled in monitoring
seriously ill unstable patients, who require
high-volume blood replacement, and has
the added responsibility of cautioning the

Table 1- Burn Patients Hospitalized in Canada'
Year

No. of
patients

Per 100 000
population

Average
hospital stay, d

19741
19782
19821

11 005
9 355
7 255

47.94
40.94
29.9§

15.5
14.8
14.2

'Northwest Territories and Yukon excluded.
tData for period from Apr. 1, 1982 to Mar. 31, 1983 from provincial ministries of health: personal
communications, 1984.
tBased on 1976 census.
§Based on 1981 census.
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surgeon to slow down or stop when the
assault threatens hemodynamic stability.
Because complications of burn injuries
may affect all body systems, staff from
most specialties must be available for con
sultation. Infection of the wound, respira
tory and urinary tracts and in association
with central lines is, a frequent major
problem, particularly in the long term,
when antibiotic resistant gram-negative
organisms appear. Infection prevention
protocols must be available to provide
uniform guidelines for all hospital staff
who have contact with the patient. The
back-up of a good microbiology labora
tory, infectious disease clinicians and the
capability to measure serum antibiotic
levels and monitor pharmacodynamics is
crucial.
Psychological support will be required
by most patients and should be recog
nized and provided by all personnel. Co
management by rehabilitation physicians
of patients who will require a long period
of musculoskeletal mobilization in a
rehabilitation hospital will speed return
to self-sufficiency.
Role o f Nursing S ta ff
The key to success is the contribution
from all members of the treatment team.
Nurses, who are with the patients cons
tantly, are often the first to identify sub
tle changes in a patient’s condition and
initiate appropriate measures. An effec
tive burn nurse must have the psycholog
ical strength to support and encourage the
patient, recognize pain, and to appreci
ate pain-producing wound procedures and
respond by administering an analgesic
and waiting for it to take effect. The nurse
must practise sterile technique, recognize
and remove devitalized tissue while bath
ing the patient and apply topical antibac
terial dressings. In some burn units nurses
are permitted to apply banked skin grafts
and manage their after care. Drug
administration and a working knowledge
of expected or abnormal responses to
drugs are necessary. A balance between
doing what is required and encouraging
the patient in self-care is important. In
addition to relieving patient boredom and
anxiety, nurses must be prepared to
absorb verbal abuse from a patient under
going profound psychological and phys
ical distress. The 12-hour shift, which is
common in many burn units, is taxing,
especially mentally, and this must be
appreciated by administrators. Without
good nursing the most sophisticated
equipment and facility are useless.
Physiotherapist
The physiotherapist must initiate active
and passive exercises early to maintain

mobility of joints and to prevent deform
ity. At the same time, therapy for the
respiratory tract must be instituted. Be
cause immobilization is required during
grafting, standing and walking are dif
ficult stages in the rehabilitation of
burned patients who have spent weeks or
months in bed. The more intensive the
physiotherapy from the start, the shorter
and more successful will be the rehabilita
tion.
Occupational Therapist
Splints are fashioned immediately to
prevent flexion contracture of hands,
ankles, elbows and knees. With the open
grafting method, custom-made splints
that maintain optimal joint position,
expose grafts yet protect them from con
tact with bedclothes demand ingenuity
and resourcefulness from the occupa
tional therapist. Compression o f healed,
deep, partial-thickness burns and grafts
decreases the ultimate thickness of scar
tissue, facilitates movement and improves
the cosmetic appearance. Custom-fit elas
tic garments allow all regions, particularly
the face and the hands, to be effectively
compressed and are worn constantly for
1 year following burn. Occupational ther
apists fit and adjust these garments which
are commercially available. Although
costly, they are invaluable for successful
rehabilitation and should be available to
all patients in whom partial-thickness
re-epithelialization of the wound is not
complete within 21 days of injury (14 days
for children, and oriental and black pa
tients) and for all grafted areas. Customfashioned transparent face masks and
conforming neck collars and aids to facili
tate eating and personal hygiene are addi
tional skills of the occupational therapist.
In addition, the therapist may organize
activities to relieve patient boredom.
Dietician
Nutritional support is vital to counter
balance the hypermetabolic state initiated
by burns on a neuroendocrine basis, to
provide protein necessary for wound heal
ing and to permit antibody formation.
The dietician will perform calorie counts
and customize diets, including the selec
tion of enteral and elemental diets. Total
parenteral nutrition may ultimately be
required for malabsorption.
Social Worker
A key member of the team, the social
worker must be aware of the steps taken
in treatment and rehabilitation and be
able to establish what becomes a long
term, close relationship with the patient
and family. Liaison with the W orkers’

Compensation Board and community
support services must be established. The
appropriate placement of patients who
cannot be discharged home may be a
difficult and time-consuming process.
Space and Equipment
Bath.— Cleansing of the affected area
is a most important aspect of burn care.
For submersion, a Hubbard tank or a rec
tangular tank that allows easy access to
the patient should be available. A plat
form and hoist are necessary to transfer
the patient and a patient mobilizer can
facilitate transport. For the patient for
whom submersion is not practical, a
stretcher modified to permit showering
and water drainage is available. Patients
can remain hooked up to monitors, and
ventilators and intravenous lines are less
likely to be disconnected. For upper limb
burns, the hand whirlpool permits cleans
ing and exercise.
Treatment room .—A treatment room
for initial assessment and stabilization of
the patient, for applying dressings and for
minor procedures, is invaluable. In both
the bath and treatment rooms, operatingroom standards of sterile technique
should be observed and temperature con
trolled.
Patient ro o m .—W here possible,
patients should be housed in large rooms
to accommodate equipment and permit
positioning of limbs and easy access to all
parts of the patient. The reverse isolation
technique requires a scrub sink, space for
sterile gowns, a pass-through for supplies
and shelves to stock dressings. Provision
to package and dispose of contaminated
materials within the room is important
and a toilet or liquid waste disposal unit
is advantageous. Two-way communica
tion to the central nursing station permits
supplies and assistance to be called for
without leaving the patient. The patient
must be kept warm to decrease heat loss
which will contribute to the hypermeta
bolic state. Overhead radiant heaters per
mit the area above the patient to be
warmed without making the rest o f the
room uncomfortable for the nursing
staff.
Operating room .—Burn care may call
for frequent operative procedures. If the
central suite is close and a flexible sched
ule possible, the burn unit can function
without an operating room of its own.
Ideally, surgery should be scheduled early
in the day, rather than at the end as is
often practised. A burn unit operating
room should be large since a dual instru
ment system, one for debridement and the
other for harvesting, preparation and
packaging of autograft skin, is necessary.
In the operating room, burned patients
may have 50% of their body surface
exposed, necessitating precise monitoring
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of core temperature; the increase in
ambient temperature caused by heating
lamps often creates an uncomfortable
environment for operating-room per
sonnel.
A dditional space.—If possible, a
designated splint workshop, exercise
room, office and staff lounge should be
included within the confines of the unit.
Hospital Support Services
The hospital with a burn unit requires
efficient 24-hour laboratory support. For
the management of large full-thickness
burns, banked allograft skin is a real
asset. Allograft banking is expensive but
permits the surgeon to excise large areas
of eschar early, removing the main source
of infection and improving the patient’s
chance of survival. If a homograft bank
is not possible, ad hoc access to cadaver
skin or funds to acquire pig skin, availa
ble in most locations within 24 hours of
ordering or the new off-the-shelf synthetic
Silastic-collagen tem porary wound
covers, are necessary.

was recognized and funded as the provin
cial referral centre starting in 1975. Table
III indicates that between 1974 and 1978
admissions to the unit increased dramat
ically, the majority being from the city of
Vancouver, with a lesser increase of seri
ous burns referred from the rest of the
province. Between 1978 and 1982 the
number of hospitalized patients with
burns decreased from all referral areas.
This decrease was likely due to less
activity in the work place and better pub
lic awareness of potential hazards.
However, alcohol abuse continues to be
a contributing factor in 15% of patients
admitted, with fires related to cigarettes
in 7% and mishandling of gasoline and
propane in 8%. Between 1978 and 1982
at the Vancouver General Hospital, our
mean stay per patient also decreased. This
reflects earlier excision of the burn wound
combined with the use of autograft
expansion procedures gaining greater
coverage per grafting procedure. At the
same time those with burns of lesser
extent may be managed as outpatients
and admitted after areas requiring skin
grafting have been defined.

Facilities in Canada
Costs
At present, it is estimated that annu
ally approximately 30 Canadians per 100
000 population, with a historically wide
provincial variation, will be hospitalized
for burn care (Table II2,3). In British
Columbia in 1982, 16% of such patients
were admitted to the burn unit at the Van
couver General Hospital, which is the
main provincial referral centre. The
criteria for admission vary. Generally,
patients with burns to more than 15% of
the total body surface, those with a full
thickness burn to more than 10% of the
body surface or full-thickness burns of
the hands or face, feet or perineum will
benefit from management in the burn
unit. However, lesser burns can tax the
facilities and personnel available in a
smaller or less-specialized hospital, so
burn units must be prepared to accept
these patients too. Since the number of
patients fluctuates widely without respect
to season, a few empty beds are always
necessary.
From 19741 to 1982 (provincial minis
tries of health: personal communications,
1984), there was a progressive decrease in
the number of hospitalized burn patients
per unit population (Table I). Province
to province there was wide variation per
100 000 population, likely reflecting a
difference in coding and reporting of dis
ease (Table II). Each province employed
its own system of coding in both 19782
and 1982 (provincial ministries of health:
personal communications, 1984). Except
for Nova Scotia, each province reported
a drop in numbers hospitalized in 1982
compared with 1978 (Table II2’3). The
Vancouver General Hospital burn unit
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Burn care is expensive because it'is

labour intensive. The Vancouver General
Hospital budget for burn-nursing person
nel was approximately $1 300 000 in the
fiscal year ending Mar. 31, 1984. There
were 173 hospital beds dedicated to burn
care in Canada in 1984,3 a year in which
five new burn units upgrading existing
burn-care facilities opened across the
country. As well, provincial government
funding has been augmented by funds
raised by many philanthropic groups,
firefighters in particular, enabling units
to purchase new equipment and upgrade
the skills and education of nursing and
medical members of the treatment team.
The Future
Public education of fire hazards (espe
cially children’s sleepwear and household
and institutional hot-water tap tempera
tures) must be increased and research
encouraged. Tissue culture techniques
that permit growth of the patient’s own
epidermal cells, thus allowing coverage of
much larger areas than presently possible
with autograft expansion, are showing
promise. Since early staged excision of the
burn wound when necessary removes the
major source of infection, development
of synthetic cover for excised wounds

Table II—Comparison of Patients With Burns Hospitalized in 1978 and 1982, ay Province
1978

1982

No. of
patients2

Patients/
100 000*

No. of
patientst

Patients/
100 0004

British Columbia
Alberta
Saskatchewan
Manitoba
Ontario
Quebec
New Brunswick
Prince Edward Island
Nova Scotia
Newfoundland

1 345
1 460
788
537
2 838
1 263
357
85
383
299

54.5
79.4
85.5
52.6
34.3
20.3
52.7
71.9
40.8
53.6

1 134
1 180
523
424
2 085
973
279
44
361
252

41.4
52.7
53.9
41.2
24.2
15.1
40.1
35.9
42.5
44.2

Totals

9 355

40.9

7 255

29.9

Province

1985
No. of
burn beds3
19
13
9
11
62
41
11
0
7
0
173

‘ Based on 1976 census.
t Provincial ministries of health: personal communications, 1984.
t Based on 1981 census.

Table Ill-Patients With Burns Hospitalized in British Columbia
Referred to Vancouver General Hospital from
All
British Columbia
City of
Remainder of
Remainder of
Total
Patients/population
hospitals
Vancouver lower mainland British Columbia province
Patients
1974
1478
56
22
32
110
1978
1378
108
39
54
201
1982
1134
97
31
52
180
100 000 population/region
1974*
59.9
13.5
3.3
2.4
4.5
54.7
1978*
26.0
5.8
3.9
8.2
19824
41.4
23.2
4.1
3.3
6.6
‘ Based on 1976 census,
t Based on 1981 census.
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would supplement homograft skin and
improve the chance of survival for victims
of extensive burns. Disaster planning
must be organized on an interprovincial
basis. It is unlikely that a burn unit can
afford to keep sufficient beds and trained
staff on hand for disasters resulting in

large numbers of burn-injury victims.
Therefore, a mechanism to distribute
large numbers of patients presenting
simultaneously for burn care amongst a
number of burn units must be in place.
A large number of fresh burns can over
tax even the best organized unit.
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3. Research in Trauma
Successful research in clinical trauma
requires the researcher to be exposed to
many injured patients, have a personal
commitment to research conducted at
inconvenient hours and be inquisitive so
as to identify clinical problems that need
scientific answers. Once initiated, a
research project necessitates the collec
tion and storage of clinical data on a
weekly basis before patient discharge. A
computer data program facilitates later
retrieval and statistical analysis. Depart
mental support of the clinical investigator
is mandatory. Although the personal
commitments for producing first-rate cli
nical research may seem excessive, the
rewards are commensurate.
Le succes de la recherche clinique chez
les traumatises suppose que le chercheur
doit etre expose d un grand nombre de
blesses, qu'il prend engagement person
nel dans sa recherche, meme si elle doit
etre menee a des heures indues, et qu'il
developpe la curiosite d'identifier les problemes cliniques qui necessitent des
reponses scientifiques. Une fois com
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mence, un projet de recherche necessite
la cueillette hebdomadaire et la mise en
reserve des donnees cliniques jusqu'au
conge du patient. Un programme informatique permet la recuperation et
I'analyse statistique ult6rieures des don
nees. II est obligatoire que le chercheur
puisse compter sur le soutien des servi
ces hospitaliers. Meme si I'engagement
personnel du chercheur envers une
recherche clinique de premiere qualite
peut paraitre excessif, la satisfaction
qu'il en tire est de meme mesure.

Research into trauma may be divided into
several categories. Since most physicians
do not have the opportunity to treat large
numbers of severely injured patients,
most ongoing studies are performed in the
experimental laboratory. Such studies can
be performed under controlled conditions
using a well-established research model
between the hours of 08:00 and 16:00.
The major impediments to good results
are lack of imagination and money.
Research on the injured patient presents
many challenges. First, the investigator
must be exposed to a large number of
severely injured patients and possess a
personal commitment to and expertise in
the care of these patients. Such involve
ment highlights the questions th at need
answering and precludes feeble attempts
at implementing a project that cannot be
incorporated into the patient-care regi
men. Next, a well-thought out system of
study or protocol needs to be developed.
Specific questions should be addressed
and the answers to those questions
provided as part of the patient-care sys
tem. Since the timing of injury is irregu
lar, post-resuscitation collection of data
must often take place at weekends or in
the evening. Although most of the data

can easily be collected as part of the
patient’s routine hospital record, special
studies related to specific organ function
may have to be obtained as part of a non
hospital system of clinical research. Such
studies might include special immunology
tests, or others not performed in the
hospital laboratory. They require outside
funding with most of the money allocated
to the individual performing such tests,
which likewise must be incorporated into
a system that implements these studies
independent of time of day or day of
the week. Finally, the prospective data
must be tabulated weekly and the data
from each patient must be incorporated
into the research record by the time the
patient is discharged from hospital. This
facilitates proper correlation between data
and the clinical record and allows the
investigator to recognize errors that
should not be incorporated into the final
investigation record.
The prospectively collected data should
be coded for computer storage, retrieval
and scientific analysis. This modality for
data handling is now available, at little
expense, to all investigators. The major
impediment to implementing such a data
system revolves around the investigator’s
commitment of time to develop such a
system. Once implemented, data storage
and data “ proof-reading” are the respon
sibility of the senior investigators. Sys
tems of data control for accuracy are well
established and again require only a per
sonal commitment for implementation.
This type of prospective clinical
research requires commitment, imagina
tion, desire and sacrifice. Clearly, the
rewards must be commensurate. When a
senior “ hands-off” investigator attempts
to “ rape” the data bank of the more
junior, but more committed, investigator,
the system will fail and the output will be
worthless.
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4. Accident-Injury Organization: Canadian Overview
Trauma from motor vehicle accidents is
a major health-care problem, resulting in
enormous economic losses to the coun
try, and is second only to heart disease
as a reason for hospitalization in Canada.
Funding for research and accident-injury
programs is critically low.
National and provincial trauma regis
tries must be developed to provide data
that can be used appropriately to plan
and monitor the strategy of accident
health-care and prevention programs.
Manitoba, which has in place a trauma
registry, has a province-wide trauma sys
tem comprising two comprehensive
trauma units and seven regional centres
located strategically in the catchment
areas of the major centres. A comparison
of the performance of this system with
that of hospitals in Baltimore has shown
that the Manitoba system provides an
equal level of care. The author recom
mends that a trauma system be estab
lished in regions of one to two million
population. Each region should have one
to three comprehensive trauma services
and a number of regional trauma serv
ices, each strategically located.
With appropriate funding for trauma
care, the proposed system would pay for
itself.
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Les traumatismes subis lors d'accidents
de la route repr6sentent un probleme
majeur de soins de sant£; ils resultent en
des pertes economiques importantes
pour le pays et ils viennent au second
rang derri&re les maladies cardiaques
comme cause d'hospitalisation au
Canada. Neanmoins les subventions £ la
recherche et aux programmes de soins
aux victimes d'accidents sont critiquement bas.
On doit etablir des listes nationale et
provinciates des traumatismes subis lors
d'accidents afin d'accumuler les donnees
qui permettront de planifier et de surveiller la strat£gie des soins aux victimes
d'accidents et celle des programmes de
prevention. Le Manitoba qui a une telle
liste, possede un systeme de soins posttraumatiques comprenant deux unites de
soins complets pour traumatises et sept
centres regionaux situes strategiquement
dans la circonscription des grands cen
tres. Comparativement au systeme qui
pr6vaut dans les hopitaux de Baltimore,
on peut dire que le systeme manitobain
offre un niveau de soins satisfaisant.
L'auteur recommande qu'un service de
soins pour traumatises soit etabli dans
chaque grand hopital et qu'une unite
regionale soit mise sur pied dans chaque
region comptant de un a deux millions de
population.
Avec les fonds appropries, le systeme
propose serait rentable.

Rushing the accident victim to the nearest
hospital and then finding a doctor is no
longer an acceptable way to manage a
traum atized patient. Modern data
processing, communications, transport,
and sophisticated pre- and inhospital
medical care should be coordinated to
provide a high standard of health care for
such victims. An accident-injury program
should be directed provincially and coor
dinated nationally.
The rate o f accident injuries has been
kept under reasonable control through the
efforts of government agencies, but the
greater numbers of motor vehicles and the
expansion of heavy industry have resulted

in a large increase in the total number of
fatalities and injured and disabled persons
over the past 30 years. Also the escalat
ing hospital costs, welfare and property
loss have seriously drained the Canadian
economy. To ease this burden, govern
ment and foundation funding should sup
port the development of a national
trauma program.
The Canadian Picture
The total years of life lost annually
through motor vehicle accidents is greater
than the total of all cardiac and respira
tory deaths.1 Lawson in 1977 estimated
Canada’s yearly economic loss from acci
dents to be $2.5 to $4 billion.2 In 1984
these losses may well double that figure.
Motor vehicle accidents account for 30%
to 40% of the total accident deaths in
Canada annually. The risk of accident to
the Canadian driver is 20% greater than
that to the US driver and 50% greater by
miles driven. Less than 1% of the
research dollar goes to trauma research
and organization of a health-care pro
gram for accident injury (Gordon J,
Gutelius JR: Unpublished data, 1975).
Between 1960 and 1975, the numbers
of motor vehicle drivers and passengers
injured increased 300% and 250% respec
tively (Fig. 1), while the incidence of
motorcycle accident injury increased
almost 1000%.3 The relatively small
increase in pedestrians injured attests to
effective countermeasures. However,
these 20 000 victims are among the most
severely injured and sustain the most
severe ongoing disability as a group.
The Traffic Injury Research Founda
tion of Canada studied blood alcohol
levels of victims in 1647 fatal traffic acci
dents in 1976 (Table I).3 Impairment
levels (more than 17 mmol/L) of blood
alcohol were found in 25% to 52% of vic
tims in the categories examined. These
figures are particularly important because
frequently innocent people in another
vehicle are involved in the accident.
The incidence of traffic accident deaths
and injuries for 1977 is compared by
province in Fig. 2.3 It is notable that the
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number injured (i.e., anyone showing any
evidence of injury or complaining of pain)
is about 40 times the number of deaths.
While Ontario and Manitoba had among

the lowest fatality rates, their injury rates
were among the highest. The development
of accident-injury programs in Ontario
and Manitoba may have contributed to
these favourable statistics.
Developing Organization for Trauma
Care and Prevention in Canada
Trauma Registries

FIG. 1—Drivers, passengers, pedestrians
and cyclists injured between I960 and 1975
(source: Statistics Canada).

The registry system is being studied at
seven hospitals across Canada. Trauma
registries that include injury severity
scoring4’5 in addition to detailed records
of all fatalities and injuries for patients
admitted to hospital indicate clear priori
ties for research and strategy when
developing prehospital and inhospital
accident health-care programs. The
present incomplete estimates of the
impact of trauma on the Canadian econ
omy could be more accurately estimated.
Improved health-care programs for the
injured and appropriate preventive meas
ures would result in substantial savings
not to mention reduced suffering.

Table I—Blood Alcohol Content Among Fatally Injured Drivers
by Vehicle Type, Seven Province* Aggregates, Canada, 1976
Blood alcohol level
(minimum % of victims)
Drivers of
Automobiles
Trucks/vans
Motorcycles
Tractor trailers
Snowmobiles

accidents

Positive!

Im paired!

1 119
291
153
32
52

47
49
40
25
60

38
42
29
25
52

‘ Prince Edward Island, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta and British Columbia,
> 2 mmol/L.
1 > 17 mmollL.
Source: Traffic Injury Research Foundation of Canada, Analysis of Fatal Traffic Crashes 1 9 7 6.
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P erso n s Killed,
R a te p e r 1 0 0 0 0 0
1977

P e rs o n s Injured,
R a te p e r 1 0 0 0 0 0 P o p u la tio n ,
1977

Population,

Canada

The data obtained from traum a regis
tries could be used to strengthen epidemi
ologic, research and treatment programs,
to assess priorities in different geographic
regions, to develop appropriate prehospi
tal health care, to define the strategy,
location and type of ambulance services
required in each region and to decide on
the type of ambulance service to be used
regionally.
The Manitoba trauma registry.—Our
registry, the only one in Canada at
present, was developed using the
ICD.9.CM6 Manitoba Health Services
Commission discharge data, which lists
all injuries, complications, procedures
and associated diseases for each victim
admitted to hospital.
The initial data is scored, assigning a
specific abbreviated injury score (AIS) to
each injury.5 A computer algorithm was
developed to assign this AIS scale as a
score to single injuries, 1 and 2 being
minor injuries and scores of 3, 4 and 5
indicating life-threatening injuries. In the
patient with multiple injuries the injury
severity score (ISS)4 is automatically
scored by a computer program. Scores be
low 15 are considered minor injuries and
those above as life-threatening injuries.
The AIS/80 scoring of injuries5 was
modified to reflect more accurately the
threat to life. The scoring table and the
computer algorithm were forwarded to
Professor E. MacKenzie, Johns Hopkins
University and seven traum a centres
across Canada for further development
and study. Every effort should be made
to maintain a uniform national scoring
system.
Prehospital Services in Canada
A Manitoba study (Fig. 3) o f 364 pre
hospital deaths for 1980, 1981 and 1982
indicates that 15% of the victims had
minor-injury severity scores. Detailed
study is needed to establish why victims
with such low scores died during the pre
hospital period and to determine methods
of prevention.

Newfoundland
Prince Edward
Island
Nova Scotia
New Brunswick
Quebec
Ontario
Manitoba
Saskatchewan
Alberta
British Columbia
Yukon
Northwest
T erritories

FIG. 2—Incidence of traffic deaths and injuries by province for 1977.

FIG. 3—Prehospital deaths in Manitoba for
1980, 1981, 1982. White bars = those with
minor-injury severity score (ISS less than 15),
dotted bars = those with life-threatening injury
severity score (ISS more than 15).
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Prehospital services in Canada are at
varying stages of development. Ontario,
Manitoba, Saskatchewan and British
Columbia provide provincial funding for
ambulance services and programs for
training ambulance attendants to the
levels of emergency medical attendant
(EMA) I and II. Paramedic programs
(EMA III level) have been developed in
Vancouver and 12 centres in Alberta.
Saskatchewan, Manitoba and Ontario are
initiating training at this level. These pro
grams are of great value in treating acute
medical emergencies, in cases where
extraction of the victim from a motor
vehicle is prolonged and when delivery
time to the hospital is extended. Rural
areas would benefit most from such serv
ices. Unfortunately, there are no largeregion dispatching centres anywhere in
Canada at present. The German system
of regional dispatch should be studied for
adoption in Canada.
Ontario has in place, through its com
munity college system, an educational
program for the training of emergency
medical attendants in its ambulance serv
ices. This is the first province-wide pro
gram in Canada. Except for Montreal,
Quebec and the eastern provinces have
accomplished little in the development of
a coordinated prehospital-care system.
There, a physician is assigned to certain
high-risk ambulance runs. This system
may provide interesting data for compar
ison with the EMA programs; it may
prove to be more effective and cost effi
cient. A trauma registry, using a standard
national scoring system, would allow for
valuable comparative studies between
centres using differing prehospital
systems.
The development of the emergency
physician specialty and the advanced
trauma life support (ATLS) course has
upgraded the potential standard of injury
care in the first hour after injury. Unfor
tunately, the services resulting from these
developments are usually found only in
large urban centres. Regional trauma
units, strategically located, using data
from registry studies, would provide
appropriate resources for rural regions.
Air-ambulance systems exist in almost
every province and have provided a valu
able resource for the transport of trauma
victims long distances to sophisticated
trauma centres. These, however, are not
well coordinated and seldom carry
appropriately trained medical attendants.
Air-ambulance services are provided
almost entirely by fixed-wing aircraft,
which, in Canada, are probably the most
appropriate. Capital cost, maintenance,
available crew and distances in Canada
are factors that strongly support develop
ment of fixed-wing ambulance services
first. Specific regions, isolated from fixedwing evacuation where a high risk of acci
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dent injury has been demonstrated, might
be considered for helicopter services.
In northern Canada are now almost
250 000 people who are exposed to an
increasing incidence of accident injury
associated with heavy industry (oil explo
ration, lumbering, mining). Army rescue
units, which are available at four levels
of expertise and response in a number of
regions, could be strategically located to
provide rapid triage and evacuation of the
injured to appropriate centres in the
south. Regional trauma centres in White
horse, Yellowknife and northern Quebec
might provide such services using army
paramedical attendants. The armed serv
ices personnel would derive practical
experience and the population a valuable
service at no extra expense.
Trauma Centres
In 1977, the trauma committee of the
Canadian Association of General Sur
geons and now the Trauma Association
of Canada designated 21 comprehensivecare centres. In addition, it is proposed

that regional trauma centres, having on
staff at least one surgeon experienced in
trauma care, be developed in each of the
catchment areas of the major centres. At
present, Manitoba is the only province
that has this system in place.
The trauma system was developed by
the medical profession not by legislation.
It has had no deleterious impact on the
health-care system as it was developed
during a phase when regionalization was
taking place.
The Manitoba system.—In Manitoba
the trauma hospital system includes two
comprehensive trauma units, both in
Winnipeg, and seven regional trauma
units across the province. Of patients with
life-threatening injuries, 55% are admit
ted initially to a trauma-unit hospital,
suggesting the appropriate strategic loca
tion of these hospitals across the
province. Of the patients with lifethreatening injuries who are not initially
admitted to the Trauma-unit hospitals,
75% are referred into the system within
the first 48 hours after injury. Obviously
not all life-threatening injuries need be
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U G . 4—Initial admission of patients with multiple or life-threatening injuries (ISS more
than 15). Comprehensive trauma unit A, which includes trauma service, treats majority of such
patients. CTU = comprehensive trauma unit, RTU = regional trauma unit, WPG = Winni
peg, MAN = Manitoba.

Tab le II— Comparison of Com prehensive T rau m a Units A and B by Survival
Probability to Discharge and According to Injury S everity Score
Injury
severity
score
1 1 -2 0
2 1 -3 0
3 1 -4 0
4 1 -5 0
> 50

Unit A

Unit B

No. patients
(deaths)

Survival
probability

No. patients
(deaths)

Survival
probability

1 1 7 (1 )
8 9 (1 8 )
2 0 (8)
2 0 (1 3 )
9 (6 )

0 .9 9 2
0 .7 9 8
0 .6 0 0
0 .3 5 0
0 .3 3 4

4 8 (0)
2 8 (7)
9 (5 )
2 (2 )
0

1 .0 0 0
0 .7 5 0
0 .4 5 5
0 .0 0 0
0 .0 0 0
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treated in a trauma-unit hospital; some
can be successfully and well treated out
side the system. However, those victims
suffering multiple injuries and almost
100% of those suffering head injury of
life-threatening severity (ISS more than
15) are immediately transferred to the
trauma-unit system (Fig. 4).
Of the two comprehensive trauma units
in Winnipeg, unit A has a special trauma
service, while unit B does not. Compari
son of survival probability at the two
units shows that in each injury severity
category except ISS 11 to 20, the proba
bility of survival was higher in unit A
(Table II). This observation suggests that
it is important to have initial triage and
total trauma health care coordinated by
a team of trauma surgeons from the time
of admission throughout the critical
phase. Such a resource probably should
be available for every 1 to 2 million popu
lation group across the country.
While the statistical significance of
these figures may be questionable, the
actual numbers speak for themselves.
Numerous variables not included in
statistical analyses are controlled in a
large registry experience.
A comparison of the performance of
the Manitoba trauma health-care system
with that reported from six sophisticated
hospitals in Baltimore (Fig. 5) shows that
in both 0 to 49- and 50 to 69-year age

groups, the survival probability in
Manitoba was equal to or greater than
that in Baltimore as measured by the
LD50 (50% mortality point). Only in the
over 70-year age group did Baltimore rate
better than Manitoba. It is possible that
the smaller number of cases in this
category in Baltimore skewed the results.
Given the limitations of this gross meas
urement of standard of care, one might
conclude that the trauma-system program
in Manitoba is providing a satisfactory
level of care. If trauma registries, using
identical scoring systems, were available
in other provinces, comparisons could be
made. Since the Manitoba fatality rate by
miles driven and by number of vehicles
registered is the lowest in the country and
the injury rate is among the highest, a fac-

tor producing this result could be the
provincial trauma program.
Funding
Trunkey7 demonstrated the mismatch
of years of life lost and the level of fund
ing in the United States for three
categories of disease (Fig. 6).
Trauma is concentrated in the under
39-year age group (our greatest natural
resource with the longest life expectancy).
Because of this, the costs of disability and
the loss of productivity are ongoing and
cumulative. This results in a great eco
nomic drain on the country. In fact, the
discrepancy clearly demonstrates the
inappropriate level of support given by
governments and research foundations to
develop health care for what is the major
pandemic affecting North American
society.
In Canada, the level of funding for
trauma care is likely to be much lower
than that in the US even though the risk
to the Canadian population as drivers of
motor vehicles is much higher than that
in the US. If we corrected this discrepancy
and did nothing more, the proposed
trauma health-care system would pay for
itself.
Conclusions
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Provincial traum a registries and a
national trauma registry should be deve
loped to provide the uniform data on
which to build a health-care system based
on logical strategy and health-care priori
ties. Epidemiologic, basic and clinical
research programs should be developed
to monitor the performance of the acci
dent program and indicate where
improvement in strategy and health care
is needed.
Trauma services in comprehensive
trauma units and a regional traum a unit
should be developed in each area of 1 to
2 million population density.
Federal, provincial and research foun
dation funding priorities should be re
examined and allocated where the grow
ing need is great. We cannot ignore the
projection made by Campbell and Lawson8 that in the next 10 years there will be
64 000 lives lost and 3 000 000 injuries
suffered in Canada.
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FIG. 5—Comparison of performance (prob
ability of survival) of trauma patients in
Manitoba system and that of similar patients
in six Baltimore hospitals. 1.050 (50% mor
tality point) was used as measure o f perfor
mance. Patients dead on arrival at hospital
were excluded. Dotted lines connect points
based on fewer than 10 cases. Circles = 0 to
49 years, triangles = 50 to 69 years, squares
= 70 years and older.
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FIG. 6—Mismatch of years of life lost and
funding for trauma in United States (after
Trunkey DD7).
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5. The German Model for Rescue of Traumatized Patients
Accidents and their sequelae are the
main cause of death in Germany among
people under 40 years of age. The cost
in disability payments and lost work
averages $40 000 per injury. The author
describes the German system for trauma
rescue.
The aims of rescue care in Germany
are to reduce the interval between injury
and hospital admission and to bring the
patient to the right hospital, bypassing
smaller hospitals if necessary.
Ambulance rescue systems are of two
types: the stationary, in which the physi
cian travels with the ambulance, and the
rendezvous, in which the physician and
ambulance, travelling separately, meet at
the accident site. A t the beginning of the
1970s the air-rescue system was started
and now comprises 32 stations and 25
BO-105 helicopters.
The Hannover experience shows that
of the initial diagnoses made at the acci
dent site by helicopter rescue service,
51.9% of victims had head injuries,
35.5% fractures of extremities, 17.0%
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thoracic trauma, 10.2% abdominal
trauma and 7.6% spinal fractures.
Because of respiratory insufficiency or
unconsciousness with danger of aspira
tion, 12.0% of the patients had to be
intubated endotracheally. One hundred
and twenty-two patients with a clinical
diagnosis of death were successfully
resuscitated at the accident scene. A
study comparing the efficiency of the
helicopter and ambulance systems
showed that as the severity of the inju
ries increases, the death rate is greater
in the group rescued by ambulance. Of
22 accidents involving rescue helicop
ters, 7 (32%) resulted in at least one
death. Between 1973 and 1983, 16
doctors, pilots or attendants were killed.

En Allemagne. les accidents et leurs
sequelles sont les principales causes de
deces chez les moins de 40 ans. Les
couts en paiements pour incapacity et en
perte de travail atteignent en moyenne
40 000$ par blessure. L'auteur decrit le
systeme allemand de sauvetage des trau
matises.
Les buts des operations de sauvetage
en Allemagne sont de reduire I'intervalle
ecoule entre la blessure et I'arrivee a
I'hopital, et de diriger le patient vers
I'hopital le plus appropriy meme s'il faut,
chemin faisant, ignorer de plus petits
hdpitaux quand cela s'avere necessaire.
Les systemes de sauvetage ambulancier
sont de deux types: stationnaire, alors
que le medecin voyage avec I’ambulance; de rendez-vous, quand le medecin
et I'ambulance, voyageant separement,
convergent vers le lieu de I'accident. Au
debut des annees 70, un systeme de
sauvetage par air a ete mis sur pied; il
comprend maintenant 32 stations et 25
helicopteres BO-105.

L'experience de Hannovre demontre
que lors du diagnostic initial fait sur les
lieux de I'accident par les services de
sauvetage par helicoptere, 51.9% des
victimes souffraient de traumatismes craniens, 35.5% de fractures des extremites, 17.0% de traumatismes thoraciques, 10.2% de traumatismes
abdominaux et 7.6% de fractures spinales. A cause d'insuffisance respiratoire
ou de perte de conscience avec danger
d'aspiration, 12.0% des patients ont du
etre intube par voie endotracheale. Cent
vingt-deux patients consideres cliniquement comme morts ont pu etre reanimes
au lieu de I'accident. Une etude comparant I'efficacite des syst$mes par ambu
lance et par h$licopt$re a montr$
qu'avec ('augmentation de la gravity des
blessures, la mortality etait plus grande
dans le groupe secouru par ambulance.
Dans 22 accidents impliquant des heli
copteres de sauvetage, 7 (32%) ont
enframe au moins une mortality. Entre
1973 et 1983, 16 medecins, pilotes ou
infirmiers ont ete tu$s.

In Germany, motor vehicle accidents and
their sequelae are the main cause of death
among people under 40 years o f age. The
death toll from trauma in 1983 in the
country was 50 000, of which 11 747 were
from traffic accidents. Injuries in that
year totalled 500 691. The cost of these
injuries in lost work and disability is
alarming, amounting to an average of
$40 000 per injury.
There is statistical evidence of a corre
lation between the time o f the accident,
the start o f treatment and the outcome;
that is, the shorter the rescue time, the
better are the results (Figs. 1 and 2). What
can we do to optimize the management
o f acute injuries?

VO LU M E 28, NO. 6, N O V E M B E R 1985 / THE CANADIAN JOURNAL OF SURGERY

Aims of Rescue Care

In Germany our aims in the care of the
severely injured patient are as follows:

lance is sent to the scene of the accident.
This is an excellent system and a good
way to provide early medical help.
Rescue Helicopter Service

• Reduce the rescue interval; that is,
start treatment early at the scene of the
accident.
• Bring the patient to the right hospi
tal, bypassing smaller hospitals not
properly equipped to handle severe
trauma.
• Shorten the transportation time.
Rescue Systems in Germany

Our emergency ambulance service was
begun about 20 years ago. It brings the
doctor to the scene of the accident so that
he can start resuscitation immediately.
The service comprises two systems — the
stationary and the rendezvous.
In the stationary system, an ambulance
is situated near the hospital and is dis
patched by the rescue control centre to
accidents within a radius of 8 km. The
obvious disadvantage of this system is
that it takes too long to arrive at the scene
of an accident any distance from the
hospital.
The rendezvous system is used mostly
in rural districts or in towns that have
only one emergency vehicle. A doctor on
call is delivered to the scene by a specially
equipped car manned by the local fire
department. He may, when necessary, use
his own car. Simultaneously, an ambu

afte r a c c id e n t

FIG. 1—Relation between survival and start
of treatment.

In the last year, 25 267 missions were
performed by rescue helicopters. The
Federal Republic of Germany started the
present air-rescue system during the
1970s. It now comprises 32 stations and
25 BO-105 helicopters. With an optimal
effective radius of 50 km, medical emer
gency help is available to 90% o f the
country’s population within 15 minutes.
Under the disaster control organiza
tion, the pilots are provided by the Fed
eral Ministry of the Interior and medical
attendants by various private local rescue
organizations and fire brigades. Doctors
are assigned by the base hospitals. The
German automobile club is responsible
for administration and cost accounting of
the rescue flights. It also negotiates con
tracts with the insurance organizations.
Operating costs are reimbursed by acci
dent and health insurance organizations
within the communities and cities to the
respective doctor.

All emergency calls are channelled to
the rescue control centre in the area,
which is in four-channel contact with the
police. The control centre coordinates and
activates all ground-rescue vehicles and
the rescue helicopter within its area of
responsibility (Fig. 3). A paramedic and
an emergency care physician are assigned
to each helicopter, which is equipped for
safeguarding the vital functions of the
injured victim, treating shock and provid
ing initial treatment of injuries, and also
providing safe transport to the hospital.
The important factor of air rescue by
helicopters compared with conventional
land-bound ambulance rescue, is that
through the early application of medical
measures by a physician the interval
without therapy is greatly shortened.
An investigation carried out in 1971
showed that even in a large city like H an
nover, it took more than 20 minutes to
get 64% of accident victims to the hospi
tal by ambulance. In 26%, more than 30
minutes elapsed before they were treated
by a doctor in a hospital and in none of
these cases was effective treatm ent
initiated before admission. The rescue
helicopter reached the accident site in less
than 10 minutes after being notified in at
least 60% of cases.
Treatment at the Accident Scene

FIG. 3—Lines of communication to rescue
control centre. ADAC = German automobile
club. Dotted lines represent radio communi
cation, solid lines telephone communication.

The initial diagnoses made at the acci
dent scene for the years 1972 to 1983 are
shown in Table I. Head injuries were the
most common. Almost 65% of the
patients were in shock. In cases of exten
sive hypovolemia, two or three large-bore
catheters are used and the patient is
infused, preferably with crystalloid solu
tion. If necessary, 2000 mL or more of
fluid may be infused before the victim
reaches hospital.
The procedures carried out at the acci
dent scene by either the ambulance or
helicopter-rescue system are listed in
Table II. Because of respiratory insuffi
ciency or unconsciousness with danger of
aspiration, 12.0% of the patients had to
be intubated endotracheally. So as not to
restrict the availability of the rescue
helicopter, only 31% of the victims were
thus transported during the period 1972
to 1983. They were patients who required
continuous medical observation or had
injuries, such as vertebral fractures,
requiring smooth transport.
Table I—Injuries Diagnosed at
Accident Scene, 1972 to 1983
Injury

FIG. 2—Relation between different types of emergency, interval without treatment and
outcome.

Head injury
Fractures of extremities
Thoracic trauma
Abdominal trauma
Spinal fractures
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51.9
35.5
17.0
10.2
7.6
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Helicopter versus Ambulance

To compare the effectiveness of
helicopter versus ambulance rescue, we
carried out a prospective study of 48 trau
matized patients. The study was restricted
to patients with one or more injuries caus
ing shock and an estimated blood loss of
1000 mL in the first hour. Children under
15 years old and patients with cranio
cerebral trauma were excluded.
In group 1, aggressive treatment was
started at the site of the accident by the
doctor from the rescue helicopter. In
group 2, patients were transported by
ambulance, without a physician, to the
nearest hospital, but because of the severe
injury were transferred to our hospital.
It was noted that group 1 patients
reached hospital in less than half the time
despite the fourfold greater distance from
the hospital to the site of the accident
(Table III). In these patients, an average
of 711 mL of fluid was infused before
arrival at hospital, while patients in group
2 received an average of 230 mL and
many of them received no infusion at all.
Accordingly, the systolic blood pressure
of group 2 patients on admission to our
clinic was only 92.3 mm Hg. On average,
the shock index (heart rate divided by
systolic pressure) in this group was 1.18.
The levels of the helicopter group clearly
show the results of better primary treat
ment — an average systolic pressure of
119.4 mm Hg and shock index of 0.88.
To find out the effects o f this circula
tory replacement, the subsequent course
of the patients was investigated. Two
patients of group 2 died in the emergency
department. Almost half of the patients
in this group had to be treated in an inten
sive care unit longer than 10 days. In com
parison, almost two thirds of group 1
patients could be moved out of the inten
sive care unit after 1 to 3 days. The aver
age duration in the intensive care unit was
only half as long in group 1 as in group
2 (Table IV).
With respect to cause of death, a high
rate of respiratory insufficiency was noted
in group 2. This complication is generally
recognized as a result of inadequately
treated hypovolemic shock. The overall
death rate in group 2 was more than 3.5
times that in group 1 (Table V).
After almost 12 years’ use of air res
Table II—Procedures Performed at Accident
Scene, 1972 to 1983, by Ambulance or RescueHelicopter Personnel
Procedure
Volume replacement
Control of bleeding
Splinting of fractures
Intubation and ventilation
Resuscitation
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% of
patients
31.3
29.1
18.7
12.0
4.9

cue in Hannover and more than 13 000
missions, the effectiveness of this system
for all involved is without question.
However, there is increasing criticism
from laymen and doctors and a resistance
to the establishment of new centres on the
grounds of pollution and cost control. So
the question is frequently asked, how
many lives have really been saved by the
helicopter? This question cannot be
answered accurately.
One hundred and twenty-two patients
with a clinical diagnosis of death were
successfully resuscitated at the accident
site. There are certainly more positive
effects from prompt on-the-scene treat
ment, using helicopter rescue, than from
spectacular resuscitations of moribund
patients. Life-threatening complications
at the site of the accident and during
transport are prevented, especially
obstructions of the airway, and through
adequate early and aggressive treatment,
complications resulting from shock are
decreased.
Management of Open Fractures and
Infection

A cardinal rule at the accident scene is
to avoid further soft-tissue injury. We
strongly recommend that fractures be
realigned or reduced where possible at the
scene to relieve pressure on the injured
soft tissues. Swelling and the spread of
hematoma are reduced by placing a sterile
dressing over the wound and immobiliz
ing the extremity in a pneumatic splint.
In our clinic, 59% of the open fractures
have already received field treatment
within about 20 minutes of injury from
a resident who accompanied the rescue
vehicle to the scene. The benefits of this
early care are substantial: a 3.5% infec
tion rate when prim ary care was
administered by air ambulance personnel
as opposed to a 22.2% rate in patients
who reached the trauma centre by way of
another hospital within 10 hours of
injury. In the latter case, infection
occurred in every fifth patient with an

open fracture. Naturally, the time factor
has a significant bearing on the end result
regardless of the quality of primary care.
Risks of Helicopter Rescue

How safe is the rescue helicopter sys
tem? Between 1973 and 1983, 146 300 res
cue missions were carried out in the Fed
eral Republic of Germany and there were
22 accidents involving rescue helicopters
— a rate of 1 accident per 6648 missions.
Of the 22 helicopter accidents, 7 (32%)
resulted in at least one death each. Dur
ing this period, 16 doctors, pilots or atten
dants were killed.
Causes o f Helicopter Accidents
Nearly 60% of these accidents were due
to human failure and the remainder were
secondary to technical failure. The higher
risk associated with rescue helicopter
flights was due to lack of extensive
navigatory preparation, landings in
unfamiliar or narrow areas, busy streets,
and housing developments, flights made
in poor weather conditions, undue haste,
and extensive involvement of the crew
associated with increased risk.
Critics of air rescue note the restricted
conditions in an aircraft and the limited
possibilities for therapy during flight.
This is only partially true, and external
heart massage can be performed during
flight in extreme cases. On the other
hand, the speed of the rescue helicopter
allows a patient early treatment accord
ing to individual requirement in a special
ized hospital even when it is not the
nearest one. True contraindications to
Table V-Cause of Death
Cause
Group 1
Group 2
Adult respiratory
distress syndrome
3
Sepsis
2
3
Exsanguination
1
2
Totals
8
3
Overall death rate, %
38.0
11.8

Table Ill-Comparison of the Effectiveness of Helicopter
and Ground Rescue Methods in Trauma Injuries in Germany
Factor
Distance from accident site to hospital, km
Interval between injury and initial treatment, min
Volume replacement during transport, mL

Group 1

Group 2

28.1
22.2
711

7.2
47.0
230

Table IV-Duration of Treatment in Intensive Care Unit*
Duration of
treatment, d
Group 1, %
1- 3
62.9
4-10
14.8
11-20
7.4
> 20
14.8
*9.5% of patients in group 2 died within 1 h of arrival at hospital.

Group 2, %
14.3
33.3
28.5
14.4
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helicopter transport, such as an un
resolved pneumothorax, are rare.
C o n clu sio n s

Our rescue system works and without
a doubt in the densely populated areas of
Europe such a system o f air rescue could
be used in the same way as in Germany
and Switzerland. For less-densely popu
lated areas, an extended missions radius
should be considered, so that sufficient

numbers of missions can be flown.
The question o f political and econom 
ical value is not easy to answer, because
it is difficult to estimate the financial
value o f a rescued life. Even with this
reservation, the political economist Baum
(personal communication) calculates the
favourable value o f the air-rescue system
to be at least comparable to that o f using
seat belts.
Why are air-rescue systems in wealthy
industrial countries not instituted more

quickly? Perhaps it requires only the
initiative o f independent or private
organizations. The Federal Republic o f
Germany’s helicopter air rescue system
was initiated by the German automobile
club which, together with the Federal
Ministry of the Interior, started the first
rescue helicopter service in Munich.
Today, this club still acts as an impetus
for further development o f air rescue and
supplies valuable help with administration
and accounts.

BOOK REVIEWS
ATLAS OF STOMAL PATHOLOGY. A.
Franchini, B. Cola and P .J.d’E. Stevens.
112 pp. Illust. Raven Press, New York,
1983. $70. ISBN 88-85937-37-2.

The surgical literature contains much informa
tion on the technical aspects of creating stomas.
In spite of this, stomas are often carelessly or
improperly fashioned, with resultant mor
bidity, embarrassment and distress to patients.
This book, written from a pathologic rather
than a surgical perspective, provides a valua
ble addition to the literature. It properly and
comprehensively describes the consequences of
poorly constructed stomas and illustrates in
detail the gamut of other processes that affect
stomas.
The book is well organized into 10 chapters,
2 of which deal comprehensively with primary
and secondary stomal conditions. The chap
ter on primary stomal conditions deals with
such problems as poor site, edema, ischemia,
retraction, prolapse, hernia and skin lesions.
Each one is well illustrated with colour pho
tographs. This is perhaps the strongest attrib
ute and raison d ’etre of the book, for, as
Professor Brian Brooke emphasizes in his
preface, “ Stomas have to be seen to be
believed...for stoma problems all too often
beggar description” .
Other chapters cover such topics as stomal
problems in radiotherapy, gynecology and
obstetrics, and pediatrics. There are also chap
ters on problems of obtaining a continent
stoma and special problems of ostomates,
including psychic and metabolic disturbances.
This book is not a comprehensive treatise
covering all aspects of stomal management —
nor does it claim to be. However, as a beauti
fully illustrated atlas of morbid conditions
affecting stomas* it fills a void in the literature.
It would make a worthy addition to the library
of surgeons or residents involved in the care
of ostomates and would be a valuable refer
ence for enterostomal therapists.
WILLIAM G . POLLETT, MD, FRCSC

Canada Limited, Toronto, 1984. $46.20.
ISBN 0-7216-9081-5.

For surgeons practising solo at a distance from
a University centre, where residents help the
staff to keep abreast of the current literature,
it is a pleasure to find a book of this calibre
that presents the current thinking of many
authorities on a problem that plastic surgeons
must deal with on a regular basis.
The first few chapters cover care of the burn
wound in general and serve as an excellent
review for all members of the burn team. The
chapter on inhalation injury is superb, while
chapters that deal with specific treatment of
the various elements of the face provide a refer
ence and put the latest state-of-the-art ideas in
perspective. These chapters are also an excel
lent source of detailed information for mem
bers of the profession who do not deal with
facial burns on a regular basis. The three chap
ters dealing with nursing, and physical and
occupational therapy reinforce the concept of
a team approach, which is essential in the care
of any burn victim. The bibliography is an out
standing source of material for further detailed
reading and represents an excellent literature
review.
The only criticism of the volume lies in its
illustrations, some of which are out o f place.
In some areas, more detailed follow-up pho
tographs would have added considerably to the
flow of the book.
This text should be on the bookshelves of
all plastic surgeons and, more importantly, in
the library of every emergency room regard
less of the size of the hospital.
D u n c a n R. B r o w n , m d , frcsc
No. 7, Endeca Place,
402-5th Avenue S,
Lethbridge, Alta.
T1J 0T5

Assistant Professor of Surgery,
Memorial University of Newfoundland,
St. John’s, Nfld.
A1B 3V6

CURRENT
SU R G IC A L
THERAPY
1984-1985. John L. Cameron. 613 pp.
Illust. C .V . Mosby Company L td.,
Toronto, 1984. Price not stated. ISBN
0-941158-20-9.

BURNS OF THE HEAD AN D NECK.
Thomas L. Wachtel and David H. Frank.
216 pp. Illust. W.B. Saunders Company

This text was designed to update surgical
management for the practising general surgeon.
It is well organized and is easy and interesting
to read. Most of the contributors are recog

nized authorities in their fields. Some sections
are better written than others, which is not
unusual for multiauthored texts, but the overall
quality of the presentations is good. Illustra
tions have been kept to a minimum and there
are many instances where an informative illus
tration or table would have streamlined the
text. For example, a table listing antibiotics,
with indications, doses, toxicity and drug inter
actions as an appendix would have saved a
search of the text for the information. Some
authors discussed only their own approach to
a problem but others included other options
for evaluation and comparison. It would have
helped the reader if some references to sug
gested approaches were cited so that the source
material could be reviewed. Some authors,
however, did include selective references that
were helpful. A few sections, such as those on
small-bowel tumours and bowel diverticula,
were too detailed in relation to their im por
tance. There should have been a section on sur
gical jaundice with new methods for diagno
sis and treatment.
In general, this text provides a practical
approach to new techniques in surgery and
should be of interest to the clinical surgeon as
well as the surgeon in training. It is not meant
to replace standard texts, which include anat
omy and pathophysiology as well as a compre
hensive coverage of a subject.
H arvey H . S ig m a n , m d , f r c s c , fa c s
Department of Surgery,
The Sir Mortimer B. Davis-Jewish
General Hospital,
3755 Cote Ste-Catherine,
Montreal, PQ
H3T 1E2

K APLAN’S FUNCTIONAL A N D SURG I
CAL ANATOMY OF THE H A N D . 3rd
ed. Morton Spinner. 446 pp. Illust. J.B .
Lippincott Company, Philadelphia, 1984.
$87.50 (US). ISBN 0-397-59583-3.

The first two editions of Kaplan’s text were
published in 1953 and 1965 respectively. Dr.
Kaplan had asked Dr. Morton Spinner to help
with this third edition, but when he died before
its completion, Spinner became the editor. Ten
contributors participated.
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New Voltaren Suppositories have
the strength most need to control it overnight
► For a lot of patients the worst part of arthritis starts when they
go to bed. Pain robs them of sleep and, by the next morning,
„ stiffness has locked up their joints.

New Vbltaren 100 m g or 50 mg Suppositories. Just one
at bedtime, lets them say good night. And look forward to
a good morning.

INTRODUCING VOLTAREN SUPPOSITORIES 50 mg or 100 mg.

Voltaren

Now Voltaren tolerability with the advantages
v of suppository delivery. For patients taking Voltaren tablets
*■ during the day, suppositories allow you to administer
the strength they require at bedtime, without compromising
the excellent tolerability they are used to.*
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(diclofenac sodium)
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‘Maximum daily dosage of Voltaren is 150 mg.
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aclivlly la equivalent dosages i l inloielkacio 115-150 mg in ly ) m l causes less central nervous
system side elicits at these lis t s Aiding ! VOLTAREN lie s in i alter Ike course il Ike nnlerlying
disease, il kas keel l u l l to relieve p m . n in e level, swelling a il tenderness, a il increase mobiluy
n pitients with rk tia a n c disorders il ike qpes listed
PHARMACOKINETICS - In m i . orally almioisterel diclofenac solium is rapidly a il almnst
completely abseiled a i l distributed n kind, liter, a il krlieys Ik e plasma ctnctniianeia skew i
linear relitionship n ike amount ol drug administered Absorption r a n more n p illy when the I n ; is
a d m u c ie d m a i empty s ln c h . I T , , , 7.5 lr|, then link meils I T ,, , 0 It). Ike In a u d ib ility
remains ibe same under h uh c u liliiis Ike mean le m n l drug kail lile n plasma was 1 8 k
after n a l lis ts . Oiclnlenac sodium is eileisnely b in d M l li serum albumin Ike plasma ADD
values In unckauged diclofenac s n liu i Ilia m i ll a l'u iiis lra liii are within ibe s m e range as these
from ike same oral lis t s il enteric coated liklels. F’. lliw u g idministntiun il sliw release diclofenac
sodium.
is readied at a p p iu m iie ly f k in s i l latti. a il a sigmlicanl n i u i i n il ding
prevails n plasma when ike lu g levels Inllowiug the [t u i t i n a ! I n bate dripped almost n
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Metabolism: It mat about 40 60*71 el Ike III) a il us n ilik iliie s aie e lin ia le l n ike m u a il
ike balance n Ike lu e s M ore ikai M el e i m l lose is m u n i lei n eliminaliin products within
7 ! k ills Ik e cliel metabolites are c«|igates el Ike 3 '-, l \ u l 5 '-, kylrnuy derivatives il
diclofenac A k in 510*71 gl a i oral lis t is eicreted unchanged n lin e Renal Clearance: A single
dose pbarmacikmelic study n patients M l vmying degrees el m i l ly s lu c im (creatinine clearance
rales ranging ham 3 m L/m ii l i 17 m i/m il. suggests Ikai in itia te m i l impairment lie s n l alien the
elimmalion m e il unchanged didolenac I n plasma but trial il may reduce Ike ifim iia iin rale if Ike
m tiabililes It t pharmacologically less acme metabolites) il Ike d ug Alih tiq h n accumulauon il
pkarmacnlogically H u e substance sens li occur ta u lm is advised while a d m iiisltriij VOUAREN la
patients with impaired kidney fu c iiii.

INDICATIONS AND CLINICAL USE - VDUAREN 'didolenac sodinml is indicated I n Ike
symptomatic Ireatmeil il ikeumaioid animus aid s e m e isltnankniis. including degeneialive |nim
disuse i l ike kip.

CONTRAINDICATIONS - VOUAREN Ididolenac sodium) s k ir t n ke used n p ilie n s wilh aclive.
nr recent history nl inflam maliry diseises of ibe gastriintestinnl traci such as peplic nicer, g a s u is.
i i i n i i l M e n u s , ir ulcerative colitis. VOUAREN is conlraindicaled n palrenls whs have s k im
bypeistisilm ly II Ike drug Since cross seusiliuiry kas k e n d in is lia le d . VOUAREN s ku ld n il hi
g n u l i patients» whom acetylsalicylic and it other non steroidal h i mllammatiiy ageiis b an
induced aslkna. rlinilis. n urticaria Ike sip pisiliiie s an in iia m lin e l u p a in s wilh any
inllammaloiy lesions il rectum it a s aid m pattens oulk n u t history il rectal ei anal bleeding
WARNINGS Use in Pregnancy and Lactation: Ike safety el VOUAREN Ididolenac sodinml

ti pregnancy aid lidaini has ill been established aid us ise is ihtiilme in recommended
Repiidvcnit studies performed n rats, rabbits aid mite shined piolonged pregnancy aid pnliailid
labour when didolenac sodiom nas administered keliie n alter the Iclneiy process bad begun Simla:
results haee kin found auk other non steroidal am iillammanry agents The evidence suggests that
Ibis may ke die ti decreased uterine caniractilny resulting Inn ibe inhibition il piistaglaidn
synthesis Oidefeoac sadiurn readily ciosses Ike placental Inner In one paiieni on tag-term niiimiit
with VOUAREN 150 ng Inly a level il 111 og/mL nas measured u hreast milk ly einapolalion. n
miaul el A-5 kg. consuming lie line pet lay il hreast milk, would receive less Iban U mg/kg/day il
VOUAREN Use in Children: VOUAREN is lit recommended n children under 16 years il age
because salily aid dosage ranges ban not been esiahlished n Ike pediatric age gup Central
Neivous System: Headache, dimness. Iighlbeililiiss. ail mental contain km bin lepuntl
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operating machinery it aim vehicles
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gasnoiniisnnal nail luicity cai occur Find (e m u aid edema have kaei repotted: ibiiilpie
VOUAREN should be used nub cannon m flints with cardiac decompensation, kypeinsiu aid renal
diseases, [lineal signs el adverse renal elfins lave rarely beei observed wild VOUAREN. ileiefate
renal loncnon shield ke monitored durieg triiliin nub Ibis lug Caonoo is advised nkiie
administering VDUAREN n pihtils with impaired m il lunenoo. ail ibe dost shield be reduced
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hepatic m ens haw keei repined with Ibis dug Allhougk suck reactions an reie. il abnormal liver
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manifestanons occur, tiealmeni wilh VOUAREN skull ke liscmlniel Inti tail* skull ke
niuiiel lung iitaiiM with ibis lug When almmislinig VDUAREN li Ike elleily. special can is
indicated. Ike dosage skull kt reduced li Ike lowest level tkal mil pintle ceiiiel il symptoms
Ike ailMillammaioiy iibpyrtnc. ail analgesic edicts ul VDUAREN u y mask Ike usual signs el
infection ail Ike physician skull ke aleit li Ike deoelnpmenl il mlecnnn il patients receiving ike
lug. Periodic iphlkaliiligical eramnanns lie recommeilel lei patients li long turn therapy with
nun steroidal am iilituaiiiry agenls Drug Interactions: li man. acetylsalicylic aerd reduces Ike
serum levels il VDUAREN when ike mi drugs ail taken simultaneously. Ike bniilakihly il
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lithium mil increase Ike luhium plasma m a n ringk» cried ai lilhiui mil demine;
dosage adjislmin il luhinm may be required VDUAREN may increase Ike plasma ciiceilialini il
ligoxm: dosage ad|isiiiii il Ike digiin may ke required Pkiinacidyiamic studies hive skim n
pniliiliu il n l hypoglycemic li lie! ultctegilait dregs die li concunent adminislianon with
VDUAREN Niienkeltss. when uiiiiagilaiis are given cimntiily wilh VOUAREN special cam is
advised. Nen-steioidal am inllammaloiy agenls bate been repined lu uhibii ike activity el diuicncs
Cmnnail almiisliilw el glocnciniciils. ikough somelimes necessary In rkeiapeulic reasons, nay
aggravate gasliiiiltstiiil side effects Concurrent oral Ireatmem with lieu n nine uii-stetiiiel
uubeinlic lugs may pnmiti the iccineici ul side ellecls
ADVERSE REACTIONS - Gasniiiiesliiil ail cental nervous system adverse teaclms an the
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SYMPTOMS AND TREATMENT OF OVERDOSAGE - There kas keen n t experience with
VOUAREN (diclofenac siiium l nveidosage H e re is i t specific antidote lit VOUAREN S ip pim ve aid
sympiomaltc n iitm e il is recommended aid may include empiyiog il ike stomach ky iidu cliu il vominng
u gasme lavage A ls i. measures n reduce a k s iip iw lic liia ie i charcoall aid n accelerate elimination
Idialysisl may kt e n d u e d
DOSAGE AND ADMINISTRATION - VOLTAREN Tablets 25 mg and 50 mg In te n t
ciaicdl - le rkeomatoii anhrmc patients. VDUAREN Ididolenac sodiuml iieatmenl shield ke inmaied
M h 75 mg lo 151 mg pei le y n 3 divided doses, depending t i ike seventy i l lie c iid iitu . f u
maintenance, the duse should ke reduced lo ike minimum amount that m il provide cam el ol symptoms,
usually 75 mg li IDS mg in ly u 3 divided dusts la nsienanbrinc patients. Ike suiting and
m am eiaice (is e is usually 75 mg day in 3 lu lle d lis ts Ike lis t s k u ll ke adjusted individually ti
Ike minimum duse that m il provide ce iltil il symptoms Ike maximum recommended duly disc is
150 mg VOUAREN skuld be liken with load and Ike tablets should be swallowed whole
VOLTAREN SR EDO m g (slow release tablets). Tiealmeni s ku ld ke initialed and individual
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ustttinkiitis on a mamlenance dnse nl 100 mg pei day may he changed In a tic c -in ly duse tl
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Overview of the Current Management of Carcinoma of the
Esophagus and Cardia
Esophagogastrectomy with esophagogastrostomy provides the best palliation for
patients with carcinoma of the esopha
gus and cardia. It affords better pallia
tion, longevity and overall survival than
do other forms of therapy either singly or
in combination. Treatment span is short,
the patient is able to return to a reasona
bly normal life-style relatively quickly and
the debilitating effects of dysphagia are
relieved in most patients.
Between January 1970 and July 1984
at the Lahey Clinic Medical Center, the
overall operability rate was 80 .3% and
the resectability rate 8 7 .2 % . Four of
191 patients who underwent resection
died for a hospital death rate of 2.1%.
The overall 5-year survival rate was
16.3% and 81.2% of patients had suc
cessful palliation of dysphagia.

L'oesophagogastrectomie avec oesophagogastrostomie offre le meiileur traitement palliatif pour les patients souffrant
de cancer de I'oesophage et du cardia. II
permet de meilleurs resultats palliatifs,
une prolongation de la longevity et une
amelioration de la survie globale par rap
port aux autres modes de traitement,
qu'ils soient utilises seuls ou en associa-
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tion. La duree de traitement est courte,
le patient est capable de reprendre assez
rapidement une vie relativement normale,
et les effets debilitants de la dysphagie
sont soulages chez la plupart des
patients.
Entre janvier 1970 et juillet 1984, au
Lahey Clinic Medical Center, les taux
d'operabilite et de resecabilitg ont ete
respectivement de 80 .3% et de 8 7 .2 % .
Quatre des 191 patients qui ont subi une
resection sont decedes, soit une mortalite de 2.1% . Pour I'ensemble, la survie a
5 ans a ete de 16.3% , et 81.2% des
patients ont ete soulages de leur
dysphagie.

Carcinoma of the esophagus is not com
mon. Its frequency per 100 000 popula
tion ranges from 3.5 among white males
to 13.3 among black males in the United
States.1 It is estimated that the disease
will develop in approximately 9400 per
sons in the US in 1985.2 It accounts for
approximately 2% to 4% of all reported
cancers of the gastrointestinal tract.
Long-term cures are rare and this will not
change until early diagnosis is possible.
Accordingly, the main goal of therapy is
palliation of the debilitating symptoms of
dysphagia. Controversy persists as to
which form of treatment provides the best
palliation and optimal opportunity for
cure. In our opinion, esophagogastrec
tomy best meets these goals, and this
paper will emphasize surgical treatment
in the management of carcinoma of the
esophagus and cardia.
Nonsurgical Therapy

Radiotherapy
Radiotherapy as the primary treatment
for carcinoma of the esophagus and
cardia is usually limited to patients whose
condition will not permit surgical inter
vention. Reported 5-year survival rates
vary from 1% to 8%.3 Earlam and
Cunha-Melo4 recently reported that the

overall 5-year survival rate as recorded in
the literature was only 6%. Survival fol
lowing radiotherapy alone is rarely longer
than 12 months and satisfactory pallia
tion of dysphagia, occurring in about two
thirds of patients, tends to be brief.5
Moreover, this form of treatment is not
without complications, which include
postradiation stricture, a development
that nullifies the possible benefits of pal
liation.
Pearson6 alone remains a strong advo
cate of radiotherapy as the primary treat
ment for esophageal cancer. His updated
results disclose a 5-year survival rate of
17%, the best that radical radiotherapy
has produced. Why others cannot achieve
such results is unclear. Patient selection
may play a role because Pearson’s statis
tics do not include approximately 50% of
his patients who were unable to complete
the treatment.
Chemotherapy
Chemotherapy as a treatment for car
cinoma of the esophagus is still in the
investigative stage and has yet to estab
lish its place in our armamentarium.
Rates of response from drug therapy vary
from 15% to 20%, and the effect is brief
(2 to 5 months). Kelsen7 reported a
response rate of 40% to 50% with com
bination therapy (cisplatin, vindesine,
bleomycin). The mean duration of
response was 7 months and toxicity was
substantial.
Pulsion Intubation
The effort to provide palliation for the
nonresectable tumour has stimulated
renewed interest in the peroral insertion
of prosthetic devices across the obstruct
ing carcinoma. Various types of tubes are
currently available. Tubes with flanged
ends that minimize the risk of migration
are preferred; the Celestin and Tytgat
tubes are examples currently in use. In a
recent review on the use of these tubes
from Great Britain, Bennett8 found that

VOLUME 28, NO. 6, NOVEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

493

perforation occurred in 9% of patients,
blockage in 8% and dislodgement in
10%. The death rate after insertion of
such a device was 4.5%. Thus, peroral
intubation of patients is not without risk
and it does not permit the patient to take
a normal diet. To minimize the risk of
blockage, a liquid or soft diet is man
datory.
Miscellaneous
Dilation of malignant esophageal stric
tures may provide temporary relief of
dysphagia, and in some patients, relief
may be surprisingly long lasting.9 As a
form of palliation of esophageal cancer
it is often overlooked. It is particularly
useful in preparing patients with inoper
able disease for more definitive palliative
therapy, such as peroral pulsion intuba
tion. Endocurietherapy involves direct
implantation of a high dose of radiation
directly into the tumour with relatively lit
tle risk o f deep penetration of the rays.3
Used in combination with external radi
otherapy, it may improve the results
obtained from palliation by external radi
ation alone. Laser therapy is a new
approach to palliation of dysphagia in
patients with inoperable disease and
preliminary results are encouraging.10
Surgical Therapy
We prefer an aggressive surgical
approach to the management of carci
noma of the esophagus and cardia, and
the majority of our patients are suitable
candidates. With current techniques and
ancillary supportive measures the risk is
reasonably low, and the patient’s swal
lowing. mechanism is restored immedi
ately and often permanently. In addition,
the duration of treatment is relatively
short, the patient returning home within

2 weeks of the operation to resume a
reasonably normal existence. While long
term survival is uncommon, the results of
aggressive surgery are superior to any
other treatment currently available in
terms of cure and longevity.
Esophagogastrectomy
Various techniques have been advo
cated to restore continuity of the alimen
tary tract after esophagogastrectomy. We
prefer when possible to perform an
esophagogastrostomy regardless of the
level of the tumour, otherwise we usually
do a colon interposition procedure. We
use a left thoracotomy for lesions of the
lower esophagus and cardia and either a
combined abdominal and right thoracot
omy or transhiatal esophagectomy with
cervical esophagogastrostomy for lesions
at higher levels. When laryngectomy must
be performed concomitantly with resec
tion of a cervical esophageal lesion, radi
otherapy is the preferred alternative.
When palliation only is possible and long
term survival is in doubt, we hesitate to
deprive a patient of speech. Furthermore,
radiotherapy has a higher success rate in
managing lesions of the cervical esopha
gus than it does for other levels.
The role of resection in carcinoma of
the esophagus and cardia is often
challenged because of the reported low
operability and resectability rates and a
high operative death rate. A recent review
of the literature by Earlam and CunhaMelo11 disclosed a resectability rate of
67% for all patients operated on, with a
hospital death rate of 33.3% and an over
all 5-year survival rate of 4%. In our
opinion, these data are derived from out
dated information and do not reflect cur
rent results. Data from several large ser
ies of patients reported recently from
different parts of the world are presented
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in Table 1.11-19 We believe that the report
of Wu and Huang14 from the People’s
Republic of China more accurately
reflects current practice. In the recent
experience of a number of Chinese hospi
tals, the resectability rate was 80%, the
hospital mortality approximately 6% and
the 5-year survival rate 25%.
In support of this belief, we present our
updated experience with carcinoma of the
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FIG. 1—Adjusted survival rates for all
patients surviving resection for carcinoma of
esophagus or cardia. Lahey Clinic Medical
Center, January 1970 to July 1984. SEM =
standard error of mean. MST = mean survival
time.
Survival %

C e d e r q v is t a n d
a s s o c ia t e s , 1 9 7 8 12
van A ndel and
a s s o c ia t e s , 1 9 7 9 13
W u and H u a n g ,
1 9 7 9 14
G r if f it h a n d D a v is ,
1 9 8 0 15
G iu li a n d G ig n o u x ,
1 9 8 0 16
E a r la m a n d
C u n h a -M e lo , 1 9 8 0 '1

E u ro p e

.

( L it e r a t u r e
r e v ie w )

83 783

A k iy a m a a n d
a s s o c ia t e s , 1 9 8 1 17

Japan

354

U n ite d S t a t e s

209

80

89

1 .3

22

U n ite d S ta t e s

181

66

80

1 1 .0

18

E llis a n d
a s s o c ia t e s , 1 9 8 3 18
S k in n e r , 1 9 8 3 19
'%

o f p a t ie n t s o p e r a te d o n .

t%

o f p a t ie n t s s u rv iv in g r e s e c t io n .

494

FIG. 2—Adjusted survival rates for patients
surviving resection for carcinoma of esopha
gus or cardia grouped according to stage.
Lahey Clinic Medical Center, January 1970 to
July 1984. SEM = standard error of mean,
MST = mean survival time.
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esophagus and cardia at the Lahey Clinic
Medical Center (Table II). Some of these
results have been reported previously.18
Between January 1970 and July 1984, the
overall operability rate of patients com
ing to this institution was 80.3%. Of 219
patients who underwent operation on the
service of the senior author (F.H.E.), 4
died within 30 days of operation. Two
died of myocardial infarction, another
with a previous pneumonectomy for car
cinoma of the lung died of pulmonary
embolism the day after operation. The
fourth patient died of a cardiac arrest, the
result of hemoptysis after an attempt to
drain a suspected mediastinal abscess percutaneously. Indicative of our aggressive
approach is the fact that the resection was
considered palliative in 32 patients
(16.8%) in that tumour was knowingly
left behind. Among the 28 patients whose
lesions could not be resected because
adjacent structures were involved, pallia
tive methods were employed, giving a
hospital death rate of over 14% and an
average duration of survival of 4 months,
no greater than that of untreated carci
noma of the esophagus or cardia.
M ajor com plications prolonging
hospitalization developed in 27 patients.
Seven patients had anastomotic leaks, two
of which were intrathoracic. Other com
plications included subphrenic abscess
(five patients), gastrointestinal obstruc
tion (five patients), respiratory failure
(five patients) and miscellaneous compli
cations (five patients). An additional 10%
of patients had minor complications. In
the absence of major complications or
staged operations, the average hospital
stay was 13 days. Most important, dys
phagia was successfully relieved in 81.2%
of those patients whose ability to swal
low could be assessed.
While palliation may be the main goal
of therapy, continued efforts to improve
survival are essential. The adjusted sur
vival rate of patients after resection was
16.3% at 5 years, the median survival
time being 17.3 months (Fig. 1). The
effect of staging on survival is shown in
Fig. 2; 36.6% of patients in stage I sur
vived 5 years, 8.3% in stage III and none
in stage IV. Comparison of curative and
palliative resections showed no 5-year sur
vivors among those who underwent pal
liative resection but a mean survival time
of 9 months. The 5-year survival of
patients having a curative resection was
19%, the mean survival time being 20.5
months. Thus, esophagogastrectomy not
only provides excellent palliation at rela
tively low risk but also offers the best
opportunity for cure of any of the avail
able forms of therapy.
Combined Therapy
In an effort to improve survival, resec
tion has been combined with radiother

apy. No convincing evidence suggests that
it helps. Two recent reports, one from
France20 and one from Belgium,21 of
controlled, randomized, prospective
studies comparing the results of surgery
alone with those of combination therapy
showed no difference.
To enhance survival, others have
included chemotherapy in the combined
therapeutic regimen. In one protocol,22
the combined administration of cisplatin
and 5-fluorouracil with radiotherapy
(3000 rad) is followed by resection in 3
to 4 weeks. Chemotherapy and radiother
apy are resumed 3 to 4 weeks postoperatively if nodes are found to be involved.
The patient is thus under treatment for
more than 3 months. Not enough time
has elapsed to know if survival has been
increased sufficiently by this combined
form of therapy to warrant such an
extended period of treatment. Until there
is convincing evidence that this form of
therapy is superior, it is hard to justify
the additional treatment time and in
creased morbidity.
Esophagogastrostomy
For nonresectable lesions of the cardia,
side-to-side esophagogastrostomy around
the growth, leaving the carcinoma in situ,
as originally proposed by d ’Allaines and
associates,23 can provide excellent palli
ation with a reasonably low death rate.
At a higher level in the thoracic esopha
gus, and particularly for lesions involv
ing such adjacent structures as the
tracheobronchial tree, an operation first
proposed by Kirschner24 provides useful
palliation. As currently modified by
O ng,25 the operation consists o f a
thorough mobilization of the stomach,
division and closure of the distal esopha
gus, and substernal placement o f the
stom ach to facilitate a cervical
esophagogastrostomy after transection of
the cervical esophagus and suture closure
of its distal end. This procedure is not
without risk and should be used only
when the patient’s condition permits.
Traction Intubation
If the lesion proves nonresectable,
another alternative is intraoperative place
ment of a plastic prosthesis across the
obstruction. Our experience has been
primarily with the Celestin tube, which is
passed perorally by the anesthesiologist,
retrieved by the surgeon through a gas
trostomy and fixed firmly in position.
Complications, such as dislodgement,
hemorrhage, perforation and obstruction,
may be anticipated in some patients. In
a recent large series,26 the hospital m or
tality was 18%. Satisfactory palliation
may still be provided even though survival
time is no different from that of untreated
patients.

Feeding Enterostomy
Feeding gastrostomy or jejunostomy
provides no palliation in that neither
restores the swallowing mechanism. Such
procedures may be justified occasionally
only as a temporary measure between
stages of a reconstructive procedure, such
as a colon interposition, or to maintain
nutrition in a patient who must undergo
radiotherapy in anticipation of the
resumption of normal alimentation.
Conclusions
Carcinoma of the esophagus and cardia
in the US is not common, but symptoms,
if not relieved, result in severe disability.
The cure rate is low and will probably
remain so until earlier diagnosis is possi
ble. The main goal of current therapy is
palliation.
We believe that esophagogastrectomy
with esophagogastrostomy provides the
best available palliation, longevity and
survival and is superior to other forms of
therapy, either singly or in combination.
Furthermore, it can now be offered to the
majority of patients with relatively low
morbidity and mortality. The treatment
span is short, permitting a rapid return
to a reasonably normal life-style and,
most im portant, dysphagia is relieved in
the majority of patients.
We are grateful to Drs. David M. Shahian
and Peter Maggs for permission to include
patients operated on by tflem.
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Course of Angina 1 to 12 Years After Aortocoronary
Bypass Surgery Related to Changes in Grafts
and Native Coronary Arteries
Among 500 patients who received aorto
coronary saphenous vein grafts at the
Montreal Heart Institute between Sep
tember 1969 and August 1972, the con
dition in 8 8 % of survivors with respect
to angina pectoris was improved 1 year
after surgery and 4 7 % were still better
after 12 years. One year after grafting,
202 patients underwent follow-up
angiography; symptoms of angina had
lessened in 8 9 % who had at least one
graft patent but in only 5 7 .5 % of those
with ail grafts occluded. This difference
was still obvious 12 years after surgery.
Loss of improvement decreased at a
mean annual rate of 3 .7 % . Of the 59
angina-free patients at 1 year who had
angiographic follow-up at 10 to 12
years, angina developed subsequently in
30 (5 1 % ); 25 (8 3 % ) of these were
found to have obstructive changes that
reduced the lumen by at least 5 0 % in
grafts or in ungrafted coronary arteries,
compared with only 13 (4 5 % ) of the 29
angina-free patients who did not have
angina subsequently. Improvement in the
degree of angina and its recurrence after
bypass surgery are closely related to
graft patency and subsequent develop
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59 patients exempts d'angine apres 1 an
et qui ont subi des angiographies de con
trole apres 10 h 12 ans, I'angine est
subsequemment reapparue chez 30
(5 1 % ); 25 (8 3 % ) d'entre-eux ont presentd des obstructions reduisant la
lumifere par au moins 5 0 % dans les art6res pontees aussi bien que celles qui ne
I'avaient pas 6t6, comparativement a
seulement 13 (4 5 % ) des 29 patients
exempts d'angine qui n'ont pas souffert
d'angine par la suite. L'amelioration de
I'etat angineux et la r£cidive des symptomes apres pontage sont intimement
reliees a la permeabilite des greffons et
au developpement subsequent de I’atherosclerose dans les greffons comme dans
les coronaires naturelles.

ment of atherosclerosis in the grafts or
in the native coronary arteries.
Des 500 patients qui, de septembre
1969 A aout 1972, ont regu un pontage
aorto-coronarien par greffe de saphene a
I'lnstitut de cardiologie de Montreal,
I'etat angineux de 8 8 % des survivants
6tait ameliore 1 an apres I'opdration et,
chez 4 7 % , cette amelioration 6tait toujours maintenue apres 12 ans. Deux cent
deux patients ont subi un angiographie
de controle 1 an apres le pontage; les
symptomes d'angine s'etaient attenues
chez 8 9 % des patients ayant encore au
moins un greffon de permeable, mais
chez seulement 5 7 .5 % de ceux qui
avaient une occlusion de tous les greffons. Cette difference etait toujours evidente 12 ans apres la chirurgie.
Les b6n£fices de I'operation ont decru
a un taux annuel moyen de 3 .7 % . Des

Amelioration of effort angina during the
first years after bypass surgery has been
found to be related to direct revasculari-
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zation of the myocardium.1-8 Recurrence
of angina, however, is frequent and it
appears to be associated with obstructive

changes in the grafts or with progression
of atherosclerotic lesions in the native
coronary arteries.9
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28
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45

42

93

144

95

66
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This report describes the course of
angina 1 to 12 years after coronary artery
bypass grafting in the first 500 patients
operated on at the Montreal Heart Insti
tute. Improvement of angina is related to
graft patency at 1 year, and its recurrence
to changes in the grafts and in the native
coronary arteries 12 years after surgery.

p a t ie n t s , 1 0 t o 1 2 y e a r s a f t e r b y p a s s o p e r a t io n .

2

H

O

YEARS AFTER BYPASS SURGERY
FIG. 1—Amelioration of angina after aortocoronary bypass graft surgery. Solid line =
complete and partial improvement, broken line = angina free. In brackets are shown number
of survivors (first number) and number improved (second number).

Patients and Method

Our first 500 patients (420 men, 80
women) were operated on between Sep
tember 1969 and August 1972. They
ranged in age from 37 to 68 years (mean
48 ± 18 years [± standard error]). They
received 1 to 4 saphenous vein grafts each
(mean 1.8 grafts). Sixty-eight percent of
the grafts had one coronary anastomosis,
14.6% had two Y-type coronary
anastomoses and 17.4% had two to three
coronary anastomoses in a sequential
fashion.
Between 6 and 18 months after opera
tion, 202 patients underwent control
angiographic examinations; 82 of these
patients were reassessed by angiography
between 114 and 153 months postoperatively. Most of them were part of a
prospective study in which angiography
was performed routinely 2 to 3 weeks
after operation, at about 1 year, between
5 and 7 years, and between 10 and 12
years (Table I).10-14
Angina was considered improved when
it decreased by one grade (Canadian
Cardiovascular Society classification15)
or disappeared completely. Improvement
rates were established by the life-table
method of Cutler and Ederer.16 The sig
nificance of differences was determined
by the method of Mantel.17
Results

Changes in Grafts

FIG. 2—Improvement of angina after surgery related to graft patency at 1 year. Solid line
= patients with at least one patent graft, broken line = those with no patent grafts.

Of the 202 patients who underwent
angiography at 1 year, all grafts were
patent in 120 (59%), at least one was
patent and one occluded in 42 (21 %) and
none were patent in 40 (20%). Changes
found in the grafts at 10 to 12 years are
described in Table II. Sixty-three percent
of the grafts were still patent, although
only 39.5% were considered in satisfac
tory condition (less than 50% stenosis),
37% were occluded and 24% showed
either early focal narrowing or late
modifications compatible with atheroscle
rosis that reduced the lumen by at least
50%.
Early focal narrowing was found at the
site of graft-aorta and graft-coronary
artery anastomoses or on the graft, due
to segmental fibrous hyperplasia of the
intima. They were attributed to inap
propriate surgical technique.11
Late graft modifications that appeared
after 1 year were always found on
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histopathologic studies, at autopsy or
reoperation, to be caused by atheroscle
rosis; in 70% o f these grafts the lumen
was reduced by at least 50%.13

Progression o f Atherosclerosis
in Native Coronary Arteries
Progression was defined as follows: (a)
new stenosis of at least 50%, (b) increased
narrowing of 20% to 30% in pre-existing
lesions or (c) the appearance o f total
obstruction.
The progression observed at 10 to 12
years in arteries with pre-existing lesions
in the baseline preoperative coronary
angiogram is summarized in Table III.18
Most o f the lesions that worsened in the
grafted arteries were proximal to the
grafts and they usually progressed to total
obstruction. New stenoses were found in
only 7% o f ungrafted arteries and in 14%
o f grafted arteries, usually near the coro
nary artery-graft anastomosis.

Improvement o f Angina
and Graft Patency
At 1 year, angina was reduced in 376
(88%) o f the 427 survivors who had this
symptom preoperatively; 294 (69%) of
the 427 survivors were angina free. At 12
years, 118 (47%) o f the 249 survivors
remained improved; 91 (37%) were free
o f angina (Fig. 1).
As shown in Fig. 2, improvement at 1
year was noted more often in the 120
patients with at least one patent graft
(88.6%) than in the 40 with no patent
grafts (57.5%). At 12 years, this differ
ence was still obvious (53% versus 27%).

Recurrence o f Angina and Changes
in Grafts and Coronary Arteries
O f the 82 patients who had angio
graphic examinations at 1 year and again
at 10 to 12 years, 59 were angina free at
1 year, 10 were partially improved and 13
were unimproved. Of the 59 angina-free
p atien ts, 29 remained so and 30
experienced recurrence o f symptoms. Of
the 10 partially improved patients, only
3 remained unchanged; the condition of
the others deteriorated.
Twenty-five (83%) of the 30 had either
substantial alterations in at least one o f
their grafts or progression o f atheroscle
rosis in the native coronary arteries. These
changes were observed in only 13 (45%)
o f the 29 patients who remained angina
free. The appearance o f a stenosis o f at
least 50% or total obstruction in one o f
the grafts or in the native ungrafted coro
nary arteries was considered significant.

Comment and Conclusions
It is gratifying that 12 years after
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bypass surgery, 47% of survivors in this
series maintained their improved condi
tion and 36% were totally free of angina.
These relatively good results were
obtained in spite of the imperfections in
surgical technique and the frequent par
tial correction required in patients treated
in this early era of coronary bypass sur
gery. Results o f such procedures carried
out today may be even better.
Improving angina and preventing its
recurrence after bypass surgery are closely
related to graft patency and the subse
quent development o f atherosclerosis in
either the grafts or the native coronary
arteries. These correlations suggest that
lessening o f angina is related to direct
myocardial revascularization. However,
they do not explain the clinical improve
ment in patients having no patent graft
(26 of 40 patients in this series, 9 o f whom
had total relief). Improvement was still
observed 12 years after surgery in 29%
o f survivors (5 of 17). Numerous mechan
isms have been considered to explain this
improvement, including combined med
ical therapy and changes in life-style,
fibrosis following intra- or postoperative
myocardial infarction replacing the
ischemic myocardium, interruption o f the
pericoronary efferent nerve pathways,
and the pain-denial placebo phenom
enon.19'21
Atherosclerosis o f vein grafts and
progression o f the disease in the native
coronary arteries consitute definite limi
tations to the long-term relief o f angina.
These complications were found to be
related to blood-lipid abnormalities,
elevated total serum cholesterol and
triglyceride levels, as well as to high levels
of low-density lipoprotein cholesterol and
apo-B lipoproteins.22 A better control of
the principal risk factors for atheroscle
rosis, and grafting using internal mam
mary arteries, which rarely develop late
changes,23 may further improve long
term results.
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Bioprostheses for Cardiac Valve Replacement
Biologic tissue has been used success
fully for cardiac valve substitutes since
the introduction of glutaraldehyde preser
vation in 1969. Assessment of the clini
cal performance of prosthetic valves
requires consideration of thromboembo
lism, anticoagulant-related hemorrhage,
prosthetic valve endocarditis, periprosthetic leak and prosthesis failure. Two
methods of assessment of valve perfor
mance, linearized occurrence rates and
multiple decrement analysis of valverelated complications, are illustrated in
evaluation of previous and newgeneration Carpentier-Edwards porcine
bioprostheses. The standard valve has a
valve-related complication rate of 2 .9 %
per patient-year over 5 years, while the
rate for the new-generation supra-annular
prosthesis is 4 .3 % per patient-year in
the 2-year interval. Thromboembolism
has been 1 .6 % and 1 .7 % per patientyear, respectively, for the previous and
new-generation prostheses. Primary tis
sue failure has occurred only in the
standard prosthesis, 0 .6 % per patientyear. The freedom from all valve-related
complications is 9 3 .1 % at 2 years and
8 7 .5 % at 6 years with the standard
valve and 9 5 .1 % at 2 years with the
new-generation prosthesis. Standardized
assessment of prosthetic performance
should provide physicians and surgeons
with the knowledge to optimize patient
management. The new-generation biolo-

From the Division o f Cardiovascular and
Thoracic Surgery, Department o f Surgery,
University o f British Columbia, Vancouver,
BC

gic prostheses with improved preserva
tion should reduce calcification and fati
gue lesions. Tissue valves have afforded
patients an excellent quality of life with
a low incidence of valve-related compli
cations.

Des I'adoption en 1969 de la conserva
tion par le glutaraldehyde, on a pu utiliser avec succes des tissus biologiques
pour le remplacement des valvules cardiaques. Pour juger de I'efficacite des
proth&ses valvulaires il faut considerer la
frequence des complications thromboemboliques, des hgmorragies reliees aux
anticoagulants, des fuites autour de la
prothese et de I'insuffisance de celle-ci.
On illustre ici deux methodes d'etude de
ces frequences, les taux linearises et
I'analvse decrementielle multiple, appliquees a revaluation des valvules porcines de Carpentier-Edwards du type
anterieur (standard) et de celles dites de
la nouvelle generation. Sur 5 ans, les
premieres montrent un taux de complica
tions reliees a la valvule de 2 .9 % par
malade et par an (dont 1 .6 % de
thrombo-embolies); ce taux est de 4 .3 %
(dont 1 .7 % de thrombo-embolies) sur
2 ans pour les nouvelles valvules susannulaires. Seules les protheses standard
manifestent une dechirure ou une perfo
ration, au taux de 0 .6 % par maladie et
par an. Les taux d'absence de toute
complication relive a la valvule sont de
9 3 .1 % au bout de 2 ans et 8 7 .5 % au
bout de 6 ans pour les valvules standard,
9 5 .1 % au bout de 2 ans pour les nouvel
les. Une telle m^thode normalisee d e v a 
luation des protheses permettra au
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Generation

medecin et au chirurgien d'offrir au
malade le meilleur traitement possible.
Les nouvelles protheses, soumises a un
meilleur procede de conservation, promettent une diminution de calcification
et des lesions de "fatigue". Les valvules
d'origine animale ont permis aux malades
une excellente qualite de vie, grevee de
peu de complications reliees aux
valvules.

Glutaraldehyde for fixing biologic tissue
was introduced by Carpentier and
colleagues1 in 1969. Their experiments
facilitated the use of bioprostheses, both
porcine and bovine pericardium, as a
satisfactory alternative to mechanical
valves. The Hancock porcine bioprosthe
sis was introduced in the early 1970s and
the Ionescu-Shiley pericardial valve and
the Carpentier-Edwards porcine valve in
1975. Glutaraldehyde-preserved biopros
theses have distinct advantages over
mechanical valves with regard to throm
boembolism and freedom from anti
coagulation. The durability of bio
prostheses beyond 10 years is unknown.
The “previous” and “new”-generation
bioprostheses and mechanical prostheses
are listed in Table I. The previousgeneration tissue valves have distinct
differences in tissue fixation, preservation
and construction. High-pressure fixation
of biologic tissue was common in porcine
prostheses, but since 1981, low-pressure
fixation of glutaraldehyde-preserved bio
logic tissue was introduced in the newgeneration tissue valves. The support for
low-pressure fixation came from Broom
and Christie2 when they reported that

Table 1—Classification of Cardiac Prostheses
Bioprosthesis
Mechanical
Hancock porcine
Starr-Edwards
Braunwald-Cutter
Carpentier-Edwards porcine
Lillehei-Kaster
Ionescu-Shiley pericardial
Bjork—Shiley
Hancock modified orifice porcine
St. Jude Medical
Hancock II porcine
Carpentier-Edwards supra-annular porcine
Medtronic—Hall
Bjork-Shiley monostrut
Hancock pericardial
Omniscience
Ionescu-Shiley low-profile pericardial
Duromedics
Mitral medical pericardial
Carpentier-Edwards pericardial
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pressure fixation of porcine tissue below
1 mm Hg will preserve tissue compliance
closer to that of fresh tissue and provide
less constraint with better coaptive mar
gins. The Hancock standard valve
has been extensively studied, up to 10
years, for functional performance and
valve-related com plications.3'9 The
Carpentier-Edwards standard porcine
valve and the Ionescu-Shiley pericardial
prosthesis have had less-extensive evalu
ation of clinical performance.10' 19 Many
of the previous-generation mechanical
valves, especially the Starr-Edwards,
have been extremely durable, but are
associated with throm boem bolism ,
thromboses and anticoagulant-related
hem orrhage.20'23 The new-generation
mechanical valves, especially the tiltingdisc and bileaflet prostheses, are an
attempt to reduce thromboembolism and
th ro m b o sis with th ro m b o resistan t
m aterials and improved blood-flow
characteristics, possibly at the risk of
durability. Long-term evaluation of all
bioprostheses with regard to valve-related
complications is required for comparing
both generations o f m echanical
valves.14,21,24,25
This paper presents data on the clini
cal performance of tissue valves. Prior to
a general discussion of the three original
previous-generation tissue valves, the
experience at the University of British
Columbia with the Carpentier-Edwards
porcine prostheses is reviewed with par
ticular attention to the valve-related com
plications of thromboembolism, anticoagulant-related hemorrhage, prosthetic
valve endocarditis, periprosthetic leak and
prosthesis failure.14,21’24'25
Methods

Reoperation for repair or replacement
of another native valve or cardiac condi
tions unrelated to the prosthesis (e.g.,
coronary artery disease) was not consi
dered to be a valve-related complication.
The methodology for assessing the clini
cal performance of cardiac valves in our
institution is designed for comprehensive
comparison of all valve-related complica
tions.14 Originally reported by Bodnar
and colleagues,26 the methodology
allows us to evaluate the valve perfor
mance of various prostheses and thus to
separate valve survival from patient
survival. Since patient populations are
not homogeneous, patient survival is
inadequate for comparing the perfor
mance of various types of valves.
Through the assessment of valve survival
by the multiple decrement analysis tech
nique, various types of prostheses can be
assessed over time to determine the best
prosthesis for any patient.14,21,26
The various valve-related complications
are defined as follows.
500

• Thromboembolism comprises all
new, focal neurologic deficits, either tran
sient or permanent, or peripheral emboli
diagnosed at embolectomy. Cerebrovas
cular accidents occurring intraoperatively
are not considered to be valve-related
thromboembolism.
• Anticoagulant-related hemorrhage
includes internal or external bleeding that
necessitates hospital care, including trans
fusion, or extensive outpatient care.
• Prosthetic valve endocarditis is any
documented infection of the prosthesis.
Operative management of prosthetic
valve endocarditis is determined by the
presence of progressive and severe con
gestive heart failure, systemic embolism
and persistent sepsis.
• Periprosthetic leak includes all epi
sodes documented by cardiac catheteriza
tion, reoperation or autopsy. This
excludes patients whose leak is caused by
infective endocarditis and is listed as such.
• Prosthesis failure is any structural
failure of the prosthesis causing stenosis
or insufficiency, including leaflet disrup
tion, calcification, stent failure or throm
bosis, documented by cardiac catheteri
zation, reoperation or autopsy. This
excludes valve failures resulting from
infective endocarditis or periprosthetic
leak, which are listed separately.
The valve-related complications can be
expressed as linearized occurrence rates
or freedom from valve-related complica
tions expressed actuarially. The defini
tions of the freedom from valve-related
complications are as follows.
• Freedom from all valve-related com
plications is the actuarial proportion of
patients who remain free of any such
complications, including those causing
death or reoperation.
• Freedom from mortality due to
valve-related complications denotes the
actuarial proportion of patients who are
alive or have died of a non-valve-related
cause.
• Freedom from valve-related mortal
ity or reoperation denotes the actuarial
proportion of patients who remain free
of valve-related death or of reoperation
for a valve-related cause.
Patients

By June 1983, porcine bioprostheses
had been implanted in 1741 patients at
the University of British Columbia. Of
these, 173 patients received Hancock stan
dard prostheses, 1197 patients the
Carpentier-Edwards standard valve and
371 patients the Carpentier-Edwards
supra-annular prosthesis. Of those who
received the standard Carpentier-Edwards
prosthesis, 235 were available for 5-year
evaluation by May 1983. The early

experience with the supra-annular
prosthesis was concluded in February
1983 with 255 patients. The clinical evalu
ation was obtained by direct contact with
the patients or attending physicians.
Carpentier-Edwards Standard
Porcine Bioprostheses

Patients
In this group of 235 patients, 252
prostheses were implanted (aortic valve
106, mitral valve 107, tricuspid valve 5
and multiple valves 34). Previous cardiac
surgery had been performed in 31 patients
(13.2%). Concomitant procedures were
performed in 34 patients (14.5%); of
these, 24 patients underwent coronary
artery bypass. The cumulative follow-up
for all patients was 900 patient-years (aor
tic valve replacement 419 patient-years,
mitral valve replacement 423 patientyears, tricuspid valve replacement 12
patient-years and multiple-valve replace
ment 46 patient-years). The patient evalu
ation was 99% complete.
Results
The early mortality was 6.8% (16
patients) — 2.8% (3 patients) for aortic
valve replacement, 8.4% (9 patients) for
mitral valve replacement, 20% (1 patient)
for tricuspid valve replacement and
17.6% (3 patients) for multiple-valve
replacement. There were 35 late deaths in
the series at the time of evaluation. The
late mortality, expressed as a linearized
occurrence rate, was 3.9% per patientyear, overall. The valve-related causes of
late mortality were thromboembolism
(four patients), prosthetic valve endo
carditis (two patients) and periprosthetic
leak (one patient). Two of these patients
died at reoperation, one from prosthetic
valve endocarditis and one from peripros
thetic leak.
The overall patient survival, including
operative deaths, expressed by the lifetable method, was 85.6% ±3.4% at 2
years and 75.4% ± 5.7% at 6 years
(82.5% ± 7.4% at 6 years for aortic valve
replacement, 76.4% ± 10.4% for mitral
valve replacement and 53.8% ± 18.2%
for multiple-valve replacement) (Fig. 1).
The linearized occurrence rate for
valve-related complications was 2.9% per
patient-year (26 events) and the mortal
ity was 0.7% per patient-year (7 events).
The freedom from valve-related compli
cations was 93.1% ± 3.5% at 2 years and
87.5% ± 4.7% at 6 years (Fig. 2).
The linearized number of events and
occurrence rates for all valve-related com
plications are shown in Table II. The
linearized occurrence rate for throm
boembolism overall is 1.6% per patientyear (14 events per 100 patient-years), for
prosthetic valve endocarditis 0.6% per
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patient-year (5 events per 100 patientyears) and for primary tissue failure 0.6%
per patient-year (5 events per 100 patient-

FIG. 1—Patient survival for all groups (over
all, AVR, MVR, MR) for Carpentier-Edwards
standard porcine bioprosthesis. AVR = aortic
valve replacement, MVR = mitral valve
replacem ent, MR = m ultiple valve
replacement.
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years). There were no deaths attributable
to primary tissue failure. There was one
serious episode of anticoagulant-related
hem orrhage following mitral valve
replacement (0.24% per patient-year).
Periprosthetic leak occurred in one
patient with mitral valve replacement
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reoperation. The other reoperation death
occurred from prosthetic valve
endocarditis.
Reoperation for valve-related compli
cations was necessary in nine patients
(aortic valve one, mitral valve five and
multiple valves three). Reoperation was
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FIG. 2—Freedom from valve-related complications with Carpentier-Edwards standard por
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Carpentier-Edwards Supra-annular
Porcine Bioprostheses
Patients
In the group of 255 patients receiving
the Carpentier-Edwards supra-annular
porcine bioprostheses, 271 prostheses
were implanted (aortic valve 121, mitral
valve 130 and multiple valves 20). Previ
ous cardiac surgery had been performed
in 20 patients (7.8%). Concomitant
procedures were performed in 82 patients
(32.2%). The cumulative follow-up was
229 patient-years (aortic valve replace
ment 108 patient-years, mitral valve
replacem ent 109 patient-years and
multiple-valve replacement 12 patientyears). Patient evaluation was 99% com
plete.
Results

207 198
205 193

cations at 2 years was 93.1% ± 3.5% and
at 6 years was 87.5% ± 4.7% . The free
dom from valve-related death at 2 years
was 97.0% ± 2.4% and at 6 years was
96.4% ± 2.6%, while the freedom
from valve-related death and reoperation
was 96.5% ± 2.5% at 2 years and
91.8% ± 4.0% at 6 years (Fig. 2).

The early hospital (30-day) mortality was
6.7% (17 patients) — 3.3% (4 patients)
for aortic valve replacement and 10.0%
(13 patients) for mitral valve replacement.
No patient with multiple-valve replace
ment died. There were 10 late deaths in
the series. The late mortality, expressed
as a linearized occurrence rate, was 4.4%
per year, overall. There were no valverelated causes of late death. There were
no deaths from reoperation.
The overall patient survival, including
operative deaths, expressed by the lifetable method, was 89.4% ± 2.4% at 2
years, 92.4% ± 3.6% for aortic valve
replacement, 85.8% ± 3.2% for mitral
valve replacement and 93.3% ± 12.6%
for multiple-valve replacement (Fig. 3).
The linearized occurrence rate for
valve-related complications was 4.3% per
patient-year (11 events) with no deaths.
The freedom from all valve-related com
plications was 95.1 ± 2 .8 % at 2 years
(Fig. 4).
The linearized occurrence rates and
number of events for all valve-related
complications are shown in Table III. The
linearized occurrence rate for throm 
boembolism overall was 1.7% per
patient-year (four events). There were no
cases of thromboembolism in patients
who had multiple-valve replacement and
no deaths from thromboembolism. The
linearized occurrence rate for prosthetic
valve endocarditis overall was 1.3% per
patient-year (three events). No patient
with aortic valve replacem ent had
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prosthetic valve endocarditis. There were
no cases of primary tissue failure in this
series.
Two patients, one with a replaced aor
tic valve the other with a mitral valve,
required reoperation for valve-related
complications, the former for periprosthetic leak and the latter for pros
thetic valve endocarditis. Both patients
survived.
The freedom from all valve-related
complications at 2 years was 95.1% ±
2.8% (Fig. 4). The freedom from valverelated death was 100%. The freedom
from valve-related mortality and reoper
ation at 2 years was 99.1% ± 1.2%.

confirmed these findings, showing that
the freedom from primary tissue failure
with the Hancock valve at 8 years was
85% for both aortic and mitral replace
ments and 81% for double replacements.

The early failure mode of calcification in
children has been well documented.29'36
Antunes and Santos36 recently docu
mented that the freedom from degen
eration at 6 years is 20% in patients 20

-«

1

•«

Discussion

-*

Tissue prostheses, both porcine and
pericardial, have provided a very satisfac
tory quality of life for patients requiring
valve replacement. They have been
associated with a low incidence of valverelated complications, especially throm
boembolism.3' 19 In our experience the
incidence of thromboembolism has been
consistently less than 2% per patientyear.10-14 Edmunds27 has provided exten
sive documentation of thromboembolism
with tissue and mechanical prostheses.
The incidence of thromboembolism in the
aortic position is less than 2% per patientyear w ith biologic valves without
anticoagulation and with mechanical
valves with anticoagulation. In the mitral
position, the incidence of thromboem
bolism is approximately 4% per patientyear with or without anticoagulation
using biologic valves, and with anticoagu
lation using mechanical valves. Hetzer
and colleagues7 have shown that with
biologic valves, the risk of hemorrhage
from anticoagulants is greater than the
risk o f thromboembolism, even though
all emboli occurred in patients with
chronic atrial fibrillation.
Even though the glutaraldehydepreserved bioprostheses have reduced all
the complications of thromboembolism
and anticoagulant-related hemorrhage,
which are well documented with mechan
ical prostheses, there remains the concern
about durability of the bioprosthe
ses,3'5'18 particularly leaflet failure and
calcification. Ishihara and colleagues28
have documented four types of primary
leaflet failure. The leaflet failure is due
to the structural failure of the connective
tissue components, primarily collagen
degeneration. The fatigue failures are
thought to be due to mechanical forces
or the presence of calcium. Magilligan
and colleagues3-5 found that 20% of
Hancock prostheses had failed within 9
years o f implantation. At 5 years,
Gonzales-Lavin and colleagues17 showed
that the freedom from intrinsic valve
failure was 96%. Gallo and associates8
502

-*
*
FIG. 3—Patient survival for all groups (overall, AVR, MVR, MR) for Carpentier-Edwards
supra-annular porcine bioprosthesis.
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Table III—Carpentier-Edwards Supra-annular Porcine Bioprosthesis: Linearized
___________________________Events and Occurrence Rates
Events, no. (%)
Aortic valve
Mitral valve
Multiple-valve
Complication______________________ replacement________replacement________replacement
Thromboembolism
Overall
3 (2.8)
1 (0.9)
0
Fatal
0
0
0
Prosthetic valve endocarditis
Overall
0
2(1.8)
1 (8.3)
Fatal
0
0
0
Primary tissue failure
Overall
0
0
0
Fatal
0
0
0
Periprosthetic leak
Overall
0
3 (2.8)
0
Fatal
0
0
0
Anticoagulation-related hemorrhage
Overall
0
1 (0.9)
0
Fatal
0
0
0
Expressed as episodes per 100 patient-years or percent per patient-year.
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years of age and younger. The structural
failure of both porcine tissue and
pericardium is greater in mitral than aor
tic valves.
Standardization of assessment for
prosthetic performance is required to
T a b le IV — C la s s ific a tio n o f V a lv e - R e la t e d
C o m p lic a t io n s
U n iv e r s it y o f
B ritis h C o lu m b ia

S t a n f o r d U n iv e r s it y

D e a t h or
re o p e r a tio n r e la te d
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d e a th s
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r e n c e o f v a lv e
f a ilu r e p lu s c o m p li
c a tio n s n o t le a d in g
t o r e o p e r a t io n o r
c a u s in g d e a th

allow physicians and surgeons to give
their patients optimal management. The
thrust for this standardization has come
from Bodnar and associates,26 Jamieson
and colleagues14 and Miller’s group.21
The emphasis has been placed on com
prehensive comparison of all valve-related
complications, to facilitate adequate anal
ysis of various mechanical and tissue
valves. Recent publications by the Univer
sity of British Columbia and Stanford
University have utilized these indicators
of valve performance,14,21 although the
two centres used slightly different termi
nology (Table IV). This methodology
allows valve performance to be deter
mined from all factors affecting perfor
mance, including structural durability.
Consideration of all valve-related com
plications was used by few investigators
before Miller and associates,21 Jamieson
and associates,14 Minale’s group24 and
Schonbeck and colleagues25 took all
these into account when comparing por
cine and mechanical prostheses. Some

FIG. 5—Comparison of valve dysfunction by Stanford University and University o f Brit
ish Columbia (UBC) definitions (prior to 1984). PPL = periprosthetic leak, TE = thromboem
bolism, thromboembolic, OR = reoperation, IE = valve endocarditis.
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FIG. 6—Patient survival for porcine and pericardial prostheses at three centres (Stanford
University, UBC and Leeds, England).

workers considered only some complica
tions in assessing valve performance. For
instance, Ionescu and colleagues15,16 con
sidered only thromboembolism and valve
failure when assessing the lonescu-Shiley
pericardial valve. The previous definition
of valve failure (new postoperative regur
gitant murmur unless proved to result
from a periprosthetic leak, throm boem 
bolism necessitating reoperation or result
ing in death, thrombotic valvular occlu
sion resulting in reoperation or death,
prosthetic valve endocarditis necessitat
ing reoperation or causing death, and
hemodynamic dysfunction resulting in
reoperation or death) by Stanford
University20 illustrates the problem of
assessing valvular performance when defi
nitions are not standardized (Fig. 5).
The literature gives us only the compar
ison of patient survival and freedom from
thromboembolism of the three biologic
valves with extended periods of perfor
mance (Hancock porcine, CarpentierEdwards porcine and lonescu-Shiley
pericardial prostheses).4’12,16 Patient sur
vival illustrates no major difference
between the three prostheses (Fig. 6).
Patient survival is not adequate for com
paring performance of various types of
valves because patient populations are not
homogeneous. The long-term assessment
of thromboembolism shows no m ajor
advantage between the tissue prostheses
available. The incidence of throm boem 
bolism may be lower when the pericardial
prosthesis is used than when porcine
prostheses are implanted (Figs. 7 and 8).
With the new method of assessment,
the performance of the porcine bioprostheses is compared to that o f the
Starr-Edwards mechanical valve (Table
V). The valve-related complications are
higher with the Starr-Edwards valve but
mortality and reoperation rates due to
valve-related complications are similar.
Extensive research has been conducted
into the design of the structural support
for tissue valves and into the preservation
of the tissue to reduce or eliminate the
leaflet failures and calcification.37-39 Carpentier incorporated the low-pressure fix
ation of the porcine tissue in the inves
tigational Carpentier-Edwards supraannular bioprostheses.37 The design of
this valve should reduce turbulence and
improved preservation should reduce the
incidence of calcification. The lowpressure fixation may prevent splitting of
the collagen bundle and the elastic fibre
crimp seen with the high-pressure fixed
valves currently in use. Extensive research
has also been performed into tissue treat
ment to reduce or prevent calcifica
tion.38,39 Both experimental and clinical
trials are in progress to determine the suc
cess of these methods.
Our documentation shows the initial
tissue failure in the standard high-pressure
fixed valves and our early experience with
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than mechanical prostheses. Pomar and
colleagues40 have shown that 58% o f
mitral tissue failures require urgent
reoperation compared with only 17% of
aortic tissue failures. Calcification is more
common in aortic prostheses while per
forations and tears are more common in
mitral prostheses.

the low-pressure fixed prosthesis without
evidence o f tissue failure at a short evalu
ation interval. In our series, the failure
o f porcine bioprostheses usually took the
form o f tears and perforations that
allowed successful reoperation. Craver
and colleagues19 have shown that catas
trophic failure is less likely with biologic
100
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Freedom from Thromboembolism

Biologic valves have allowed our
patients an excellent quality o f life and
the incidence o f valve-related complica
tions, especially thromboembolism and
anticoagulant-related hemorrhage, has
been low. Durability remains the concern
for the future. The new-generation tissue
valves, such as the Carpentier-Edwards
supra-annular valve, should improve the
long-term durability for all patients and
reduce the risk of calcification in the highrisk groups, children and patients with
renal failure. The quality of control o f tis
sue selection, preservation and construc
tion of biologic valves will likely contrib
ute to improved clinical performance.
Standardized assessment o f valve perfor
mance is essential for full comparison of
all biologic and mechanical prostheses.
1 thank the members of the Division of
Cardiovascular and Thoracic Surgery of the
University of British Columbia for allowing me
to include the clinical appraisal of their
patients. Appreciation is also extended to
research assistants Ms. Joan MacNab and Ms.
Florence Chan, for formulation of data and
patient follow-up, and to Ms. Vicki Mah for
preparing the manuscript.
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Determinants of Risk for Coronary Artery Bypass Grafting
in Stable and Unstable Angina Pectoris
Although the operative risk and mor
bidity associated with coronary artery
bypass grafting for chronic stable angina
is exceptionally low, clinical and angio
graphic factors exist that may predict
differing outcomes in patient subsets.
Forty-five variables were prospectively
recorded on all 1302 patients who
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underwent coronary artery bypass graft
ing at Toronto General Hospital over a
24-month period. Twelve selected varia
bles were analysed by univariate and
multivariate techniques. The patients
were divided in two groups depending
upon their clinical presentation (stable
versus unstable angina) and the timing of
surgery (elective versus urgent). The
results of risk-factor analysis revealed
that the unstable cohort had four predic
tors for operative mortality: sex, age, left
ventricular function and left main coro
nary stenosis greater than 50% , whereas
the stable cohort had only three predic
tors: sex, age and left ventricular func
tion. The results for postoperative mor
bidity (perioperative myocardial infarction
or low-output syndrome) showed that
the unstable cohort had six predictors:
sex, age, left ventricular function, timing
of surgery, extent of coronary artery dis
ease and the type of myocardial protec
tion used. The stable cohort had only
three predictors of morbidity, the same
as for mortality. This analysis of multiple
risk factors on patients grouped accord
ing to stability and timing of surgery
clearly demonstrated determinants of risk
in the two groups (operative mortality for
the stable group of 2.9% versus 5.4% for

the unstable group, and periopera
tive infarction rate for the stable group
of 9.1 % and for the unstable group of
13.7% ).

Bien que le risque operatoire et la morbi
dity associes au pontage aortocoronarien
pour angine chronique stable soient
exceptionnellement bas, il existe des facteurs cliniques et angiographiques pouvant predire des resultats differents dans
des sous-groupes de patients. Quarantecinq variables ont ete enregistr^es de
facon prospective chez chacuri des 1302
patients qui ont subi un pontage aortoco
ronarien au Toronto General Hospital au
cours d'une periode de 24 mois. Douze
variables choisies ont 6te analysees au
moyen de techniques de variance ou de
covariance. Les patients ont ete divises
en deux groupes selon le tableau Clinique
(angine stable vs instable) et I'urgence
de la chirurgie (non urgente vs urgente).
Les resultats de I'analyse des facteurs de
risque revele que le groupe instable presentaient quatre facteurs previsionnels
de mortality operatoire: le sexe, I'age, la
fonction ventriculaire gauche et une stenose de la coronaire gauche superieure a
50% ; le groupe stable n'offrait que trois
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facteurs previsionnels: le sexe, I'age et la
fonctlon ventriculaire gauche. Les resultats concernant la morbidite postoperatoire linfarctus peroperatoire ou
syndrome de faible debit) ont identifie six
facteurs previsionnels pour le groupe ins
table: le sexe, I'age, la fonction ventricu
laire gauche. I'urgence de I'operation,
I'etendue de la maladie coronarienne et
le type de protection myocardique utilise.
Le groupe stable presentait pour la mor
bidite les memes indices previsionnels
que pour la mortalite. Cette analyse des
facteurs de risques multiples chez des
patients regroupes selon la stability de
leur maladie et I’urgence de I'intervention
demontre clairement les determinants de
risque pour les deux groupes (mortalite
operatoire pour le groupe stable de 2.9%
par rapport a 5.4% pour le groupe insta
ble, et taux d'infarctus peroperatoire de
9.1 % pour le groupe stable et de 13.7%
pour le groupe instable).

The operative mortality for coronary
artery bypass grafting has declined
progressively over the past decade. The
low risk, the gratifying relief of symptoms
and improved exercise capacity have
created an increased public demand for
such procedures. The expectations of suc
cess are as great in the elderly patient with
extensive disease and left ventricular scar
as in the younger patient with new-onset
anginal distress. However, patients, and
often their physicians, are unaware of
clinical subsets in which operative mor
tality and morbidity are sufficiently high
that medical therapy should be considered
an alternative. The purpose of this review
is to identify high-risk patients so that the
physician can make the best therapeutic
decision for each patient. We examine
risk factors associated with death and
morbidity in a contemporary patient
population which has enjoyed the poten
tial benefits of the most recent advances
in medical therapy, anesthesia, surgical
technique and perioperative myocardial
protection.

nique, myocardial protection and veingraft patency has been reported pre
viously.13
Two distinct, mutually exclusive,
cohorts were identified: 1003 patients
with stable angina pectoris (group 1) and
299 patients with unstable angina pectoris
(group 2) (Table I). Group 2 comprised
two sets of patients: those who underwent
urgent (or emergent) surgery and those
who satisfied the clinical definition of
unstable angina syndrome (vide infra) at
the time of operation. Therefore, group
1 comprised all patients not included in
the unstable or urgent category: patients
with classic chronic stable angina and
with new-onset angina or crescendo
(progressive) angina or previous episodes
of unstable angina responsive to intensive
medical therapy. All were sufficiently sta
ble to permit an elective bypass proce
dure, although some had previously
experienced one or more episodes of
unstable angina.
Group 2 patients underwent urgent
revascularization (within a few hours to
a few days) often with intra-aortic balloon
pump support, due to refractory ischemic
pain associated with their unstable state.
They included patients with acute coro
nary insufficiency, rest pain lasting longer
than 15 to 20 minutes, reversible or per
sistent ST-T-wave changes accompanied
by enzyme rises indicative of myocardial
injury (subendocardial infarction) and
continued pain, or patients with con
tinued ischemia within the first 30 days
after an established transmural infarction.
The clinical spectrum of ischemic injury
with unstable angina has been extensively
studied in this hospital.4 All patients in
group 2 were unstable at the time of sur
gery and underwent coronary bypass

grafting for failure to respond to inten
sive medical therapy.
Methods
Forty-five variables were prospectively
recorded for each patient and the infor
mation was stored as part of the cardi
ovascular surgery data base at Toronto
General Hospital.5 The overall rates of
operative death, perioperative myocardial
infarction and postoperative low-output
syndrome for the two groups were statisti
cally compared using x 2 or x 2 Fisher’s
exact test where appropriate (Statistical
Analysis Systems Institute Inc., Cary,
NC).
In addition, 12 of the most pertinent
and informative variables were statisti
cally analysed for both groups to deter
mine those measurements that were sig
nificantly predictive of morbidity and
mortality in each group (Table II). Mor
tality was defined as death before release
from hospital or within 30 days of oper
ation, whichever was shorter. Morbidity
was defined as either a perioperative
myocardial infarction (presence of new Q
waves) or the development postoperatively of a low-output state (requiring
inotropic or intra-aortic balloon pump
support).
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Between Jan. 1, 1982 and Dec. 31,
1983, 1302 consecutive patients under
went isolated coronary artery bypass
grafting at the Toronto General Hospi
tal. No patient was included who under
went concomitant resection of a left ven
tricular aneurysm or valvular repair. Five
staff surgeons and their residents con
tributed to this series and used a standard
surgical technique. All patients were
cooled to systemic temperatures of 28°C
using a bubble oxygenator; in the
majority, cold potassium crystalloid
cardioplegia was used to arrest the heart
during construction of distal anasto
moses. Information on surgical tech
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Initially a univariate risk-factor analy
sis was performed using contingency table
X2 statistics for the discrete variables and
/-tests for the single continuous variable

%

analysed, specifically age by progressive
decade increments. In each case the
potential risk factor was compared to
operative mortality in addition to peri

10

Operative
Mortality

operative infarction and low-output state.
Significant (p < 0.05) m athem atical
independence was then assessed. Those
variables that achieved significance
(p < 0.05) or marginal significance
(p < 0.1) by univariate analysis were then
presented for a multivariate stepwise
logistic regression risk-factor analysis
(B M D P Statistical S o ftw are, Los
Angeles, Calif.).
Results

%

15

Operative
Mortality _

LMC Stenosis

NYHA Class

FIG. 1—Rates and influence of sex, left ventricular function (LV Grade), New York Heart
Association (NYHA) functional class and left main coronary (LMC) stenosis on operative mor
tality. White bars = group 1 (stable angina), dotted bars = group 2 (unstable angina).
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The results of isolated coronary bypass
grafting based on clinical presentation
and the timing of surgery are presented
in Table III. The operative mortality was
2.9% for group 1 and 5.4% for group 2.
The rates and influence of sex, left ven
tricular function, New York Heart
Association (NYHA) functional class and
the presence of left main coronary steno
sis greater than 50% are noted in Fig. 1.
Women in both groups had a higher oper
ative mortality than men (7.9% versus
2.1% in group 1 and 11.9% versus 3.8%
in group 2, p < 0.05). Worsening left ven
tricular function was associated with an
increased operative mortality in both
groups (p < 0 .0 1 ); in patients with an
ejection fraction less than 20% there was
a 14.8% death rate with stable angina and
20.0% with unstable angina. All patients
who died in group 2 were in NYHA func
tional class IV (p < 0.01). The presence
of left main coronary artery stenosis in
unstable angina was associated with a
12.5% mortality compared with 4.0% for
those without left main coronary steno
sis (p < 0.05).
Clinical, angiographic and surgical fac
tors associated with death and morbidity
as determined by univariate analysis are
listed in Table IV. For operative mortal
ity, the sex, age and left ventricular grade
were constant; NYHA functional class
and the presence of left main coronary
stenosis were important only in group 2.
When multivariate discriminant anal
ysis was applied (Table V), the operative
mortality in both groups was adversely
influenced by female sex, advancing age
or worsening left ventricular function and
in addition for group 2 patients, the
presence of left main coronary stenosis.
Whereas sex and age only influenced the
occurrence of perioperative myocardial
infarction in group 1, sex, age and left
ventricular function influenced the
presence or absence of low-output state
postoperatively in both groups. The
extent of coronary artery disease and the
timing of surgery further affected patients
in group 2.
Discussion
It has been well established that the
morbidity and mortality of coronary
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artery bypass grafting has declined stead
ily since its introduction.6-8 The operative
risk for patients with chronic stable
angina pectoris of effort who underwent
isolated coronary bypass at Toronto
General Hospital between 1982 and 1983
was 0.9% with a perioperative myocardial
infarction rate of 1.6%. These patients
form a discrete subset within group 1 of
this study. The reasons for continued
improvement are undoubtedly the inter
action o f newer pharmacologic agents,
better understanding of the hemodynamic
events that occur during induction and
weaning from heart-lung pump support,
improved surgical techniques, better peri
operative myocardial protection and
changing criteria for patient selection.
There are, however, certain patients at
considerably higher risk, and analysis of
multiple clinical and angiographic varia
bles reveals predictors of risk in these sub
sets.9-12 The present report is unique in
that it reviews and examines current
results of patients who underwent surgery
within a contemporary experience where
all the factors responsible for improve
ment have been available and applied.
Other studies on surgical results for
patients with unstable angina have not
always separated those who were actually
unstable at the time of surgery (our group
2) from those who may have experienced
instability previously.
The risk-factor analysis presented in
this report reveals that the clinical varia
bles statistically predictive of morbidity
and death for the two compared cohorts
do not differ greatly. Conventional wis
dom and clinical experience suggests that
the degree of acute myocardial injury, or
conversely the amount of chronic left ven
tricular scarring, adversely affects sur
vival. Surgical risk, however, is rarely
determined by a single factor and usually
a combination of factors will determine
the overall risk for a given patient. The
technique of multivariate discriminant
analysis permits definition of that com
bination of variables offering the greatest
predictive value of risk.
The results for operative death revealed
that the unstable cohort (group 2) has
four predictors while the stable cohort
(group 1) has only three. Left main coro
nary stenosis, a reflection of the extent
of coronary artery disease, emerged as the
only difference.
Similarly, the results for postoperative
morbidity showed six predictors for the
unstable cohort: sex, age, left ventricu
lar function, timing of surgery, number
of coronary arteries with stenosis greater
than 70% and the type of myocardial pro
tection employed. The timing of surgery
was a criterion for inclusion in this group
and the type of myocardial protection was
biased towards blood cardioplegia. Thus,
only sex, age and extent of coronary
508

artery disease are significant predictors of
morbidity in the unstable angina cohort.
The stable cohort had the same three
predictors for morbidity as for death: sex,
left ventricular grade and age. Thus, the
extent of coronary artery disease again
remains a difference between the two
groups.
These contemporary results correlate
with those of the Collaborative Study in
Coronary Artery Surgery (CASS) which
included patients from an earlier period,
but none the less identified “ advanced
age, female sex, symptoms of left heart
failure, impaired ventricular function, left
main coronary stenosis and nonelective
surgery” as predictors of operative
death.10'11 Was the unstable group biased
towards patients with extensive disease?
Although the pathophysiology of unsta
ble angina is complex and not fully under
stood, it is generally recognized that
unstable patients do not have more exten
sive disease than patients with stable
angina.4 Do the unstable patients
represent a further stage in the progres
sion of coronary artery disease?4,13 Cer
tainly our patient selection is biased
towards a delay because of the demand
for surgery, resulting in unstable patients
having a longer course of failed medical
therapy, “breakthrough” angina and rest
pain superimposed on chronic stable
angina. Most patients with unstable
angina entering our coronary care unit are
already receiving medical therapy and
have previously been adm itted to
peripheral or suburban hospitals for
earlier management of prolonged rest
pain. Thus, subtle myocardial injury
accompanying the unstable anginal state
is common in our patients.4'13
This study allocated patients to two
groups according to clinical stability at the
time of surgery and the actual timing of
the operation. Thus, surgical crossovers
of medically treated patients with unsta
ble angina who responded to therapy dur
ing their acute ischemic phase are
included in the stable group who later
underwent elective revascularization.
Even patients with new -onset or
crescendo angina, and some with brief
episodes of rest pain, were included in
group 1. Prolonged rest pain, myocardial
injury and the urgent (or emergent)
requirement for surgery were criteria for
inclusion in group 2. While arbitrary,
controversial and certainly in defiance of
classic definitions of stable or unstable
angina pectoris, this grouping reflects our
local referral patterns, therapeutic deci
sions in patient management and the
inherent delays associated with centralized
resources for coronary angiography,
angioplasty and bypass graft surgery.
We thank Cathy Tong, MRL, for her
invaluable assistance in providing statistics
from the cardiovascular surgical data base for
this paper.
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In a retrospective study of 54 patients
with primary carcinoma of the tongue
seen at the Montreal General Hospital
from 1979 to 1984, the overall 2-year
survival for those with stage I disease
was 92%. Surgery alone was the initial
treatment in 84% of these patients. Dis
ease recurred in 36%. In stage II
patients, 8 of 12 had surgery followed
by radiotherapy; 37% had recurrent dis
ease. Surgery alone was used in 4 of 12
and with recurrence in 3. Overall survival
in stage II was 83% at 2 years. In cases
of localized disease, the survival rate for
surgery alone was not significantly
different from that after surgery plus
radiotherapy. Combined surgery plus
radiotherapy might offer better regional
control in stage II disease. Of 18 stage
III patients, 7 were treated by surgery fol
lowed by radiotherapy; 3 died and 4 are
disease free. All had commando proce
dures. Radiotherapy alone was used in
seven and six of them had recurrences.
Overall, the 2-year survival for stage III
was 61%. Control of regional disease
was achieved in 57% of those who had
surgery plus radiotherapy as opposed to
39% overall. Stage IV patients had a
2-year survival of 10%. Nine of the 11
received chemotherapy followed by radi-
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otherapy. This combination did not
improve survival and most of these
patients died within 1 year.
Cette etude retrospective porte sur 54
patients souffrant d'un cancer primitif de
la langue qui ont ete vus e I'Hopital
General de Montreal de 1979 & 1984. La
survie a 2 ans pour le groupe de stade I
fut de 92%. La chirurgie seule constitua
le traitement initial chez 84% de ces
patients; il y eut rgcidive dans 36% des
cas. Chez 8 des 12 patients de stade II,
la chirurgie fut suivie de radiotherapie; il
y eut 37% de recidive. La chirurgie fut
utilisee seule dans les quatre autres cas,
avec trois recidives. La survie globale
pour les patients de stade II fut de 83%
a 2 ans. Dans les cas de tumeur
localisee, la survie reliee a la chirurgie
seule ne fu t pas significativement
differente de celle qui a ete vue aprfes
chirurgie et radiotherapie. La chirurgie
associee a la radiotherapie offre peut
etre un meilleur controle regional de la
maladie au stade II. Sept des 18 patients
au stade III furent traites par chirurgie
suivie de radiotherapie; 3 sont decedes
alors que 4 ne presentent pas de trace
de maladie. Tous ont subi une operation
de type "commando". La radiotherapie
fut utilisee seule dans sept cas et six
eurent des recidives. La survie a 2 ans
pour le groupe de stade III fut de 61%.
La chirurgie associee a la radiotherapie
permit le controle regional de la maladie
dans 57% des cas par rapport a 39%
pour I'ensemble. Les patients ayant un
cancer de stade IV ont presente une sur
vie a 2 ans de 10%. Neuf patients sur
11 avaient recu de la chimiotherapie
suivie de radiotherapie. Chez ces
patients, la chimiotherapie associee £l la
radiotherapie n'a pas ameliore la survie
et la plupart sont decedes en moins d'un
an.

In 1985 in the United States alone, a new
cancer of the oral cavity will develop
in approximately 28 900 persons; these
cancers constitute 4% of all tumours in
men and 2°lo in women. There will be
5200 new carcinomas of the tongue and
2050 patients will die of lingual car
cinoma.1
The duration and rate of survival of
those with lingual carcinoma have
increased little in the past few decades
despite aggressive surgery and radiother
apy, alone or in combination.2-3 The
recent introduction of combination sys
temic chemotherapy preoperatively to
reduce the size of locally advanced carci
nomas of the tongue has led us to re
evaluate the results of current treatment.
In this report, data from a retrospec
tive review o f 54 patients with primary
carcinoma of the tongue treated at the
Montreal General Hospital from 1979 to
1984 are analysed with respect to survival
and treatment failures with current treat
ment methods. These results are com
pared to a previously published series
from this institution4 as well as to
reports from other centres.
Patients and Method
We reviewed the records of 54 patients
with primary carcinoma of the tongue
who underwent treatment at the Montreal
General Hospital between Jan. 1, 1979
and Dec. 31, 1984. The mean follow-up
was 25 months (range from 2 to 60
months).
All patients were staged, according to
the TNM classification,5 from informa
tion on the hospital charts. No change in
staging was made after first evaluation
regardless of whether the disease subse
quently progressed or regressed.
No differentiation was made in re
porting the location o f the lesion on the
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tongue (i.e., anterior two thirds or base
of the tongue).
Survival was calculated by the life-table
method. The small samples in some of the
treatment groups made analysis unrelia
ble except for indicating a trend.
The incidence of all second primary
tumours was also analysed. Any subse
quent squamous-cell carcinoma that arose
on the tongue or floor of the mouth was
considered to be persistent or recurrent,
regardless of time since diagnosis and
treatment of the initial tumour.
Treatment
Cases were discussed at a weekly
tumour conference before the patients
were treated. The departments of general
surgery, otolaryngology, medical oncol
ogy, radiotherapy and pathology were
represented at these conferences. Recom
mendations were made by the tumour
board, but the final decision on treatment
remained the responsibility of the refer
ring doctor. Local disease referred to the
primary tumour itself. Regional disease
included both the primary tumour and
involved cervical lymph nodes. The first
attempt to control the lesion was termed
initial therapy. Secondary therapy
referred to further therapeutic interven
tion in patients whose regional disease
was not controlled by initial therapy.
Surgery, radiotherapy and chemother
apy were used. Surgical procedures
included partial glossectomy, hemiglossectomy, resection with suprahyoid dis
section or commando operation (hemiglossectomy, hemimandibulectomy and
radical neck dissection).
Radiotherapy was given preoperatively
in a few cases but mostly postoperatively
as external beam irradiation to a total of

5500 to 7000 rad to the primary lesion and received combined surgery and radiother
neck fields. Some patients had radiother apy; 2 of them had resection with nodal
apy as the only treatment. Interstitial dissection. The other four had surgery
implants combined with external beam only and one of these had a commando
irradiation as initial therapy were used in operation.
only two patients.
Systemic combination chemotherapy Stage III
was used in some patients with locally
advanced lesions to reduce tumour size
Eighteen patients had stage III
before surgery or radiotherapy. This was tumours. Initial treatment in three was
done according to an in-house protocol. surgery alone; one of these had a com
Chemotherapy was given at 1-month mando operation. Seven (39%) had radi
intervals for two cycles. The patient was otherapy only. Another seven had surgery
reassessed and, if the lesion was consi combined with radiotherapy; all seven
dered operable, surgical excision was car had a commando operation, two had
ried out followed by radiotherapy. If the their radiotherapy preoperatively and five
tumour was considered inoperable, the postoperatively. The last patient had
patient received radiotherapy only. The chemotherapy alone.
chemotherapeutic agents used were
bleomycin, cyclophosphamide and cis- Stage IV
platinum. One patient had a combination
of 5-fluorouracil and cis-platinum. Other
In 8 (72%) of the 11 patients with stage
agents were used in a few patients but IV lesions, the initial treatment was
only for palliation.
preoperative chemotherapy followed by
radiotherapy. One patient had a com
Findings
mando operation followed by irradiation.
The 54 patients (42 men, 12 women) Another patient had systemic chemother
ranged in age from 35 to 84 years. The apy only. The last patient had chemother
carcinomas occurred most frequently in apy preoperatively followed by a com
the 50 to 70-year age group (39 patients) mando operation, then radiotherapy.
(Fig- 1)The stage at first clinical evaluation was Cell Type
quite evenly distributed, although there
All but three lesions were squamous
was a slightly higher proportion of
patients with stage III tumour (18 cell carcinomas. One was a verrucous car
cinoma, a highly differentiated form of
patients) (Table I).
squamous-cell carcinoma, one was an
adenoid cystic carcinoma and the other
Stage I
was a plasmacytoma.
Secondary primary tumours were seen
Of the 13 patients with a stage I lesion,
11 (85%) were treated by surgery alone in 8 (15%) of the 54 patients; four of
as initial treatment (Table II). Two of these were squamous-cell carcinomas
them had a prophylactic node dissection involving the supradiaphragmatic aeroas well as local resection. One patient, in digestive tract. The others were infiltra
whom carcinoma of the esophagus was tive ductal carcinoma of the breast,
diagnosed at the time of operation, also adenocarcinoma of the colon, endome
had chemotherapy followed by radiother trial carcinoma and ovarian carcinoma.
apy. Another patient had chemotherapy
preoperatively followed by hemiglos- Treatment Outcome
sectomy.
Stage I.—Control of regional disease
after initial therapy was reached in 7
Stage II
(64%) of the 11 surgically treated
Of 12 patients with stage II disease, 8 patients. None of the four patients who
T a b le I I - - C a r c in o m a o f t h e T o n g u e : In it ia l T r e a t m e n t b y S ta g e

FIG. 1—Age distribution for carcinomas of
tongue.
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had local recurrence after surgery alone
responded to secondary therapy. All are
alive but had recurrence within 11 to 60
months (median 25 months). Two were
treated by surgery alone, the two others
had combined surgery and radiotherapy.
Of the 13 patients with stage I disease, 2
died; 1 who had a local recurrence at 60
months died of hepatic cirrhosis, the
other of carcinoma of the esophagus at
11 months after diagnosis.
Stage II.—Regional disease was con
trolled in five (63%) of the eight stage II
patients who underwent surgery and radi
otherapy, as opposed to one of four who
had surgery alone. One patient in each
treatment group was disease free after
secondary therapy, which consisted of
further resection followed by radiother
apy. O f the eight patients who had com
bined surgery and radiotherapy, one died
11 months after diagnosis of carcinoma
of the tongue, after refusing to complete
the full course of radiotherapy, the other
died of respiratory failure from carci
noma of the lung 10 months after diag
nosis. The only patient who was disease
free after surgery alone had had a com
mando operation; the three others had
recurrences within 4 to 23 months. One
died of lingual carcinoma 38 months after
operation.
Stage III.— O f the seven patients
treated by combined surgery followed by
radiotherapy, four were disease free at a
median follow-up of 39 months (range
from 10 to 50 months), the other three
died within 5 to 45 months (median 20
months). Secondary therapy did not con
trol the recurrent disease. Six of the seven
who had radiotherapy alone initially had
regional recurrences. Only one patient
was disease free, 35 months postoperatively, after secondary therapy for recur
rent disease consisting of a commando
operation. The two patients who had
radiation alone died at 22 and 24 months
after operation respectively; one died of
pulmonary embolism following surgery

*•
<r
►
►
►

FIG. 2—Overall survival by stage for
patients with tongue carcinoma by life-table
calculation. Open circles = stage I (13
patients), closed circles = stage II (12 patients),
open triangles = stage III (18 patients), closed
triangles = stage IV (11 patients). Asterisk
indicates less than five patients entering follow
up interval.

for gastrostomy, the other of carcinoma
of the tongue and larynx. Three patients
in this group were treated by surgery
alone. Only one was disease free at 30
months after operation. The two others
died, one of postoperative complications,
the other of carcinoma of the tongue at
43 months. One patient in this group,
who had chemotherapy, died of bleomy
cin toxicity 2 months after diagnosis.
Stage IV .—In five of the eight stage IV
patients treated with chemotherapy fol
lowed by radiotherapy, regional disease
was not controlled. Two had complete
responses regionally but one subsequently
had cerebral metastases and died 16
months after diagnosis and the other had
widespread metastases and died 19
months after diagnosis. One patient was
alive but had local recurrence at 8
months. One patient who underwent a
commando procedure and radiotherapy
died 5 months after diagnosis. The patient
who received chemotherapy only died 3
months after diagnosis. The patient
treated by chemotherapy preoperatively
followed by a commando procedure and
then radiotherapy had regional failure at
11 months and died 23 months after diag
nosis. In this group of 11 patients, 9 died
of their carcinoma within 3 to 23 months
(median 11 months).
Survival
Although the small numbers in each
stage made analysis unreliable, they did
suggest a trend (Fig. 2). The overall 2-year
survival rate for stage I was 92%, for
stage II 83%, for stage III 61% and for
stage IV patients the overall 2-year sur
vival rate was only 10%.
Comments
Cancer of the tongue remains a disease
of older people, the majority in our ser
ies being in the 50 to 80-year age group.
This is unchanged from an earlier
experience with 100 patients reviewed
from 1953 to 1957 at the Montreal
General Hospital.4 The earlier report
had a male-to-female ratio of 4.8:1 com
pared with 3.5:1 in the current series.
Survival has not changed substantially.
High m ortality was reported with
advanced disease.4 When we compared
our results with those of a recent study
from the Massachusetts General Hospi
tal,2 we found that our results were
slightly better for localized disease (stages
I and II) (2-year survival 92% for stage
I and 83% for stage II versus 73% for
stage I and 51% for stage II). In these
cases, survival rates with surgery com
bined with radiotherapy were not signifi
cantly different from those with surgery
alone. The combination might offer bet
ter regional control in stage II disease.

In advanced disease (stages III and IV),
our 2-year survival rates were 61% and
10% respectively com pared w ith
Ildstad’s2 rates of 41% and 42%. Most
stage IV patients in their series were
treated with radiotherapy alone, while
72% of our stage IV patients received
chemotherapy followed by radiotherapy.
Chemotherapy combined with radiother
apy did not improve survival in this group
and most patients died within 1 year of
diagnosis.
Several reports6-8 give an encouraging
response rate for advanced head and neck
carcinoma with combination chemother
apy that includes cis-platinum. Increased
survival still has to be demonstrated.
Overall control of regional disease was
achieved in 57% of stage III patients
treated with surgery plus radiotherapy as
opposed to 39% overall. Vikram and
associates9 concluded that elective irradi
ation of a neck that is clinically free of
disease, to doses of about 5000 rad in 5
weeks, markedly decreases the likelihood
of subsequent appearance of cancer in the
neck.
Initial treatment should offer the best
chance for cure. Only 33% at best, less
with advanced disease, responded to
secondary therapy. This is a very low sal
vage rate even when the early lesions only
are considered.
More effort should be made to evalu
ate aggressive prospective therapeutic
protocols to increase survival in patients
with carcinoma of the tongue.
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Technetium-99m-Labelled Red Blood Cell Scanning
to Diagnose Occult Gastrointestinal Bleeding
f

A partir de leur experience portant sur
60 patients, les auteurs demontrent que
la scintigraphie a I'aide d'6rythrocytes
marques au technetium-99m est une
technique diagnostique sensible (91%) et
specifique (76%) d'un interet previsionnel eleve, aussi bien pour ses resultats
positifs (81%) que negatifs (92%). Elle
doit etre preferee a I'angiographie selec
tive et elle est moins couteuse comme
epreuve diagnostique de premiere ligne
des saignements gastro-intestinaux
occultes.
The diagnosis and location o f occult gas
trointestinal bleeding can be a very tax
ing problem. Until recently, angiography
was the final investigation used in
attempts to localize the site o f bleeding
before laparotomy was done. It is an
expensive invasive procedure, frequently
giving negative results because o f the
intermittent nature o f the bleeding. Since
1977 numerous nuclear medicine proce
dures have been available for diagnosing
the site o f gastrointestinal bleeding.1'2
Although controversy exists as to which
is the best radiopharmaceutical to use for
the procedure, we chose technetium 99m.
Our decision was based mainly on the
ability o f this agent to remain in the
intravascular compartment; thus, repeat
scanning can be performed 24 hours after
injection if required.
From the Division o f Nuclear Medicine,
Vancouver General Hospital, Vancouver,
BC
Accepted fo r publication June 12, 1985
Reprint requests to: Dr. I.J. Szasz, Divi
sion o f Nuclear Medicine, Vancouver
General Hospital, 855 West 12th Avenue,
Vancouver, BC V5Z 1M9
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Patients and Method
Sixty consecutive patients (42 men, 18
women) admitted over a 1-year period to
the Vancouver General Hospital with
acute occult gastrointestinal hemorrhage
were studied. In all, 71 scans were
obtained.
We used autologous erythrocytes,
labelled in vitro, according to the Indi
ana University erythrocyte-labelling pro
tocol.3 This process requires 8 mL o f the
patient’s blood and takes 20 to 25 minutes
to perform. A labelling efficiency o f 98%
or better is achieved routinely.3'4
Imaging was carried out on a largefield-of-view gamma camera, at 2
s/frame for 15 frames, immediately after
injection of the labelled erythrocytes, and
at 60 s/frame for 90 frames thereafter.
All data were stored on an image proces
sor. Patients were positioned so that the
abdomen and pelvis were imaged. When
the scan showed bleeding, a diagnosis
could be made. If the scan showed noth
ing, imaging was discontinued, to be
resumed if the patient showed signs of
active bleeding during the ensuing 24
hours. In certain circumstances, at the
end of 90 minutes o f imaging, special
lateral or posterior views were requested
by the nuclear physician.
The target organ for exposure in this
procedure is the spleen. The radiation
dose to the spleen from the usual dose of
12 mCi o f " mTc is approximately 0.6
rad, while the whole body exposure is
approximately 0.2 rad.5

Of the 71 scans, 46 demonstrated
bleeding. Table I shows the bleeding sites
(i.e., small bowel and large bowel), the
number o f proven correct localizations
(true positive), incorrect localizations
(false positive) and those that we deemed
“ indeterminate” because the patients had
stopped bleeding and no further diagnos
tic procedures were performed. Of the 46
scans, there were 30 (65%) true positive,
7 (15%) false positive and 9 (20%)
indeterminate scans.
Table II demonstrates the discrepancies
in the seven false-positive scans. While
the 15% false-positive rate is higher than
that reported in other studies, we should
point out that these patients were actively
bleeding at the time of the study and the
sites o f bleeding identified from the scan
were incorrect. This may be owing to lack
o f experience on the part o f the nuclear
physician, but also demonstrates the
difficulty in accurately identifying bleed
ing sites in the right lower quadrant and
differentiating between cecal, terminal
ileal or Meckel’s diverticular hemorrhage.
In the true-positive category, our diag
nosis was proven by either angiography,
endoscopy and contrast roentgenography
of the bowel or by surgery. O f 46 patients

The sex distribution was the same in
our subgroups as it was overall, suggest
ing that the acute gastrointestinal hemor
rhage is more than twice as common in
men as in women.

r
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The authors, from their experience in
60 patients, demonstrate that
technetium-99m-labelled red blood cell
scintigraphy is a sensitive (91%) and
specific (76%) diagnostic procedure with
a high predictive value, when both posi
tive (81%) and negative (92%). It is
preferable to and more cost-effective
than selective angiography as a first-line
diagnostic test for occult gastrointestinal
bleeding.
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with positive scans, 16 underwent surgi
cal procedures. In the group with nega
tive scans, only one surgical procedure
was performed (Table III).
Thirteen of the 46 patients with posi
tive scans had angiography, 5 before scin
tigraphy. All angiograms appeared nor
mal. Eight obtained after scintigraphy
were in agreement with the scan findings.
Possibly the scan findings influenced the
radiologist’s in terp retatio n o f the
angiogram.
The average hospital stay of patients
with positive scans was 24 days; the aver
age amount of blood transfused was 15
units.
Twenty-five (35%) scans failed to
demonstrate active bleeding sites; 3 of
them were found to be false negative. One
patient was bleeding from esophageal
varices, outside the camera’s field of
view. We misinterpreted activity in the
stomach as technetium that had dis
sociated from the erythrocytes and was
secreted into the stomach by the gastric
mucosa. A second patient was bleeding
from an ileostomy stoma and a third from
gastric erosions. We accepted the remain
ing 22 scans as true negatives, although
three patients had positive scans 2, 5 and
11 days later. Five patients with negative
scans had normal angiograms. One
patient in this group underwent smallbowel resection for Crohn’s disease. The
average hospital stay in the group was 14
days and the average blood transfusion
was 8 units.
Four patients with positive scans died
within 4 weeks of the study. None of these
deaths resulted from gastrointestinal
hemorrhage.
Discussion
Scintigraphy with WnlTc-labelled ery
throcytes to demonstrate and localize gas
trointestinal bleeding is a noninvasive
procedure with no mortality and minimal
morbidity. In our experience it has a high
sensitivity (91%) and specificity (76%).
Angiography, on the other hand, is
invasive and is associated with a lower
sensitivity and specificity. Predictive
values in our series were 81% and 92%
for positive and negative scans respec
tively. In addition, labelled-erythrocyte
Table Ill-Surgical Procedures

molliner
laboratories

Procedure

INC.

“Bringing New Ideas to Life.”
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T6E 2A4

5 14

Positive

Gastric procedures
Small-bowel resection

3
1

Resection of Meckel's
diverticulum
Partial colectomy
Total colectomy

4
7
1

Scans
Negative
1
(for Crohn's)
disease)

scintigraphy is useful in orientating
angiography to the appropriate vessel.
It is our contention that angiography
following erythrocyte scintigraphy is indi
cated only for therapeutic purposes, such
as Gelfoam embolization or vasopressin
infusion. Because of our findings that all
angiograms performed before scanning
gave negative findings, this procedure
should not be performed before scanning,
a belief borne out by the results of other
studies.6 Not only is angiography inher
ently less sensitive than labellederythrocyte scintigraphy, it is also more
expensive and hazardous to the patient.7
The long-term prognosis and manage
ment of patients with positive and nega
tive scans differ considerably. Patients
with positive scans on average spent
almost twice as long in hospital as did
those with negative scans (24 versus 14
days) and received almost twice as much
blood (15 units versus 8 units). There were
four deaths in the study (6.7%), all in
patients with positive scans, a rate simi
lar to that of Markisz and colleagues;6
this emphasizes the high morbidity and
mortality in these patients.
Conclusions
Technetium-99m erythrocyte scintigra
phy for occult gastrointestinal bleeding is
noninvasive, inexpensive and relatively
simple compared with angiography. It is
highly sensitive and specific and a patient
may be imaged repeatedly within 24 hours
without further injection of radiophar
maceutical. Thus, it is a better agent than
" mTc sulfur colloid and is better than
angiography. While it does not eliminate
the need for angiography, it increases its
accuracy and use for therapeutic pur
poses.
We thank the staff o f the Department of
Surgery and Department of Radiology, Van
couver General Hospital, for their cooperation
in conducting this study.
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The Madreporic Cementless Total Hip Arthroplasty:
Short-Term North American Experience
F o rty -fo u r M adreporic, cem entless, to ta l
hip arth ro p lastie s perform ed on 41
p a tien ts w ere review ed, w ith special
a tte n tio n to overall clinical results and
rad iologic fin d in g s. F ollow -up averaged
17 m on th s (range fro m 6 to 2 7 m onths).
S u b je ctive ly, 8 7 % o f patien ts rated the
results o f their operation as being excel
le n t or good; o b je ctive ly, 9 2 .5 % were in
th e e xcellent or good ca te go ry, using the
Harris hip scale rating system . S h o rt
te rm radiologic fin d in g s w ere o f major
in te re st, w ith proxim al m edial calcar
reabsorption (7 hips), th icke nin g o f the
lateral c o rte x at the tip o f the fem oral
stem (2 hips) and sclerosis a t th e tip of
th e fem oral co m p o n e n t (15 hips) all
being present. C om plications w ere
associated w ith 11 operations, b u t
adversely a ffe cte d long-term results in
o nly tw o hips.
The authors conclude th a t short-term
clinical results using M adreporic total
hip replacem ent are sa tisfa cto ry.
H o w e ve r, long-term biom echanical
e ffe c ts o f stress shielding and use o f a
large, rigid, fem oral co m p o n e n t in the
uncem ented to ta l hip replacem ent are
u n k n o w n . A long-term , fo llo w -u p study
is necessary to d e m onstrate w h e th er the
early radiologic fin d in g s in th is series are
progressive and w h e th e r th e y w ill result
in serious m orb id ity w ith tim e. The
a u tho rs stro n g ly believe th a t the
M adreporic cem entless to ta l hip
a rth ro p la sty should be used on ly in
centres dealing w ith a large volum e o f
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hip co n d itio n s w here s ta ff are c o m m itte d
to d o cu m e n tin g and reporting th e re su lts
o f surgery regularly.
Les dossiers de 41 patien ts chez qu i 4 4
a rth ro p lastie s to ta le s de la hanche
M adreporic non-cim entees fu re n t p ra tiquees o n t ete exam ines. Le but e ta it une
e valuation des resultats cliniques generaux et des donnees radiologiques. La
duree des suites e ta it de 17 mois,
s'e ch e le n a n t entre 6 et 2 7 m ois. S ubjective m e n t, 8 7 % des patien ts o n t ju g e
I'o p e ra tio n excellente ou bonne; e t objectiv e m e n t, 9 2 .5 % de ces patients e ta ie n t
dans la categorie excellente ou bonne.
L'echelle d e v a lu a tio n de Harris e ta it
u tilisee com m e base d e v a lu a tio n . A
co u rt-te rm e , les donnes radiographiques
e ta ien t tres interessantes, avec la rea b 
so rp tio n proxim ale interne de la plaque
tissu laire e n to u ra n t le col du fe m u r (7
hanches), un epaississem ent de la
couche externe a I'e xtre m ite de la p ro 
these fem orale (2 hanches) et une
o ste ite de condensation a I'e x tre m ite de
la prothese fem orale (15 hanches). Des
co m p lica tio n s se sont developpees dans
11 operations, m ais o n t d e favo ra b lem e n t
a ffe c te les resu lta ts dans seulem ent
deux de ces hanches.
Les auteurs o n t conclu que les resulta ts cliniques a co u rt-te rm e de c e tte
opera tio n so n t satisfaisants. M ais, q u 'a
lo n g -te rm e les e ffe ts biom ecaniques de
p ro te ctio n co n tre la te n sion et I'u s u re
d 'u n e prothese fem orale large e t rigid e
dans I'a rth ro p la stie to ta le de la hanche
n o n-cim entee so n t actuellem ent
inconnus. Une etude de suivie a lo n g te rm e serait necessaire pour d e m o n tre r si
les prem iers resultats radiologiques dans
ce tte serie so n t progressifs et si, au b o u t
d 'u n certa in tem ps, ils re su lte ro n t dans
une m o rb id ity im po rta n te . Les a u te u rs
so n t d 'a v is que I'arth ro p la stie to ta le de
la hanche M adreporic n on-cim ent6e d o it
etre e ffe ctu e e u niquem ent dans les
centres hospitaliers qui e ffe c tu e n t un
assez grand nom bre de ces o p e ra tio n s et
o il les ch iru rg ie ns sont obliges de
d o cu m e n te r et de faire des rap p o rts des
resu lta ts de leurs operations ci des in te r
v a l s reguliers.

A recent 10-year follow-up study of
cemented total hip arthroplasties reported
overall incidences of femoral and
acetabular loosening of 40% and 29%
respectively. Revision was necessary in
25% of cases,1and the results have been
most discouraging with many intraoper
ative complications, infection, postoper
ative dislocation, bony reabsorption and
subsequent prosthetic loosening.2 Thus,
there has been a recent trend toward the
research and development of a satisfac
tory uncemented total hip prosthesis that
would bypass the use of methylmethacry
late, implicated as the reason for loosen
ing and subsequent failure in the conven
tional arthroplasty.3-6 The Madreporic
cementless total hip (Benoist Girard,
Paris; French manufacturing division of
Howmedica Inc.) has been used clinically
by Gerard Lord in Paris since 1975.4-6
However, there has been no report of a
North American experience with this
technique. This paper reports the short
term results in a series of Madreporic
cementless total hip arthroplasties, with
special emphasis on overall clinical results
and radiologic findings.
Patients and Methods

Fifty-five Madreporic cementless total
hip arthroplasties were performed in 51
patients over 20 months. There were two
deaths and eight patients were lost to
follow-up, leaving a total of 44 hips in 41
patients (20 men, 21 women) for review.
The average age at surgery was 67.5 years
(range from 40 to 87 years). Two patients
were younger than 55 years, 16 were
between 55 and 65, and 23 patients were
over 65 years of age at time of surgery.
Follow-up averaged 17 months (range
from 6 to 27 months). Degenerative
osteoarthritis was the most common rea
son for total hip replacement (32 cases).
Other reasons included rheumatoid
arthritis (one), subcapital fracture (three)
and failure of a Moore arthroplasty or
Richards pinning (four).
In all cases the universal, cementless,
porous-coated femoral component was
used with an interchangeable femoral
head. In 36 hips, an uncemented acetabu
lar screw ring made of chrome cobalt with

VOLUME 28, NO. 6, NOVEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

515

a polyethylene interchangeable socket was
used. In five hips with no acetabular dis
ease, the Madreporic femoral component
was inserted with a floating cup, and in
three hips with insufficient acetabular
bone stock, a conventional acetabular
component was cemented in place. Posi
tioning of the patient, operative exposure
and preparation of the acetabulum and
femur were exactly as described by
Lord.4-6
Patients were examined and questioned
by the authors and each patient was asked
to grade the result of the total hip replace
ment. Recent roentgenograms were
assessed and compared to postoperative
films. All hips were graded pre- and
postoperatively using the Harris hip
scale.7

medullary canal distal to the femoral
component in 15 hips (Fig. 3). Acetabu
lar analysis showed a radiolucent line with
migration in one hip (Fig. 2). This was the
only hip requiring acetabular revision.
There were no cases of protrusio. Two of
the components were inserted in retrover
sion, resulting in dislocation in one. In
five hips, vertical inclination of the
acetabular component was greater than
55°. One of these hips dislocated. There
were seven hips with poor collar calcar
seating. Some degree of medial calcar
reabsorption was seen in four of these

hips at follow-up (Fig. 1). Five of the
seven cases showed some degree of scle
rosis in the medullary canal just distal to
the tip of the femoral prosthesis. Radiologic analysis of the nine patients with
mild discomfort of the middle segment of
the thigh showed five with early bone scle
rosis at the femoral prosthetic tip and one
with lateral cortical thickening that was
associated with varus malalignment of the
femoral component. In three hips there
was no specific radiologic correlation.
Complications occurred intraoperatively or immediately postoperatively in

Findings
Subjectively, the result of operation
was rated as excellent or good in 86.4%
(38 hips). There were four fair ratings due
to persistent discomfort in the hip region
and two patients rated the result poor and
required early revision. In one a cemented
femoral prosthesis was inserted after a
vertical fracture of the femoral shaft
allowed the femoral component to sub
side substantially. The other patient
suffered a dislocation in the convalescent
hospital. Heterotopic ossification made
it impossible to reduce the dislocation so
the prosthesis was removed and a Girdlestone procedure was done. These two hips
are not included in the Harris hip scale
analysis or radiologic assessment.
The Harris hip scale rating showed an
average preoperative score of 31.6 points.
Postoperatively, the average was 87.5
points with 88% of the hips (37) being in
the excellent and good categories and
12% (5) in the fair and poor. These lesssatisfactory results were due to continued
pain in the hip region postoperatively
(four) and a persistent bursitis of the
greater trochanter (one). All patients had
a good range of motion with no serious
deformities. Nine had a persistent dull
ache in the anterior region of the middle
thigh. This mild discomfort did not com
promise activities. In five patients discom
fort was less at the time of examination
than at 6 months postoperatively. Lord
reported similar findings but found that
the ache disappeared with time.5 Radiologic analysis showed substantial hetero
topic ossification in only one hip. It was
difficult to assess the degree of bony
ingrowth around the femoral acetabular
components at this early follow-up
period. The femoral components showed
no evidence of loosening or migration;
however, there were early supporting zone
changes in nine hips, seven showing
medial, proximal calcar reabsorption
(Figs. 1 and 2) and two showing thicken
ing of the lateral cortex at the stem tip.
Some degree of sclerosis was noted in the
516
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FIG. 1—Cemented acetabular component with (a) poor femoral collar-calcar contact (arrow)
postoperatively and (b) proximal medial calcar reabsorption (arrows) after 18 months.

>
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25 mo

■
Fig. 2a

Fig. 2b

FIG. 2—(a) Loose acetabular component (arrow) in 68-year-old man 2 months after oper
ation. Radiolucent line with migration is visible (arrow), (b) Revised acetabular component and
medial proximal calcar reabsorption (arrow) 25 months postoperatively.
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23% of the operations. There were three
undisplaced fractures of the greater
trochanter (Fig. 4), three hips had verti
cal fractures of the femoral shaft, there
were three dislocations, one case of
acetabular loosening (Fig. 2) and one
technical error in which the size of the
acetabular component did not match the

size of the femoral head. Revision was
necessary in four hips as a result of
femoral shaft fracture, an irreducible dis
location, a loose acetabular component
and a mismatch in the sizes of the femoral
head and acetabular component. Long
term results were adversely affected in
only two of the hips with complications.
There were no cases of infection.
Discussion
Subjective and objective results in this
study were comparable to those reported
by Lord.4'6 However, it is the short-term
roentgenographic findings in our series
that are of particular interest. The 17%
incidence (seven hips) of early medial cal
car reabsorption is of concern. Little
resistance is encountered when placing the
prosthesis in the proximal fem ur.
However, there is moderate friction when
inserting the last 5 to 8 cm of the stem
before collar calcar seating occurs. This
results in close contact and rigid fixation
between the femoral shaft and the distal
half of the prosthesis. Proximally, there
is little or no contact between the prosthe
sis and cortex. This stress shielding results
in bony reabsorption proximally. In 15
hips (36%) there was some sclerosis at the
tip of the femoral component. This is due
to the sudden transition from the rigid
ity of the large femoral component to the
normal elasticity of the femoral diaphysis and is probably the reason why several
patients experienced a dull ache in the
thigh postoperatively. The sclerosis is an
attempt by the body through bony
remodelling to smooth out this area of
transition. Once this remodelling has
taken place, the anterior thigh pain
decreases and eventually disappears. Per
fect collar calcar seating should allow for
transmission of some stress to the prox
imal medial femoral cortex. If this seat-
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ing is not exact, most of the stress will be
distributed distally, resulting in more
stress shielding and a greater transition
gradient at the tip of the femoral com
ponent.
The operation is technically demand
ing. Proper insertion of the acetabular
component is difficult. Once tapping has
started, it is extremely difficult to change
alignment. The 14% incidence o f frac
tures of the greater trochanter (three) and
the femoral shaft (three) is unacceptably
high. It is most important to resect suffi
cient bone laterally from the greater
trochanter to prevent trochanteric frac
ture and, if necessary, to ream the
femoral canal with the flexor AO (Associ
ation for Osteosynthesis) reaming set
rather than trying to force the femoral
component down the shaft. Lord claims
that this type of reaming improves
endosteal bone ingrow th into the
prosthesis.6
Conclusions
Objective and subjective short-term
results using the Madreporic cementless
total hip arthroplasty are acceptable.
However, they are not superior to the
short-term results o f conventional
cemented total hip arthroplasty. The
unacceptably high incidence of complica
tions indicates that a high degree of exper
tise is necessary when performing this
operation. We recommend that use of the
M adreporic cem entless to ta l hip
arthroplasty be restricted to centres han
dling a large volume of patients with hip
diseases that have staff who are willing
to follow up their patients closely and
report results at regular intervals. A
10-year follow-up study is necessary to
demonstrate whether results using the
Madreporic prosthesis are indeed superior
to those of conventional cemented
arthroplasty and whether the early radi
ologic findings of supporting zone
changes seen in our study are progressive,
resulting in significant morbidity with
time.
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Fig. 3b
FIG. 3—Tip of femoral component in med
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immediately after operation (a), while at 13
months (b) sclerosis can be seen (arrow).
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trochanter (arrow).
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Early Bronchial Revascularization With an Intercostal
Pedicle Graft Following Canine Lung Autotransplantation
f

«
The contribution of an intercostal pedicle
flap to early revascularization and healing
of the bronchial anastomosis following
lung autotransplantation was evaluated
in dogs.
Left lung reimplantation was performed
both in 33 control dogs (group 1) and in
38 dogs in which a pedicled intercostal
muscle graft was wrapped around the
bronchial anastomosis (group 2). Radiologic injection studies, estimation of the
cross-sectional area of the anastomosis
and histologic examination to assess the
degree of healing were made at autopsy
— 7, 14 and 28 days respectively after
transplantation.
Within a week, the bronchial mucosa
was more normal and the anastomosis
substantially more patent in group 2 than
in group 1 animals.
This study indicates that the inter
costal pedicle flap significantly improves
bronchial healing by promoting revas
cularization across and beyond the bron
chial anastomosis at least as early as 7
days after lung reimplantation.

mose bronchique (groupe 2). Les animaux ont 6te mis a mort 7, 14 et 28
jours apres intervention. A Tautopsie,
des etudes radiologiques avec des injec
tions de Microfil ont ete effectuees sur la
circulation bronchique; la surface de la
coupe transversale de I'anastomose
bronchique a ete estimee, et des examens histologiques ont 6te faits pour
evaluer le degre de cicatrisation.
En dedans d'une semaine, la surface
de la coupe transversale du site anastomotique etait considerablement plus
large, et la muqueuse bronchique distale
de I'anastomose bien plus normale dans
le groupe 2 d'animaux avec une graffe
de lambeau musculaire intercostal que
dans le groupe 1 d'animaux temoins.
Cet etude a demontre que le pedicle
d'un lambeau musculaire intercostal ameliore, d'une maniere significante, la cica
trisation des bronches en favorisant la
revascularisation arterielle a travers et au
dela de I'anastomose bronchique, au
moins 7 jours apres reimplantation du
poumon.

La contribution d'un pedicle de lambeau
musculaire intercostal pour la revasculari
sation precoce et la cicatrisation de
Tanastomose bronchique apres une autoplastie pulmonaire, a ete evaluee chez le
chien.
La reimplantation du poumon gauche a
ete effectu^e dans 33 chiens temoins
(groupe 1) et dans 38 chiens dans lesquels un lambeau musculaire intercostal
a ete employ^ pour envelopper I'anasto-

Between 1963 and 1982 approximately 40
human lung transplants were performed
as treatment for end-stage lung dis
ease.1"3 So far this procedure has been
unsuccessful, the longest survivals being
6 and 10 m onths.1 This lack of success
has generally been attributed to three
problems: procurement of donor lungs,
rejection of lung allografts and compli
cations involving the bronchial anastomo
sis. These complications, which include
leakage, stenosis, hemorrhage, infection
and mucosal necrosis with aspiration
pneumonia, are due to ischemia of the
allotransplanted or autotransplanted
bronchus resulting from interruption of
the normal vascular pathways of the
bronchial tree.1
Various attempts have been made to
improve bronchial healing after lung
transplantation: transecting the transplant
bronchus as close as possible to the pul
monary hilus,4 reinforcing the bronchial
anastomosis with peribronchial connective
tissue5 or pericardial flap,6 telescop
ing the bronchial end at the anastomosis7
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and suturing a button of donor aorta con
taining the origin of bronchial arteries
into the recipient aorta.8 Although these
techniques have helped to prevent bron
chial complications in experimental trans
plants, they have not resolved the
problems encountered in humans several
weeks after lung transplantation.1’2
These complications are probably caused
by a combination of factors such as ische
mia, rejection of the allograft bronchus,
the high dosage of immunosuppressive
drugs, and the size difference between
donor and recipient bronchi.
To shorten the period of ischemia, thus
enhancing bronchial healing, new opera
tive procedures are being developed.
These involve lobar bronchial anastomo
sis to improve pulmonary-to-bronchial
collateral blood supply,9 microsurgical
techniques such as reconstitution of
divided bronchial arteries10 or end-toend anastomosis of the bronchial artery
to an intercostal artery,11 and bronchial
omentopexy12 to allow immediate reper
fusion of the distal bronchus. While these
procedures improve bronchial anasto
motic healing, they add to the difficulty
of the transplant operation and prolong
the operating time.
In a recent pilot study, Mollenkopf and
associates13 evaluated the role of a pedi
cled intercostal muscle graft on the heal
ing of a completely devascularized bron
chial autograft following pneumonec
tomy in dogs. They demonstrated revas
cularization of the autograft 21 to 46 days
after operation. We believe that this
canine model should optimize early revas
cularization and bronchial healing. We
therefore undertook to assess the effects
of the intercostal pedicle flap on the early
re-establishment of the bronchial circu
lation following canine lung autotrans
plantation.
Material and Methods

Seventy-one mongrel dogs, weighing
between 15 and 25 kg, were divided into
two groups at random. In group 1, 33
dogs underwent left lung reimplantation
and in group 2, 38 underwent left lung
reimplantation with a pedicled intercostal
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muscle graft wrapped around the bron
chial anastomosis.
Atropine sulfate (0.04 mg/kg) was used
as premedication and anesthesia was
induced with droperidol-fentanyl citrate
(Innovar-Vet, 0.1 m L/kg). Anesthesia
was maintained with 1% to 1.5%
halothane in oxygen and nitrous oxideoxygen in a ratio o f 3:2 administered with
a VMS Frazer Sweatman anesthesia
machine (Fraser Sweatman Inc., Lan
caster, NY) and a Harvard positivepressure ventilator (Harvard Apparatus
Co. Inc., S. Natick, Mass.). Muscular
relaxation was provided by pancuronium
bromide (0.05 mg/kg).
Operative Procedures
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Sterile conditions were observed
throughout. The animals were placed in
the right lateral recumbent position with
the left foreleg in full extension. A no. 5
French heparinized catheter was placed in
the aortic arch through the left common
carotid artery for blood sampling and to
record the systemic arterial pressure.
Another no. 8 French catheter was placed
in the superior vena cava through the left
external jugular vein to take reference
blood samples, administer medication,
infuse fluids and measure central venous
pressure. The distal ends o f the catheters
were positioned behind the neck.
The chest was entered through the left
fifth intercostal space. The fifth rib was
removed by careful subperiosteal resec
tion. The intercostal muscle graft was cut
anteriorly near the sternum and superi
orly and inferiorly along the bed of the
excised rib. It was then stripped from the
underlying visceral pleura, leaving the
parietal pleura attached to the pedicle.
The orifice of the distal end o f the inter
costal artery was ligated and the graft
wrapped carefully in a gauze soaked with
Ringer’s lactate solution to keep it moist.
The inferior pulmonary ligament was
divided and the pericardium opened
posterior to the phrenic nerve. Heparin
(0.6 mg/kg) was given intravenously, then
the left pulmonary artery was dissected
free of all adventitia and divided half way
between clamps. The left main bronchus
was transected just proximal to the lobar
orifices. The bronchial arteries were
clamped and ligated as they were encoun
tered at the line of bronchial division. The
single-lumen endotracheal tube was
advanced into the right bronchus to pre
vent an air leakage after division. A
DeBakey tangential occlusion clamp was
placed across the left atrium as far medi
ally as possible and the atrium was
divided to provide a cuff containing the
left pulmonary veins. The pulmonary
artery was cannulated and the excised
lung was flushed from a height o f 50 cm
with 500 mL o f a cold, buffered solution
(15°C) of Ringer’s lactate to which 10.0

mg of heparin had been added. Flushing
was continued until the effluent from the
left atrial cuff became clear.14
The lung was then reimplanted. The
atrial cuff was anastomosed with a run
ning everting mattress suture of 5-0 Prolene. The bronchial anastomosis was done
with 5-0 Prolene sutures, a single layer of
continuous sutures for the membranous
bronchus and interrupted ones for the
cartilaginous portions.15 Care was taken
to ensure good mucosal approximation.
The left pulmonary artery was reapprox
imated with a continuous 6-0 Prolene
suture. The viable intercostal pedicle was
wrapped around the bronchial anastomo
sis with its external surface applied to the
anastomosis and held in place with several
4-0 chromic sutures. Following an
intravenous injection of 10.0 mg o f hepa
rin, all vascular clamps were removed and
blood flow was re-established in the left
lung. The endotracheal tube was reposi
tioned, the lung re-expanded and the chest
incision closed. Artificial respiration was
discontinued 30 to 45 minutes after the
end of the procedure. During the opera
tion all animals received Ringer’s lactate
at a rate o f 6.0 m L/kg per hour. Antibi
otics (ampicillin) were given prophylactically for 7 days postoperatively. Serial
chest roentgenograms were obtained rou
tinely in the postoperative period.
Autopsy was done on all dogs after
they were put to death electively 7, 14 or
28 days postoperatively.
In group 1, bronchial artery circulation
was demonstrated by injecting 20 mL o f
a radiopaque latex rubber preparation
(Microfil) at 120 mm Hg pressure into the
descending aorta, which was clamped
immediately above and below the origin
o f the bronchial vessels. In group 2, the
pedicled intercostal artery was ligated at
its proximal end and the distal segment
was cannulated and injected with 15 mL
o f Microfil at the same pressure to deter
mine if the anastomosed bronchus had
become revascularized through the pedi
cled intercostal circulation. To prevent
microcirculatory thrombosis, and there
fore to realize improved Microfil injec
tion preparations, all animals were
heparinized (3.0 m g/kg) at the time of
sacrifice. Three hours after Microfil injec
tion, the thoracic viscera were excised and
magnification roentgenograms were
obtained o f the injected specimens.
The state o f the anastomotic site and
the distal bronchus was assessed. The
cross-sectional area (CSA) of the bron
chial anastomosis was calculated from the
following formula: CSA = a /2 x b /2 x
7r, where a was the transverse diameter
and b the sagittal diameter. Diameters
were measured at the anastomotic site and
immediately proximal to the site using a
Mitutoyo Model MN84 dial caliper
(Rideout Tool & Supply Ltd., St. John’s,

Nfld.). The CSA o f the anastomosis was
then expressed as a percentage o f the CSA
o f the left main bronchus just proximal
to it.
Following CSA measurements, the left
and right bronchial tree were slit for gross
examination o f the mucosa, the speci
mens were photographed and longitudi
nal sections o f the left bronchus were cut
from four different quadrants o f the
anastomosis for microscopic study. The
sections were fixed in 10% formalin,
embedded in paraffin, cut and stained
with hematoxylin and eosin. Histologic
examination was performed in a blind
fashion by the pathologist (S.M .C.) to
evaluate the degree o f healing, the viabil
ity and the structural integrity o f the
a n astom otic co m p o n en ts and the
presence o f Microfil in vessels distal to the
anastomosis.
The animals in these studies received
humane care in compliance with the
“ Guide to the Care and U se o f
Experimental Animals” formulated by
the Canadian Council on Animal Care.
Analysis o f variance was used to cal
culate the significance o f differences
within and between groups. Results are
given as mean ± 1 standard error o f the
mean and p values.

Results
O f the 71 dogs operated on, 14 died
within 24 hours o f operation and 21 were
sacrificed as a result o f complications dur
ing the first 6 postoperative days. Six o f
the 14 dogs died o f respiratory arrest
resulting from anesthetic problems. Two
dogs aspirated stomach contents and one
animal died o f operative hemorrhage
from tears in the thin posterior left atrial
wall. Ventricular fibrillation developed in
five dogs during the procedure. Three
were successfully resuscitated but died
within 18 hours. Anoxia was the cause of
fibrillation in these three dogs. In the
other two animals, ventricular fibrillation
was caused by occlusion o f the circum
flex artery with the cardiovascular clamp
while the atrial cuff was being prepared.
Severe respiratory distress was observed
in one dog on day 2 and four others on
day 3 after surgery. Autopsy revealed that
all animals had pulmonary atelectasis as
a result o f retained mucosal secretions dis
tal to the anastomosis. Fifteen animals
were sacrificed 2 to 6 days after surgery
because o f intermittent cough productive
o f either blood-tinged or heavily blood
stained sputum. Autopsy examination
showed that six hemoptysic dogs had
infarction o f the left lung secondary to
thrombosis between the pulmonary veins
and the left atrial suture line. The other
animals exhibited marked congestion
both in the interstitial areas and in the
alveolar walls o f the pulmonary paren
chyma with some extravasation o f red
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cells in the alveolar spaces. In most of
them the upper lobe was affected. In one
dog, thrombosis of the pulmonary artery
resulted in focal pulmonary infarcts.
The remaining 36 dogs were allowed to
survive 7, 14 or 28 days according to the
experim ent protocol. During these
time intervals, all of the planned bron
chial anastomotic studies were satisfac
torily completed. There was no instance
of wound infection, pneumonia, bron
chial leak or dehiscence in any of the
animals. The mean ischemic time, meas
ured from the time of clamping the pul
monary artery until all anastomoses were
completed, averaged 107.3 ± 6.4 min and
101.8 ± 4.0 min in groups 1 and 2 respec
tively. This slight difference in ischemic
times between groups was not significant.

mucosal healing with fibrosis and granu
lation tissue at the suture line (Fig. 2b).
Roentgenograms obtained at 28 days
demonstrated apparently complete re
establishment of bronchial blood flow to
the reimplanted lung. There was a good

Plain Film Roentgenography

reconstitution of the bronchial mucosa.
Histologic examination paralleled the
gross appearance. There was some minor
distortion of the smooth muscles of the
bronchial wall and some areas of fibro
sis at the anastomotic site; otherwise, the
mucosal lining appeared intact.
Group 2.—Microfil injection studies
were carried out on 12 dogs and on 8 dogs
with a viable intercostal flap on days 7
and 14 respectively, and on 2 other dogs
at day 28.
At 7 days, many small Microfil-injected
vessels were visible at the level of, and
extending just beyond, the anastomosis
(Fig. 3a). Gross examination of the inter
costal pedicle flaps indicated that the flaps
were already adhering strongly to the
underlying bronchus. Histologic exami
nation of specimens revealed partial
peripheral infarction and organizing

1

A

A

In both groups, serial chest films were,
as a rule, clear during the first 48 hours
after surgery. In some instances opacifi
cation o f the entire transplanted lung, or
part of it (mostly the upper lobe), was
observed for the next 3 to 4 days. There
after, the lung’s appearance returned to
normal.
At autopsy, focal atelectasis, patchy
edema and adhesions were observed in the
reimplanted lungs of group 1 dogs 7 and
14 days postoperatively. Adhesions and
focal atelectasis were still present at 28
days. The gross appearance of the lung
was norm al in group 2 animals 7 and 14
days after autotransplantation, except in
four dogs in which some adhesions were
seen at the site of the thoracotomy
incision.

A

A

1
A

i
◄

Injection Studies
Group 1.—Microfil injection studies
were performed on seven dogs at day 7,
five at day 14 and two at day 28.
No filling of the bronchial circulation
beyond the anastomotic site could be seen
at the end o f the first postoperative week
(Fig. la) except in one animal in which
scanty vessels were visualized crossing a
small portion of the suture line. In that
particular dog, histologic examination
showed microcalcification and necrosis of
smooth-muscle fibres as well as focal loss
of lining epithelium below the anastomo
sis. In the other dogs, the distal bronchus
showed epithelialization but subepithelial
tissue was attenuated and distorted with
small areas o f erythema and ulceration at
the suture line (Figs, lb and c).
At 14 days, many small arteries that
had been restored at the level of the divi
sion of the left main bronchus were
observed extending to the distal bronchi
in the inferior portion of the autotransplanted lung (Fig. 2a). In most speci
mens, light microscopic examination of
the left main bronchus revealed normal
520
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Fig. lc
FIG. 1—Group l dog 7 days after left lung
reimplantation, (a) Roentgenogram of distal
trachea and main-stem bronchi. Radiopaque
dye (Microfil) has been injected into ascending
aorta clamped immediately above and below
origin of bronchial vessels. Bronchial circula
tion stops at level of anastomosis (arrow), (b)
Microfil-injected specimen of distal trachea and
main-stem bronchi. Suture line is granuloma
tous and no Microfil-injected vessels can be
seen in apparently intact mucosa below suture
line. There is atrophy and dystrophic calcifi
cation in smooth muscle of bronchial wall dis
tal to anastomosis, (c) Area distal to suture line
of bronchus (arrow and inset). There is
epithelialization but attenuation and distortion
of subepithelial tissue. Spaces in bronchial car
tilage are artifacts (original magnification x
4, inset X 8).

Fig. 2b
FIG. 2—Group I dog 14 days after left lung
reimplantation, (a) Many small vessels have
been restored at level of division of left mainstem bronchus (arrow), some are extending to
distal bronchi in inferior portion of autotransplanted lung, (b) Microfil-injected specimen
of main-stem bronchi shows normal healing of
distal bronchus but distortion and fibrosis at
suture line.

VOLUME 28, NO. 6, NOVEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

fibrosis of the skeletal muscle flap, nor
mal epithelialization of the bronchial
mucosa and good revascularization dis
tal to the suture line (Figs. 3b and c).
On day 14, multiple capillaries had
regenerated around the bronchial anasto
mosis, spreading out towards the periph
ery of the bronchial tree. They originated
from the intercostal pedicle flap and com
municated with the distal bronchial cir
culation (Fig. 4a).

Histologic sections of the left main
bronchus revealed intravascular collec
tions of injected Microfil and excellent
reconstitution of the structural integrity
of the bronchial wall distal to the anasto
mosis (Fig. 4b). At 14 days the flap
showed signs of metaplastic ossification
and fibrosis without bronchial con
striction.
There was no significant difference
between the abundant bronchial circula
tion distal to the anastomosis, observed
at 28 days, and that described at 14 days.
Light microscopy demonstrated normally
reconstituted bronchial mucosa with
excellent neovascularization but nodular
calcification in the intercostal flap and
focal metaplastic ossification. However,
there was partial preservation and viabil
ity of the intercostal flap. Slight attenua
tion of the bronchial smooth-muscle
fibres was present.

Fig. 3c
FIG. 3—Group 2 dog 7 days after left lung
reimplantation with application of intercostal
pedicle flap, (a) Microfil has been injected
through intercostal artery. Part of intercostal
muscle graft has been removed, showing
regenerated small bronchial vessels at level of
anastomosis and beyond (arrow), (b) Microfilinjected specimen demonstrating normal
epithelialization of mucosa and neovascular
ity proximal and distal to suture line, (c) Pho
tomicrograph showing epithelialization and
subepithelial apparent neovascularity with vas
cular channels partially filled with Microfil.
Focally fibrosed pedicle graft is present under
cartilage at right. Spaces in bronchial cartilage
are artifacts (original magnification X 4, inset

x 8).

Fig. 4b
FIG. 4—Group 2 dog 14 days after left lung
reimplantation with intercostal pedicle graft
surrounding bronchial anastom osis, (a)
Microfil has been injected through intercostal
artery (white arrow). Multiple capillaries have
regenerated around bronchial anastomosis
(black arrow), spreading out towards periph
ery of bronchial tree, (b) Microfil-injected
specimen demonstrates good revascularization
and excellent reconstitution of structural
integrity o f bronchia] wall distal to anasto
mosis.

Cross-Sectional Area
The CSA increased significantly
(p<0.01) with time until day 14 in group
2 animals with a pedicle intercostal flap.
There was no significant change with time
in group 1 dogs.
The mean CSA of the bronchial
anastomosis in group 1 animals at 7 days
was 61.9% ± 5.2% of normal compared
with 76.7% ±2.7% in group 2 (p<0.01).
At 14 days the mean CSAs were
67.0% ±5.2% and 86.4% ±3.4% for
groups 1 and 2 respectively (p <0.01). No
further significant change in the degree
of bronchial patency could be found
between the two groups at 28 days.
Discussion
Unsatisfactory bronchial healing fol
lowing lung allotransplantation occurs for
three reasons: ischemia distal to the
anastomotic site, the effect of immuno
suppressive drugs on healing and the re
jection response that takes place at the
anastomosis. The present study addresses
the first point only.
Improved bronchial healing and revas
cularization of the bronchus distal to the
anastomosis has been demonstrated in
dogs 4 days after left-lung reimplantation
with omentopexy,12 whereas regenera
tion of the bronchial circulation across
the anastomotic site without omentopexy
takes 2 to 4 weeks in both canine
autografts16 and allografts.17 Indeed, the
use of a pedicle omental flap to enhance
vascular regrowth in the region of the
bronchial anastomosis emphasizes the
importance of a good blood supply as a
determining factor in successful healing;
however, the abdominal intervention
required to fashion the pedicle omental
flap adds to the complexity of the trans
plantation procedure and may be a source
of complications postoperatively.18,19
Recent evidence also shows that the
diaphragm is depressed after abdominal
surgery by mechanisms that have yet to
be outlined.20 As an easier alternative to
omentopexy we used an intercostal mus
cle flap and assessed its usefulness in
preventing ischemia-related bronchial
anastomotic problems.
The intercostal muscle bundle has long
been used by thoracic surgeons to rein
force closure of bronchial stumps and to
repair tracheobronchial defects.21-23 In
particular, Mollenkopf and associates13
have shown in their recent pilot study that
the intercostal pedicle flap can revascula
rize a bronchial autograft 3 to 6 weeks
after canine pneumonectomy. Our results
indicate that the pedicled intercostal mus
cle graft can substantially improve bron
chial healing with a more normal mucosal
pattern and much less stenosis by promot
ing revascularization across and beyond
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the bronchial anastomosis at least as early
as 7 days after lung transplantation. The
graft offers several advantages: it is read
ily available at thoracotomy, it is viable
with a good blood supply to contribute
to the development o f a rich capillary net
work at the anastomosis and to ensure
success in healing; moreover, it provides
reinforcement of the suture line.
A point o f interest is that even in our
control animals there was no occurrence
o f ischemic bronchial necrosis and acute
bronchostenosis. This re-emphasizes the
importance of dividing the transplant
bronchus close to its lobar orifices7’16 to
provide the best possible collateral flow
from the pulmonary arterial circulation.
Had we elected to reanastomose the bron
chus nearer the carina, the incidence
o f complications would have been greater
in the control group9 and the beneficial
effect o f the intercostal pedicle flap would
have been better demonstrated.
The ability of the intercostal pedicle
flap rapidly to re-establish bronchial cir
culation in experimental lung transplan
tation now remains to be evaluated: (a)
under the influence of immunosuppres
sion and rejection, either separately or in
combination, and (b) when the bronchial
component is reanastomosed just distal
to the carina.

We thank Ken Austin, Luke Grenning,
Gladys Jackson, Janet Dupree, Peter Noble
and the medical audiovisual staff for provid
ing technical support and Gail Cornick for her
secretarial expertise. We are grateful to Drs.
C.M. Couves, P.J. McManamon and R.S.
Harris for valuable discussion.
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Long-Term Follow-up of Concomitant Band Ligation
and Sclerotherapy for Internal Hemorrhoids
From 1978 to 1983, 111 patients with
symptomatic internal hemorrhoids were
treated as outpatients by a modification
of the Barron ligation technique. Each
ligated hemorrhoid was injected with a
sclerosant. Follow-up, available for 94 of
the patients, ranged from 2 to 60
months (mean 18 months). Presenting
symptoms were bleeding in 75 (80% ) of
the 94 patients, pain in 46 (49% ), pruri
tus in 22 (23%) and prolapse in 24
(26%). Results were excellent in 51
(54%) patients, good in 20 (21% ) and
fair in 9 (10%). Fourteen (15% ) patients
had unsatisfactory results; only 4 of
these required hemorrhoidectomy. The
other 10 had residual symptoms but did
not require further treatment. Nine
patients had minor complications, which
included pain lasting 24 to 72 hours in
seven, bleeding in one and syncope in
one.
The addition of sclerotherapy to tradi
tional band ligation for the management
of internal hemorrhoids has the advan
tages of exciting a greater inflammatory
reaction between the mucosa and sub
mucosa and preventing premature slip
ping of the band. The authors conclude
that this method of therapy is effective
for symptomatic hemorrhoids and that
surgical hemorrhoidectomy is seldom
indicated.

dans chaque h^morroide ligaturee. La
surveillance des suites therapeutiques
portant sur 94 patients s'etend sur de 2
a 60 mois (moyenne de 18 mois). A
I'arrivee, les symptomes cliniques etaient
le saignement, 75 fois sur 9 4 (80% des
cas), la douleur 46 fois (49% ), le prurit
22 fois (23%) et le prolapsus 24 fois
(26% ). Les resultats de traitement furent
excellents chez 51 patients (54% ), bons
chez 20 (21% ) et moyens chez 9 (10% ).
Quatorze patients (15% ) eurent des
resultats peu satisfaisants; seulement 4
necessiterent une hemorroidectomie. Les
10 autres se plaignaient de symptomes
residuels mais ne requirent pas d'autres
traitements. Neuf patients ont souffert
de complications mineures dont de la
douleur durant 24 a 72 heures dans sept
cas, du saignement chez un et une
syncope chez un autre.
Dans le traitement des h6morroVdes
internes, la scl£rotherapie ajoutee a la
ligature classique par bande elastique
offre I'avantage theorique de provoquee
une reaction inflammatoire plus importante entre la muqeuse et la sousmuqueuse empechant le glissement pre
mature de la bande Elastique. A partir de
leurs observations, les auteurs concluent
que le mode de traitement est efficace
dans les cas d'hemorroVdes avec sympto
mes et que I'hemorroVdectomie chirurgicale est rarement necessaire.

De 1978 & 1983, 111 patients souffrant
des symptomes d'hemorroVdes internes
ont ete traites en clinique externe techni
que modifiee de la ligature de Barron.
Une substance sclerosante fut injectee

The traditional method for treating inter
nal hemorrhoids refractory to conserva
tive treatment has been surgical ligation
and excision. Pain, major complications,
high cost and prolonged hospitalization
detract from this method. Other methods
that have been proposed include cryother
apy, band ligation and injection
sclerotherapy. The purpose of this study
was to evaluate the long-term effective
ness of band ligation combined with
sclerotherapy. Results of this combined
method have not been reported previ
ously.
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Patients and Method

The records of 111 patients with all
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degrees of symptomatic internal hemor
rhoids who were treated as outpatients by
band ligation and sclerotherapy from
1978 to 1983 were reviewed. Only one sur
geon (J.B.F.) was involved. Ninety-four
patients were contacted for follow-up in
the clinic or by telephone interview. There
were 62 women and 32 men ranging in age
from 23 to 80 years (mean 46 years).
Follow-up ranged from 2 to 60 months
(mean 18 months, median 15 months).
One or two hemorrhoids were treated at
each session. Weekly visits were con
tinued until all hemorrhoids were treated.
The number of visits ranged from 1 to 5
(mean 2.15 visits). Most patients had
follow-up visits 1 to 4 weeks after the last
treatment. Any hemorrhoids found at
that time were treated in the same man
ner. They presumably were either new
hemorrhoids or ones too small to be
ligated during the initial visits that had
grown in size. They were not considered
treatment failures. Flexible sigmoido
scopy and air-contrast barium enema
were performed in all patients over 40
years of age who complained of bleeding.
All patients were advised to take
Metamucil (G.D. Searle and Co. of
Canada, Ltd., Oakville, Ont.) regularly,
but the number of patients who actually
followed this advice was not recorded.
Of the patients followed up, 80%
presented with bleeding, 23% with pru
ritus, 49% with pain and 26% with
prolapse. All degrees of hemorrhoids
were treated similarly regardless of the
severity of symptoms or the presence or
absence of external hemorrhoids.
The technique of rubber-band ligation
was similar to that described by Barron.1
After a digital rectal examination, a welllubricated anoscope was inserted with the
patient in the left lateral position. Inter
nal hemorrhoids were observed in their
three traditional positions, immediately
above the dentate line. It is important to
check for pain sensation by pulling on the
hemorrhoid with forceps before applying
the band. Pain usually indicates that the
hemorrhoid should be ligated higher
above the dentate line. Only one band was
used for each hemorrhoid. The band was
523
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Results
At follow-up, 51 patients (54%) were
asymptomatic, 20 (21%) were greatly
improved, 9 (10%) were moderately
improved, 13 (14%) were unimproved
and 1 (1%) was worse. Of the 14 patients
with an unsatisfactory result, 4 subse
quently required surgical hemorrhoidec
tomy. The other 10 required only medi
cal treatment despite residual symptoms.
Good patient acceptance was indicated by
the fact that 82 (87%) of the 94 patients
said they would undergo the same treat
ment again if necessary.
A number of patients had associated
anorectal problems (Table I). Complica
tions were relatively minor and arose
mainly in patients treated early in our ser
ies. Seven patients complained of pain
lasting 24 to 72 hours after ligation. One
patient had moderate bleeding. She was
hospitalized for observation but did not
require transfusion. One patient fainted
when she tried to get up after the treat
ment but she did not require hospitali
zation.
Discussion
While internal hemorrhoids have tradi
tionally been divided into different stages
T a b le l - A s s o c i a t e d A n o r e c t a l P ro b le m s
N o. of
P r o b le m

p a t ie n t s

A n a l fis s u r e

6

A n a l f is t u la

1

R e c t a l p o ly p s

7

C o n d y lo m a

1

U lc e r a t iv e c o litis

1

S ig m o id c a r c in o m a

1

according to the degree of prolapse, it is
the symptoms rather than the stage of
prolapse that dictate treatment. This view
was supported by both the St. Mark’s2
and the Cleveland Clinic3 groups.
Indeed, M arino and colleagues,4 in a
symposium devoted to hemorrhoid sur
gery, suggested that he would not oper
ate on a hemorrhoid simply because it
belonged to a certain classification. In this
series, the results were classified accord
ing to the patient’s subjective assessment.
Despite the relatively good results
reported in the literature, surgical hemor
rhoidectomy is associated with major
complications that include pain postoperatively, incontinence, stenosis and bleed
ing. These complications, together with
surgical costs, hospitalization and the
need for general anesthesia, make it an
unattractive first-line treatment for inter
nal hemorrhoids. Both band ligation and
injection sclerotherapy have been sug
gested as alternatives to surgical hemor
rhoidectomy. The addition of injection
sclerotherapy to band ligation, as in this
study, has the theoretical advantages of
exciting a greater inflammatory reaction
between the mucosa and submucosa and
preventing premature slipping of the
band. The latter, although an accepted
complication, has not been widely
reported in the literature.
Our 54% excellent, 21% good and
10% fair results compare favourably with
those of other studies using band ligation
alone (Table II). Excellent results were
reported by Jeffery and associates,2
Wrobleski and colleagues5 and Stein
berg’s group6 in 37%, 43% and 44% of
their patients respectively. Gehamy and
Weakly3 and Groves and colleagues7
reported better results, but their studies
included patients who had only bleeding
or prolapse; those with pain or pruritus
were excluded. Also of note is that in
these two studies, 34.6% and 26% respec
tively of patients had discomfort lasting
longer than 3 days. Our study suggests
that the addition of injection sclerother
apy to ligation for internal hemorrhoids
produces at least as good a result as liga
tion alone. Whether a better result can be
achieved with experience can only be con
firmed or negated with a randomized
prospective study.

T a b le II— R e s u lt s o f P r e s e n t S t u d y C o m p a r e d W it h T h o s e
o f O th e r s U s in g B a n d L ig a tio n A lo n e
R e s u lt s , %
G r e a t ly
A u th o r s

E x c e lle n t

im p ro v e d
21

P r e s e n t s e rie s

54

J e f f e r y a n d a s s o c ia t e s , 1 9 8 0 2

37

-

W r o b le s k i a n d a s s o c ia t e s , 1 9 8 0 s

43

26

S te in b e r g a n d a s s o c ia t e s , 1 9 7 5 6

44

46

G e h a m y a n d W e a k ly , 1 9 7 4 3

77

-

G r o v e s a n d a s s o c ia t e s , 1 9 7 1 7

66

—
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Conclusions
Concomitant ligation and injection
sclerotherapy for symptomatic internal
hemorrhoids is safe, effective, economi
cal and has a high degree of patient accep
tance. Surgical hemorrhoidectomy is sel
dom indicated regardless of the severity
of symptoms.

t<

placed around the base of the hemor
rhoid. Following ligation, 0.5 to 1.0 mL
o f the sclerosing solution, sodium
tetradecyl sulfate (Thrombovar; Therapex
Inc., Montreal, PQ), was injected submucosally into the hemorrhoid and
around its base. This left a mobile
polypoid lesion measuring 0.8 to 1.0 cm.
After the anoscope was removed, the anal
canal was examined digitally to be certain
that this polypoid mass had not prolapsed
into the canal.

References
1. BARRON J: Office ligation of internal hemorrhoids. Am
J Surg 1963; 105: 563-70
2. J effery PJ, R itchie SM, M iller w , H awley PR: The
treatment of haemorrhoids by rubber band ligation at St.
M ark’s Hospital. Postgrad M ed J 1980; 56: 847-9
3. G eham y RA, W eakly FL: Internal hemorrhoidectomy
by elastic ligation. Dis Colon Rectum 1974; 17: 347-53
4. Marin o AWM j r , Mazier w p , M organ B, Salvati
EP, SMITH LE: Symposium: anorectal surgery — hemor
rhoids. Dis Colon Rectum 1980; 23: 211-22
5. W robleski DE, C orm an m l , Veidenheim er MC,
Coller JA: Long-term evaluation of rubber ring ligation
in hemorrhoidal disease. Ibid: 478-82
6. Steinberg DM, Liegois H, A lexander -W illiams J:
Long-term review o f the results o f rubber band ligation
of haemorrhoids. Br J Surg 1975; 62: 144-6
7. G roves AR, Evans JC, W illiams JA: Management of
internal haemorrhoids by rubber band ligation. Br J Surg
1971; 58: 923-4

BOOKS RECEIVED

f

t
v

.1

1

4

This list is an acknowledgement of
books received. It does not preclude
review at a later date.
Care of the Postoperative Surgical Patient.
Edited by John A.R. Smith and John Wat
kins. 273 pp. Illust. Butterworths, Stoneham, Mass., 1985. $59.95 (US). ISBN
0-407-00286-3.
Chirurgie de la main/Surgery of the Hand.
Transferts tissulaires libres par micro
anastomoses vasculaires et nerveuses/Free
tissue transfers by nerve and vascular
microanastomoses. D.V. Egloff. 146 pp.
Illust. Editions Medecine et Hygiene,
Geneve, Suisse, 1984. Price not stated.
ISBN 2-88049-015-4.
Complications in Vascular Surgery. 2nd ed.
Victor M. Bernhard and Jonathan B.
Towne. 793 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla.; Academic Press
Canada, Don Mills, O nt., 1985. $130.
ISBN 0-8089-1747-1.
Laser Application to Occlusive Vascular Dis
ease. Edited by Michael W. Berns and
Mohmood Mirhoseini. 145 pp. Illust. Alan
R. Liss, Inc., New York, 1985. $28. (US).
ISBN 0-8451-0246-X.
Neonatal Neurology. 2nd ed. Gerald M.
Fenichel. Clinical Neurology and Neurosur
gery Monographs. Volume 2. 342 pp. Illust.
Churchill Livingstone, Edinburgh; Aca
demic Press Canada, Don Mills, Ont.,
1985. $52.25. ISBN 0-443-08446-7.
Normal and Abnormal Bone Growth. Basic
and Clinical Research. Proceedings of the
Second International Conference Held at
the University of California Center for the
Health Sciences, Los Angeles, California,
January 3-5, 1985. Edited by Andrew D.
Dixon and Bernard G. Sarnat. 524 pp.
Illust. Alan R. Liss, Inc., New York, 1985.
$76. (US). ISBN 0-8451-5037-5.
Tumors and Tumorlike Conditions of the
Ovary. Edited by Lawrence M. Roth and
Bernard Szernobilsky. 296 pp. Illust. Chur
chill Livingstone, Edinburgh; Academic
Press Canada, Don Mills, Ont., 1985.
$85.75. ISBN 0-443-08280-8.

VOLUME 28, NO. 6, NOVEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

<
4

i

t

1

J ean I. T chervenkov ,

md;

E sa D iano ,

abt ;

N icolas V. C hristou ,

md , p h d , frcsc , facs

Effect of Cyclosporine on Host Defence
To discover whether cyclosporine
administered daily in therapeutic equiva
lent doses for 3 consecutive weeks sup
pressed host defence, the authors meas
ured the delayed-type hypersensitivity
(DTH) skin response to keyhole-limpet
hemocyanin (KLH) in rats. Twenty, male,
Sprague-Dawley rats were sensitized to
KLH and reactivity was confirmed 14
days later. Following sensitization,
cyclosporine (20 mg/kg orally) was
administered daily for 21 days to 10
rats. The other 10 (control group)
received equivalent volumes of diluent
(polysorbate 80 and ethanol). There was
no difference in the DTH response
between the cyclosporine and control
groups for 5 weeks following treatment.
Larger doses of cyclosporine (100
mg/kg) given intraperitoneally 30
minutes before and 6 hours after skin
testing, suppressed the DTH response
(7.2 mm to 2.4 mm) but resulted in a
high mortality (eight of nine rats) at 48
hours. Delayed-type hypersensitivity was
also suppressed in the control group but
to a lesser extent and with no deaths
(6.4 to 3.9 mm, p < 0.05). Cyclosporine,
in therapeutic equivalent doses, does not
suppress the nonspecific immune compo
nent of host defence as reflected by the
DTH skin response in previously sensi
tized animals. This may partially explain
the lower frequency of septic morbidity
and mortality in cyclosporine-treated
transplant patients, compared with those
receiving conventional therapy.
Utilisant un modele animal, les auteurs
ont 6tudie I'hypothese que la cyclospo-
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rine, administree quotidiennement en
doses therapeutiques durant 3 semaines
consecutives, supprime la reaction
d'hypersensibilite retardee (HR) suite a
une injection intracutanee d'hemocyanine
provenant d'un mollusque (keyholelimpet hemocyanin — KLH). Vingt rats
males Sprague-Dawley ont ete sensibilises au KLH et la reaction HR a ete con
firmee 14 jours plus tard. Par la suite,
la cyclosporine (20 mg/kg per os) a ete
administree selon I'hypothese (groupe 1,
n = 10). Le groupe de controle (groupe
2, n = 10) a recu un volume equivalent
de solvant (polysorbate 80 et ethanol).
Aucune difference de HR entre le groupe
1 et le groupe 2 n'a 6te trouvee, ceci
allant jusqu'a 5 semaines suivant le
traitement. Des doses massives de
cyclosporine (100 mg/kg), administrees
par voie intraperitoneal 30 minutes avant
et 6 heures apres le test cutane au KLH,
ont supprime la reaction HR (7.2 mm a
2.4 mm). Dans les 48 heures, huit rats
sur neuf sont morts. Dans le groupe con
trole, I'HR a subi une diminution de
moindre importance (6.4 mm a 3.9 mm,
p < 0.05) et aucune mortalite n'est survenue. La cyclosporine, a dosage therapeutique. n'inhibe done pas la partie
nonspecifique de I'immunite tel que
demontree par la reaction d'HR chez un
animal deja sensibilise. Ceci peut expliquer, en partie, la moindre incidence de
morbidity et mortalite due a la septicemie
chez les patients subissant une trans
plantation d'organe et traitSs a la
cyclosporine compare aux autres ayant
un traitement conventionnel.

Cyclosporine is a cyclic undecapeptide1
used extensively as an immunosuppressive
agent for transplant surgery. It has also
been used in clinical trials to treat
allograft rejection, graft-versus-host reac
tion, and in systemic lupus erythemato
sus.2 First introduced clinically in 1978,
it is now administered in combination
with small doses of prednisone.3
Cyclosporine has been shown to work at
the level of the T lymphocyte.1 It has
also been demonstrated to inhibit Thelper cells for antibody production to Tcell-dependent antigens,1,4 to inhibit the

generation of cytotoxic T cells induced in
allogeneic mixed lymphocyte reaction,1,5
and to abrogate the concanavilin-Ainduced suppressor-cell fu n c tio n .1,6
More recently, its effects on the T lym
phocyte have been shown to be mediated
by suppression of interleukin-2 syn
th esis1,7 and T-cell responses to
interleukin-1 and interleukin-2.1,8,9 In
clinical studies on kidney10 and liver
transplantation,11 cyclosporine plus low
doses of prednisone resulted in higher
transplant and patient survival than a
standard treatment of azathioprine and
higher doses of prednisone with or with
out antilymphocyte serum. Improved sur
vival after liver transplantation in children
with biliary atresia could be attributed to
two factors: improved surgical technique
and reduced septic complications with the
use of cyclosporine.11 Rynasiewicz and
colleagues12 reported improvement in
graft and patient survival in cyclo
sporine-treated patients compared with
those receiving conventional therapy.
A depressed delayed hypersensitivity
(DTH) skin response to ubiquitous anti
gens expressed as a skin-test score in sur
gical patients correlates with increased
rates of sepsis and death.13' 15 A fitting
hypothesis is that the DTH response to
recall antigens is a measure of both
specific and nonspecific immune hostdefence mechanisms, important in con
trolling bacterial infection. Cyclosporine
administered during the “ sensitization
phase” 3,16 or in high doses (more than 50
m g/kg) at the time of intradermal anti
gen recall3,17,18 has been shown to sup
press the DTH response.3 However, at
therapeutic equivalent doses, the effect of
cyclosporine on the DTH response in a
presensitized host is not known.
We assessed the effect of cyclosporine
on the DTH response of rats already sen
sitized to keyhole-limpet hemocyanin
(KLH). Doses equivalent to human ther
apeutic levels, given daily for 21 consecu
tive days, had no effect on this response.

Materials and Methods
Male Sprague-Dawley rats, each
weighing 130 g, were housed two to a cage
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in a controlled environment and fed regu
lar rat chow.
Skin-Testing Technique
Keyhole-limpet hemocyanin was used
as the sensitizing antigen.19 Although not
one o f the antigens used in the clinical
study, it was the only one found to
produce a reliable sensitization and DTH
response in the rat.19 After 2 days of
acclimatization, the animals were sensi
tized by injecting 1 mg KLH in 70% com
plete Freund’s adjuvant into a hind foot
pad. Two weeks later, a strong DTH
response to KLH was confirmed by the
intradermal injection of 0.3 mg KLH in
0.1 mL of normal saline in a shaven
flank. A 0 .1-mL aliquot of normal saline,
control injection was given in the oppo
site flank. The DTH response was
expressed as a skin-test score, defined as
the maximum mean induration diameter
(mm) measured at 24 or 48 hours (or
upon death) minus that of the saline con
trol (0 mm in our series, i.e., no reac
tion). In 90% of the animals the reaction
reached maximum intensity by 24 hours.
Although weekly skin testing does not
augment the skin-test score in this model,
more intense skin testing (e.g., every 2 to
3 days) leads to a 1 to 2-mm variation in
the score due to frequent handling of the
animals.
Cyclosporine
Cyclosporine (Sandoz Canada Inc.,
Dorval, PQ) was given orally (20 mg/kg
daily) or intraperitoneally (100 mg/kg).
Both oral and intraperitoneal mixtures
were prepared as follows: 14 mg of
cyclosporine were dissolved in 0.5 mL of
96% ethanol and 0.2 mL of polysorbate
80 made up to volume with normal saline.
The “ diluent” consisted of equal volumes
of ethanol, polysorbate 80 and normal
saline. Oral preparations were given by
orogastric intubation using a pediatric
feeding tube. The need to keep the prepa
ration in injectable form and the limited
supply o f the drug was the reason for not
using olive oil suspensions for oral
administration.
Experimental Protocol
In part A of the experiment, following
confirmation of a positive DTH skin-test
response to KLH, 10 rats were given
cyclosporine (20 mg/kg) daily for 21 con
secutive days (group 1), while the other
10 rats received equal volumes of
“ diluent” for the same length of time
(group 2). All the animals were skin-tested
weekly with KLH, starting with the first
dose of cyclosporine, and the skin-test
scores and weights were recorded for 5
consecutive weeks thereafter.
In part B of the experimental protocol,
2 weeks after completion of part A, group
526

1 rats were given two doses of 100 mg/kg
cyclosporine each, intraperitoneally 30
minutes before and 6 hours after skin test
ing with KLH. Group 2 rats were given
an equal volume of “ diluent” intraperi
toneally and the resultant skin-test scores
were recorded.
Statistics
The unpaired Student’s /-test was used
to compare two groups of data; analysis
of variance was used where three or more
data sets were analysed. Mean ± stan
dard errors of the mean were recorded.
Significance was set at p < 0.05.
Results
One rat in each group died of aspira
tion during the daily orogastric intuba
tions (days 7 and 10). Cyclosporine in
doses comparable to routine immunosup
pression used in humans10 did not alter
the DTH skin response beyond that of the
normal variability of the model (Table I).
Following a recovery period of more
than 2 weeks, the same group of animals
received a large dose of cyclosporine or
diluent around the time of KLH intrader
mal injection. Large doses of cyclospo
rine given at the time of antigen recall
substantially helped in inhibiting the nor
mal DTH skin response to KLH (Table
II). The diluent also suppressed this
response, but to a significantly lesser
extent (p < 0.05). Eight of the nine rats
given cyclosporine intraperitoneally died
within 48 hours. The reported DTH
measurements were taken at 24 hours and
upon death (36 to 48 hours after skin test
ing). No rats in the control group died.

Discussion
In recent years, both organ and patient
survival after transplantation have
improved.10'11 In renal transplantation,
mean patient survival at 3 years with
cyclosporine therapy is 86% compared
with 76% for conventional therapy. Graft
losses are 26.6% with cyclosporine and
37.9% with conventional therapy.18
With the advent of cyclosporine, better
survival rates have resulted after liver and
heart transplantation.1118 Improved
results in patients treated with cyclospor
ine may be attributed in part to the
smaller number of postoperative bacterial
infections. Renal transplant recipients
treated with azathioprine and prednisone
had more bacterial infections than those
treated with cyclosporine and pred
nisone.18,19
In this study we demonstrated that
cyclosporine given in therapeutic equiva
lent doses to KLH-sensitized rats failed
to suppress the DTH skin response to
KLH. However, very high (lethal) doses
of cyclosporine given intraperitoneally at
the time of antigen challenge markedly
suppressed the DTH skin response. This
confirms the findings o f previous
studies.2,3 Other groups have shown that
cyclosporine suppresses the DTH
response to oxazolone,20 dinitrochlorobenzene3,20 and tuberculin.3,20 Most of
these studies administered cyclosporine
during the sensitization phase of the DTH
reaction, and thus may have shut off the
DTH at the sensitization or the afferent
stage.
A depressed DTH response expressed
as a skin-test score in surgical patients
correlates very closely with the develop-

Table 1-Effect of Therapeutic Equivalent Doses of Cyclosporine on Delayed-Type Hypersensitivity
(DTH] Skin Response (Mean ± SEM) to Keyhole-Limpet Hemocyanin (KLH)
Skin response, mm*
Group

Before
cyclosporine

Week 1

Week 2

Week 3

Week 4

Week 5

1t
24

6.2 ± 0.8
6.7 ± 0.6

8.4 ± 0.4
8.2 ± 0.4

7.3 ± 0.5
7.6 ± 0.4

8.7 ± 0.5
8.4 ± 0,5

6.7 ± 0.4
7.0 ± 0.6

7.2 ± 0.6
6.4 ± 0.5

*No significant differences, analysis of variance.
tCyclosporine, 20 mg/kg daily, given orally for 21 consecutive days.
(Equal volume of diluent given for 21 consecutive days.

Table II—Effect on DTH Skin Response of Cyclosporine Given in Large Doses
at Time of KLH Intradermal Injections
Skin response, mm
Group

~V
2t

Before
cyclosporine

After
cyclosporine

7.2 ± 0.6
6.4 ± 0.5

2.4 ± 0.84
3.g + 0.24

‘ Cyclosporine, 100 mg/kg, given intraperitoneally 30 min before and 6 h after intradermal injection
of KLH.
(Equivalent volume of diluent given intraperitoneally at same time intervals as cyclosporine
tp < 0.05.
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ment of major and minor sepsis and mor
tality from sepsis in the clinical setting. 13
This close relation between decreased
DTH reactions both pre- and postoperatively and increased risk o f sepsis from
common bacterial pathogens is not in
keeping with conventional theories in
which the DTH reaction represents a
function of the cell-mediated arm of host
defence. This theory would have patients
with a decreased DTH response to recall
antigens succumb to viral, parasitic or
fungal pathogens. However, clinical ex
perience shows that sepsis in these pa
tients is the result of common bacterial
pathogens. What, then, does a decreased
DTH response to recall antigens really in
dicate? Recent evidence suggests that, in
vivo, the events leading to the induration
produced by the DTH response follow
ing recall intradermal antigenic challenge
are very similar, although o f different
time course, to those involved in the
localization process o f bacterial infec
tion .21-22 The mechanisms o f foreign an
tigen recognition, whether in the form of
free protein molecules or on the surface
o f live bacteria, are similar both in the
DTH reaction and the antibacterial reac
tion . 13-21 Cell-mediated immunity, com
prising complex antigen-recognition and
amplification reactions between histo
compatibility bearing monocytes, and T
memory lymphocytes seem to be the
major components o f these early process
es. The resulting nonspecific inflamma
tory cell responses are involved in
eradicating the foreign antigen or bacteri
al pathogen. These amplification reac
tions, mediated by various lymphokines
produced by T lymphocytes and mono
cytes, result in the attraction o f many
nonspecific inflammatory effector cells.
The DTH response to recall antigens,
which comprises an early recognition
phase that is specific and cell-mediated
and a latent inflammatory reaction phase
that is nonspecific and amplified, is a
global measure o f host defence . 23-26 The
suppression or failure o f the DTH
response indicates a transient, acquired,
immunodeficiency syndrome predispos
ing the patient to bacterial sepsis . 13-21
The finding that cyclosporine at therapeu
tic equivalent doses does not suppress the
DTH response to a recall skin-test anti
gen indicates that both the specific recog
nition phase and the nonspecific inflam
matory cell accumulation and activity are
unaffected. The lower incidence o f sepsisrelated death in cyclosporine-treated
transplant recipients than in those with
conventional immunosuppressive treat
ment supports this hypothesis.
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Dosage:
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rectly to the wound and covered
with an appropriate dressing. If
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leg ulcers cut dressing accurately
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tion has been observed following intravenous, intraduodenal and oral admin
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Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra
tions being achieved within 2 to 3 hours. These plasma concentrations are not
significantly influenced by the presence of food in the stomach at the time of the
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina
tion half-life is approximately 3 hours. The principal route of excretion is the urine
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is
prolonged. However, in a study of 27 patients with varying degrees of renal impair
ment therapeutic plasma levels of ranitidine were shown to be achieved without
risk of drug accumulation, using half the normal dose of ranitidine in patients with
plasma creatinine concentration greater than 300 pmols/litre.
There is a significant linear correlation between the dose administered and the
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma ranitidine concentration of 50 ng/ml. has an inhibitory effect upon stimu
lated gastric acid secretion of approximately 50%. Estimates of the ICS0 range from
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma
concentrations in excess of this lasted for more than 8 hours and after 12 hours the
plasma concentrations were sufficiently high to have a significant inhibitory effect
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations
in excess of 100 ng/mL were achieved within five minutes of administration and
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two
hours and maintained this level over the test period. The volume of gastric secre
tion was reduced by more than 55%. Doubling the infusion rate to
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine
followed by a continuous infusion of 0.2 mg/kg/hour the number o f‘at risk’ days
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output,
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at
dose levels of up to 100 mg four times daily for ten days. These levels are in excess
o f those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal
or central nervous system side effects; moreover, pulse rate, blood pressure, electro
cardiogram and electroencephalogram were not significantly affected in man
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma
levels of the following hormones: cortisol, testosterone, estrogens, growth
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating
hormone, aldosterone or gastrin - although like cimetidine, ranitidine reduced
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase
(AST/SGOT) levels were observed in some patients. No other liver function tests
were abnormal for these subjects and the cause and clinical significance of these
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the
cytochrome P4S0-linked hepatic mixed function oxidase system. In man, ranitidine
treatment has been shown not to impair the metabolism of antipyrine,
aminopyrine, warfarin or diazepam.

ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with
Zantac. There has been no clinically significant interference with endocrine,
gonadal or liver function, nor has the drug adversely affected the central nervous
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very
little greater than that among placebo-treated patients (7.7%). Only five adverse
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi
enced itching or burning at the injection site. This reaction was mild and usually
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection.
The majority of these cases were not thought to be treatment-related. In some in
stances the headache was thought to be due to over-rapid injection of ranitidine,
and did not recur on rechallenge with slow intravenous injection. Similarly, some
patients experienced nausea after rapid injection of the drug, but on subsequent
occasions with slow-intravenous injection, experienced no ill-effects.

OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are
expected following overdosage with the drug. Symptomatic and supportive therapy
should be given as appropriate. If need be, the drug may be removed from the
plasma by haemodialysis.

DOSAGE AND ADMINISTRATION
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Adults: Zantac injection may be given either as a slow (over one minute) intra
venous injection of 50 mg, which may be repeated every six to eight hours; or as an
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from
peptic ulceration, parenteral administration may be continued until oral feeding
commences. Patients considered to be still at risk may then be treated with Zantac
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval
uated in clinical studies - see PRECAUTIONS.

1. Morison, David H. et al: A Double-Blind Comparison of Cimetidine and
Ranitidine as Prophylaxis Against Gastric Aspiration Syndrome, Anesthesia and
Analgesia, Vol. 61, No: 12, December 1982.
2. van Blankenstein, M. and van den Berg, B., The Prevention of Stress-Induced
Upper Gastrointestinal Bleeding by Ranitidine in Critically 111 Patients,
In: Tytgat G.N. (ed) Ranitidine, The Selective New H 2-Receptor Antagonist,
Theracom 1982, Pages 41-45.
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WARNINGS
Gastric ulcer - Treatment with a histamine H2-antagonist may mask symptoms
associated with carcinoma of the stomach and therefore may delay diagnosis of the
condition. Accordingly, where gastric ulcer is suspected the possibility of malig
nancy should be excluded before therapy with Zantac is instituted.

ANTAGONIST.

Glaxo
Glaxo Laboratories
A Glaxo Canada Limited Company
Toronto, Ontario Montreal, Quebec
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CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).
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AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on
one face and GLAXO on the other containing 150 mg ranitidine (as the
hydrochloride), in packs of 28 & 56 tablets.

INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and
other conditions where reduction of gastric secretion and acid output is desirable.
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients
with bleeding peptic ulcers and before general anaesthesia in patients considered to
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients
during labour.
For appropriate cases Zantac Tablets are also available.
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Histamine H 2-receptor antagonist

PRECAUTIONS
Use in pregnancy and nursing mothers - The safety of Zantac in the treatment
of conditions where a controlled reduction of gastric secretion is required during
pregnancy has not been established. Reproduction studies performed in rats and
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to
Zantac. If the administration of Zantac during pregnancy is considered to be neces
sary, its use requires that the potential benefits be weighed against possible hazards
to the patient and to the fetus. However, therapeutic doses of Zantac administered
to obstetric patients in labour or undergoing caesarean section have been without
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical
significance of this has not been fully evaluated.
Use in impaired renal function - Ranitidine is excreted via the kidney and in
the presence of severe renal impairment, plasma levels of ranitidine are increased
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi
larly it is recommended that ranitidine injection be administered in doses of 25 mg
to patients with renal dysfunction.
Children - Experience with Zantac in children is limited and such use has not been
fully evaluated in clinical studies. It has however been used successfully in children
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.
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The authors present four cases of acute
acalculous cholecystitis complicating
major burn injury and review the recent
literature on acalculous cholecystitis. All
patients were men and ranged in age
from 22 to 40 years. The mean extent
of the burn was 50% of the total body
surface area, with an average 29% thirddegree component. All four patients sur
vived. Because of their severity, major
burn injuries expose patients to many
risks, including acute acalculous
cholecystitis. Recent experimental evi
dence supports a vascular insult through
the activation of Factor XII pathways as
the initial event. A diagnosis is made on
clinical grounds, supported by laboratory
and ultrasonographic findings, in a
patient with a burn covering more than
30% of the total body surface area and
who has signs of acute cholecystitis.
Cholecystectomy is the treatment of
choice; tube cholecystostomy is reserved
for critically ill patients.
Les auteurs decrivent quatre cas de cho
lecystite acalculeuse aigue compliquant
des brulures majeures et etudient les
publications recentes sur la cholecystite
acalculeuse. Tous les patients etaient
des hommes dont I'age variait entre 22
et 40 ans. L'etendue moyenne des brulu
res etaient de 50% de la surface corporelle, avec 29% de brulure au troisieme
degre, en moyenne. Les quatre patients
ont survecu. A cause de leur gravite, les
brulures majeures exposent les patients a
de nombreux risques dont la cholecystite
acalculeuse aigue. Des resultats experimentaux recents montrent qu'un acci
dent vasculaire relie a I’activation des
voies du Facteur XII peut etre & I'origine
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de cette complication. Le diagnostic
relive du tableau Clinique, complement^
par les epreuves de laboratoire et I'echographie ultrasonique chez un brule presentant une atteinte sur plus de 3 0 % de
la surface corporelle et qui montre des
signes de cholecystite aigue. La cholecystectomie est le traitement de pre
mier choix; la cholecystostomie tubaire
doit etre reservee aux patients dont
I'etat est desespere.

Acalculous cholecystitis accounts for 2 °lo
to 14% o f all cases o f acute cholecysti
tis.1’4 Its occurrence varies with the
group of patients considered, being much
higher postoperatively, after trauma and
in pediatric and burned patients than in
the general population.5’11 Although its
occurrence postoperatively and following
trauma has been reported extensively,
fewer than 30 instances in burned patients
have been documented since I960.1'2,11-17
We report four cases of acute acal
culous cholecystitis found in 113 patients
with burns to more than 30% o f the total
body surface area (TBSA), who were
admitted to Vancouver General Hospital
during the period 1980 to 1983.

Case Reports
Case 1
A 32-year-old man sustained flame burns to
40% of the TBSA — the lower limbs, perineum
and lower back. In 38% of the area there was
third-degree burn. Fluid resuscitation followed
the Parkland regimen,18 and bilateral lowerlimb escharotomy and fasciotomies were car
ried out immediately.
Adult respiratory distress syndrome and bac
teremia with enterococci, Staphylococcus
aureus and Proteus morganii developed dur
ing the first 10 days. Burn wounds became
colonized with P. morganii and enterococci.
Surgical treatment included bilateral belowknee amputation, followed by revision above
the knee, debridement and skin grafting on two
occasions. In all, 49 units of packed red blood
cells were transfused. Enteral feeding was
started 13 days after the accident.
On the 30th day, while the patient was
still being ventilated, a fever developed; he

had a temperature of 39.0°C, intolerance to
enteral feeding, and pain and tenderness in the
right upper quadrant. Laboratory investiga
tions revealed the following: leukocyte count
15.8 x 109/L (polymorphonuclear neu
trophils 74%, band cells 16%); the total
bilirubin level was 44.5 ftmol/L (normal 13.7
to 22.2 ftmol/L); aspartate aminotransferase
(AST) level 50 U/L (normal 19 to 38 U/L);
serum albumin level 33 g/L (normal 35 to 50
g/L) and amylase level 20 U/L (normal 40 to
105 U/L). The alkaline phosphatase level was
within normal limits. Ultrasonography showed
a thickened, dilated gallbladder, measuring 5.6
x 8 cm, containing sludge. Laparotomy rev
ealed an acutely inflamed gallbladder with
patches of gangrene and perforation.
Cholecystectomy was performed; no gallstones
were found. Intraoperative cholangiography
was not carried out for technical reasons. Bile
cultures were negative. The postoperative con
valescence was uncomplicated and he was dis
charged to a rehabilitation hospital 103 days
after the injury.

Case 2
A 22-year-old man suffered flame burns to
37% of his TBSA, 25% of which was third
degree. An associated inhalational injury
required immediate intubation and ventilation.
Following resuscitation,18 escharotomy was
performed for circumferential burns to both
upper limbs.
Total parenteral nutrition was begun 12 days
after the accident. Debridement of wounds and
harvesting of skin grafts were done twice,
requiring 32 units of packed erythrocytes. Burn
wounds were colonized with S. aureus and
enterococci. Sputum was positive for S. aureus
and Haemophilus influenzae. Bacteremia was
not documented. Enteral feeding was begun on
day 20.
On day 23, during continued ventilation, the
patient had a fever (body temperature of
39.2°C) and right upper quadrant tenderness.
Laboratory data revealed the following abnor
mal values: leukocyte count 23.9 x 109/L;
total bilirubin 63.3 pimol/L; AST 68 U/L; alka
line phosphatase 297 U/L; albumin 29 g/L and
amylase 155 U/L. As in case 1, ultrasonogra
phy showed a dilated, thickened gallbladder,
4.6 x 11 cm in dimension, containing sludge.
A tube cholecystostomy was performed. The
gallbladder was acutely inflamed and distended
but showed no evidence of gangrene or perfo
ration. Bile was free of calculi and cultures
were sterile.
A cholecystogram obtained 7 days after
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operation was normal. The cholecystostomy
tube was removed 50 days after the burn injury
and the patient discharged 8 days later.

edematous, with no palpable stones. Specimens
of bile showed no calculi and cultures were
negative. Postoperatively, the patient had acute
renal failure from which he gradually reco
vered. A cholecystogram obtained 28 days
postoperatively was normal, so the tube was
removed.
The patient was discharged to a rehabilita
tion centre 114 days after injury.

Case 3

FIG. 1—Case 4. Appearance of gallblad
der at laparotomy. Patches of gangrene can be
seen on gallbladder wall.

Case 4
A 40-year-old man suffered flame burns to
50% of his TBSA, 40% of the burn being of
third degree. An associated upper airway burn
required immediate intubation and ventilation.
Following fluid resuscitation,18 the patient
urgently required four-limb escharotomy and
fasciotomy.
Enteral feeding was begun 2 days after
injury. Bacteremia with Streptococcus viridans
and Klebsiella pneumoniae developed on day
3, Escherichia coli on day 12 and Candida albi
cans on day 20. Burn wounds were colonized
by enterococci. An upper gastrointestinal
hemorrhage, due to erosive gastritis, developed
on day 29. Debridement of wounds and skingraft harvesting were carried out under general
anesthesia on seven occasions. In all, 53 units
of packed erythrocytes were transfused.
On day 62, the patient experienced nausea
and vomiting, with right upper quadrant pain
and tenderness. Fie had a temperature of
38.6°C. There were signs of generalized perito
nitis. Laboratory findings were as follows: leu
kocyte count 18.7 x 109/L ; total bilirubin
level 13.7 /tmol/L; AST level 92 U /L; alkaline
phosphatase level 273 U /L; serum albumin
level 37 g/L and amylase level 100 U /L.
Laparotomy revealed a large, edematous gall
bladder with patches of gangrene (Fig. 1).
Cholecystectomy was performed; no calculi
were found. Cholangiography gave normal
results. Culture of the gallbladder mucosa grew
C. albicans.
The postoperative course was uncomplicated
and he was discharged to a rehabilitation centre
75 days after the burn injury.

The mean area o f the burn for the four
patients was 50% o f the total body sur
face, with an average 29% o f the burn
being o f third degree. Hypotension and
respiratory failure required mechanical
ventilation and the addition o f 5 cm of
positive end-expiratory pressure in all
patients. Only patient 4 was not being
ventilated at the time the diagnosis was
made.
Three patients required immediate
escharotomy and fasciotomy for circum
ferential burns of arms or legs. In all
patients the burn wounds were colonized
by at least one organism, the most com
mon being enterococci. Two patients had
documented bacteremia with four differ
ent organisms, but in only one was the
same organism cultured from the gall
bladder. Seven surgical procedures were
carried out in three patients before the
onset o f symptoms; each of these patients
received more than 30 units o f blood. In
two patients, cholecystitis developed
within 3 days of the initiation o f enteral
feeding and both had received total
parenteral nutrition before that.
The average time from the burn injury
to the onset o f cholecystitis was 33 days
(ranging from 16 to 62 days). Initial
symptoms in all patients were fever, right
upper quadrant pain and tenderness. One
patient (case 3) had second-degree burns
o f the abdominal wall in the area of
elicited tenderness. With one exception,
the most abnormal results o f liver func
tion tests were noted within 24 hours of
surgery. The two patients on total paren
teral nutrition had normal results o f liver
function testing until cholecystitis deve
loped. Two patients had an elevated
serum amylase level. Ultrasonography in

T
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A 23-year-old man suffered flame burns to
75% of his TBSA, 15% being third-degree
burns. Second-degree burns covered the trunk
and right upper quadrant. The patient was
resuscitated and total parenteral nutrition
begun 7 days later. Staphylococcal pneumo
nia with respiratory failure developed on day
12 and he required mechanical ventilation.
Burn wound cultures grew Pseudomonas aer
uginosa. Blood cultures were negative. Enteral
feeding was begun on day 14. Four units of
erythrocytes had been transfused.
On day 16, a fever (body temperature
38.1°C) and right upper quadrant tenderness
developed. Abnormal laboratory findings were
as follows: leukocyte count 18.8 x 109/L ;
total bilirubin level 32.5 ^rnol/L; AST 38 U/L;
serum albumin level 31 g/L and amylase level
179 U /L . Ultrasonography revealed a thick
ened, dilated gallbladder, measuring 4.8 x 7
cm and containing sludge. Septic shock deve
loped and an emergency tube cholecystostomy
was performed. The gallbladder was tense and

Summary

Table 1-Summary of Case Characteristics
Patient no.
Characteristics
% total body surface area burns/% third-degree burn
Transfusion, units packed cells
Bacteremia

1

2

3

4

40/38
49
Enterococci,

37/25
32
None

75/15
4
None

50/40
53

Enterococci,

Enterococci

P. morganii

S. aureus

Pseudomonas
aeruginosa

Staphylococcus aureus,
Proteus morganii

Burn wound colonization
Total parenteral nutrition, d
Total bilirubin, /unol/L
Aspartate aminotransferase, U/L
Alkaline phosphatase, U/L
Albumin, g/L
Amylase, U/L
Onset of cholecystitis related to enteral feeding
Days post-burn onset of cholecystitis
No. of operative procedures before
onset of cholecystitis
Operation
‘ Abnormal value.
tMaximum of 29.1 ftmol/L on day 34 after injury.
530

Streptococcus viridans,
Klebsiella pneumoniae,
Escherichia coli,
Candida albicans

Enterococci

None
44.5*
50*
141
33*
20
No
30

23
63.3*
68*
297*
29*
155*
Yes
23

14
32.5*
38
74
31*
179*
Yes
16

None
13.7t
92*
273*
37
100
No
62

5
Cholecystectomy

3
Cholecystostomy

0
Cholecystostomy

8
Cholecystectomy
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three patients revealed a dilated gallblad
der with thickened walls and containing
sludge in all.
A correct preoperative diagnosis was
made in three patients. Operative treat
ment was equally divided between
cholecystectomy (cases 1 and 4) and
cholecystostomy (cases 2 and 3). At sur
gery in cases 1 and 4, patchy gangrene of
the gallbladder wall was noted, with frank
perforation in case 1.
All four patients survived and the aver
age time to discharge was 87 days after
injury. Neither case 2 nor 3 had recurrent
symptoms of cholecystitis at 12-month
follow-up. A summary of the important
features is presented in Table I.
Discussion
Acalculous cholecystitis accounts for
2% to 14% of all cases of acute
cholecystitis. A review by Glenn and
Becker2 suggests a current increase in
this form of the disease. The incidence in
the pediatric, post-traumatic, postoper
ative and burn patient populations is
much higher. Brenner and Stewart9 in
1964 reported acalculous disease in 58
(71.6%) of 81 children with acute or suba
cute cholecystitis, while Pieretti and
colleagues10 found acalculous cholecysti
tis in 81 % of affected children. In patients
Table 11-Factors Implicated in the
Development of Acute Acalculous Cholecystitis
Congenital
Abnormal cystic duct
Aberrant cystic artery
Infection
Gram-negative septicemia
Typhoid fever
Leptospirosis
Trauma
Direct injury to biliary tree
Associated major system injury
Drugs
Narcotics
Anesthetics
Antibiotics
Total parenteral nutrition
Iatrogenic
Surgery
Fasting
Transfusion
Mechanical ventilation/
positive end-expiratory pressure
Intra aortic balloon pumping
Vascular
Hypotension or shock
Arteriosclerosis
Diabetes
Collagen vascular disease
Congestive heart failure
Miscellaneous
Burns
Carcinoma
Cigarette smoking
Obesity
Pancreatitis
Prolonged labour
Renal failure

production.33 The resulting increase in
fluid and intraluminal pressure may
adversely affect perfusion of the gallblad
der wall, further promoting the inflam
matory process.17
Lindberg and associates20 and Weeder
and colleagues34 stressed the importance
of multiple transfusions and sepsis in the
pathogenesis of the disease. They pro
posed that multiple transfusions increased
the bilirubin load to the gallbladder.
However, Long and colleagues35 found
no difference in the amount of blood
transfused to critically ill patients who
subsequently suffered from acalculous
cholecystitis compared with control sub
jects. Although not quantitated in previ
ous reports, blood replacement during
debridement of burn wounds can be exten
sive. Three of our patients received more
than 30 units of blood before cholecysti
tis developed. In only one (case 4) was the
total bilirubin level elevated above nor
mal before the onset of cholecystitis.
Glenn36 and Glenn and W antz5 have
suggested a functional obstruction of the
cystic duct with increased viscosity of bile
produced by the combination of fever,
dehydration, fasting and narcotic anal
gesics as the cause o f acalculous
cholecystitis. They proposed that refeed
ing leads to contraction of the obstructed
g allb lad d er with developm ent o f
cholecystitis. Further obstruction in
Cause
burned patients may exist at an ampulPostulated mechanisms for the cause of lary level secondary to surrounding edema
acute acalculous cholecystitis include bile from hypoalbuminemia and local inflam
stasis and increased bile viscosity, func matory processes.25 Others36"38 have pro
tional obstruction to outflow o f bile, posed the passage of an unrecognized
impaired blood supply to the gallbladder stone as the cause of obstruction and
wall and secondary bacterial or fungal indeed small calculi may be concealed in
the valves of Heister. Reflux of pancreatic
invasion.
juice into the gallbladder also may initi
The risk factors for acute acalculous
ate the inflammatory process.2
cholecystitis are presented in Table
Experience with postoperative and
J J 1,17,24-27
Bile stasis secondary to prolonged fast trauma cases has suggested other causes.
ing may be an important initial step Thompson and colleagues6 emphasized
toward the development of acalculous that shock and resultant vascular insuffi
cholecystitis. Total parenteral nutrition is ciency could lead to gangrene of the gall
associated with an increased incidence of bladder wall. In suggesting that increased
the disease;28 Roslyn and associates29,30 sympathetic tone in the shock state
reported a twofold increase of cholecysti increases ischemia, Howard and col
tis in patients on total parenteral nutri leagues39 demonstrated the protective
tion who received little or no oral sup effect of sympathectomy in preventing
plementation, compared with those who cholecystitis in dog shock models. Again
did. Prolonged fasting also seems to supporting a vascular etiology, Laws and
reduce the cholesterol concentration of Elliott40 demonstrated an anomalous ori
bile, leading to the development of sono gin of the cystic artery associated with
graphic sludge. Allen and associates31 postoperative cholecystitis. Positive endhave shown that the sludge is composed expiratory pressure may play a role by
of calcium bilirubinate with an increase reducing blood flow th ro u g h the
in the proportion of unconjugated choled o ch o d u o d en al ju n c tio n and
bilirubin. Ostrow32 found that uncon increasing venous congestion.41
jugated bile salts were more injurious to
Glenn and Becker2 and Thompson
the gallbladder mucosa of guinea pigs and associates6 have demonstrated the
than conjugated salts. The inflammation characteristic histologic findings, from
of the gallbladder mucosa results in patients with acalculous cholecystitis, of
increased production of prostaglandins focal necrosis in the serosa and tunica
promoting fluid secretion and mucus muscularis of arteries and veins with sub-

posto p eratively, the incidence of
cholecystitis ranges from 20% to 62%,
and is higher still following traum a or
multisystem failure.6,7'16'19 Acalculous
disease was present in all 12 patients with
acute cholecystitis among 2412 Vietnam
casualties reported by Lindberg and
associates.20 Dupriest and colleagues,8
reporting on a combined series of 98
trauma patients with acute cholecystitis,
found the acalculous form in 85 (86.7%).
Recent reviews have reported an over
all occurrence of 0.4% to 0.5% o f acute
acalculous cholecystitis in burned
patients.11,13’21 Alawneh11 and Munster
and colleagues13 reported acalculous dis
ease in all their burned patients who
suffered acute cholecystitis, while Kirksey and colleagues21 reported acalculous
disease in seven of nine.
In co n trast to acute calculous
cholecystitis in the general population, the
acute acalculous form occurs more fre
quently in men and at a younger age.
Although 75% of cases of acalculous
cholecystitis in postoperative patients
occur in those older than 50 years, the
average age in post-traumatic and burn
p atien ts ranges from 21 to 48
years.5'19'20,22’23 The average age of 29
years in our series is consistent with that
of previous reports.
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Keating14 thought that it was a secon
dary event, superimposed on an already
damaged or ischemic gallbladder. Lindberg and associates20 and Weeder and
associates34 reported high rates of infec
tion in their patients. Alawneh11 demon
strated positive cultures from bile in 6 of
7 burned patients, while Munster and
colleagues13 identified 8 of 10 patients
with septicemia and gallbladder seeding.
Only one patient in our series had posi
tive bile cultures, although all had sepsis.
Diagnosis
The signs and symptoms are similar to
those of calculous cholecystitis, with right
upper quadrant pain, tenderness, fever
and leukocytosis being the most frequent.
The diagnosis may be clouded by local
injury and use of endotracheal intuba
tion. Unexplained fever, right upper
quadrant pain and tenderness, sepsis,
abnormal liver function test findings or
intolerance to enteral feeding should sug
gest the possibility o f acalculous
cholecystitis. Glenn and Wantz5 reported
the association of a resumption of enteral
feeding to the onset of symptoms, and we
observed this in two of our patients.
Ultrasonography and cholescintigraphy
may be useful in diagnosing acute acal
culous cholecystitis.15’44'47 Three of our
patients had ultrasonograms that showed
an enlarged gallbladder containing
sludge, consistent with acalculous
cholecystitis or the fasting state. With no
more specific sonographic findings, the
absence of stones and other pericholecystic condition prompted the diagnosis in
each case. Hepatobiliary scanning with
aminodiacetic derivatives, although more
sensitive and more specific for acute
cholecystitis secondary to cystic duct
obstruction as in acalculous disease, was
not performed in the intensive care unit.
Treatment
Once the diagnosis is made, surgical
exploration is necessary because of the

high proportion of cases of gangrene or
perforation. In the series reported by
Dupriest and colleagues,8 gangrene was
present in 52% of cases and perforation
in 11%. Cholecystectomy is regarded as
the procedure of choice; however, others
have performed cholecystostomy in chil
dren and critically ill patients with good
results.14,25’35 Glenn1 recommended inter
val cholecystectomy for those having ini
tial decompressive cholecystostomy. The
natural history of patients treated by
cholecystostomy alone for acalculous dis
ease is unknown and cholecystectomy fol
lowing cholecystostomy is a more difficult
operative dissection with increased blood
loss.48 It remains to be determined, par
ticularly in young patients, whether
cholecystectomy should follow cholecyst
ostomy to prevent complications or recur
rence. A decision should be based on re
assessment of the patient’s clinical status.
Both our patients treated with chole
cystostomy alone remained free of symp
toms for more than 12 months.

Series
Taylor and associates, 196212
Munster and associates, 197113
Ternberg and Keating, 197514
Alawneh,197811

Sex
M
M

Average
age, yr
29
29

The morbidity and mortality with acute
acalculous cholecystitis is much higher
than those for calculous disease. Glenn1’2
recently reported a death rate twice that
for calculous cholecystitis, and this is con
firmed by other reports.4,8’20 In patients
who are critically ill, and thus at increased
risk for the complication, the degree to
which cholecystitis itself contributes to
death is uncertain. M unster and
associates13 identified two distinct groups
of burned patients with acalculous
cholecystitis; the first had overwhelming
and invariably fatal sepsis, while in the
second, extensive bacterial invasion was
not present, but cholecystitis contributed
significantly to mortality and morbidity.
Our patients all had substantial sepsis in
combination with cholecystitis, yet all
recovered, and in only one was the gall
bladder shown to be secondarily seeded.
A summary of the 27 cases of acute
acalculous cholecystitis in burned patients

Average total body
surface area burn
(third degree), %
50 (-)
56 (33)

Average time of
onset of cholecystitis
post burn, d
2
19 (autopsy, 4)

F
M
F
M
M
M
M

2
43

36 (36)
46 H

4
23

Chen and Aliapoulious, 197815
Glenn, 19791
Rice and associates, 198016
Glenn and Becker, 19822

1
6
1
1
1
2
2

55
36
27
42

50 (22)
48 (-)
50 (23)
38 (-)

6
14
33
17 (autopsy, 2)

Gately and Thomas, 198317
Present series

1
4

M
M

19
29

50 (-)
50 (29)

33
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Table III--Summary of Cases of Acalculous Cholecystitis Following Burn Injury Reported Since 1960
No. of
patients
1
10

T

* X

sequent thrombosis. Experimentally,
gram-negative endotoxin, polyphenols,
collagen and cigarette-smoke condensate
have been shown to induce the same ves
sel injury through the activation of Fac
tor XII pathw ays.27 42 Becker and
associates42 injected 12 dogs and 3 Afri
can Green monkeys with chemical acti
vators o f Factor XII, E. coli endotoxin
and saline to observe the effects of Fac
tor XH-dependent pathways on the gall
bladder and other tissues. They demon
strated vascular thrombosis, necrosis,
edema and hemorrhage in the serosa and
tunica muscularis of the gallbladder.
Microthrombi were observed to a lesser
extent in the lungs and other organs. The
reason for the apparent sensitivity of the
gallbladder to damage is unclear, but
Glenn and Becker2 have proposed the
existence of a kininogen, related to
cholecystokinin, within the gallbladder
wall that may increase local vasospasm
and injury. Since the release of substances
from damaged tissue, exposure of colla
gen, bacterial sepsis and transfusion of
blood products, all of which are
associated with the activation of Factor
XII, occur in burned patients, it seems
reasonable to conclude that blood-vessel
damage through Factor XH-dependent
pathways may be the initial step in the
development of acute acalculous chole
cystitis.
Other endogenous vasoactive sub
stances may play a role in severely burned
patients. Several circulating mediators
of vascular permeability, size and ca
pacitance are altered in burned patients.
Thromboxane B2 (the stable metabolite
of throm baxane A2 levels increase
immediately after a burn injury and
remain elevated above control levels.43
The vasoconstrictive effects, as well as
those of other prostaglandins and throm
boxanes, are thought to be important in
the pathophysiology of burn-wound
ischemia and may well contribute to vas
cular insult on the gallbladder.
W hether bacterial invasion of the gall
bladder is a primary or secondary event
remains controversial. Ternberg and

Outcome
Died
8 died
2 survived
Died
1 died
6 survived
Survived
Survived
Survived
Died
Survived
Survived

VOLUME 28, NO. 6, NOVEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

reported since 1960 is contained in Table
III. The average age o f 35 years in these
cases falls between the mean values found
in the trauma and postoperative groups.
The male to female ratio was 8:1, a
predominance that may be partly
explained by the 4:1 male to female ratio
in the burn population o f a similar age
(Snelling CFT: Unpublished data, 1983).
There were three reported cases of elec
trical burn, two with gangrene o f the gall
bladder wall. Twenty-two percent of cases
were complicated by Curling’s ulcer and
most had significant sepsis, reflecting the
severity of their illness. Although gan
grene occurred in 33% of cases, there was
a surprising lack of perforation when
compared with the high incidence in
trauma victims. Two patients were treated
with cholecystostomy with good results,
but the overall death rate remained high
at 51.8%.

Conclusions
As a group, burned patients are subject
to many risk factors associated with the
development o f acalculous cholecystitis.
The extent of tissue injury in those who
have the complication (generally a total
body surface area burn greater than 30%)
may support the activation o f Factor XII
pathways and vascular injury as central
to the pathogenesis of the disease. Burned
patients with pain in the right upper quad
rant and tenderness or a suspicion o f
intra-abdominal sepsis should undergo
diagnostic laboratory tests and ultra
sonography o f the abdomen. Although
cholecystectomy is the treatment o f choice
in critically ill patients, cholecystostomy
can more easily be performed and gives
good results.
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NOTICES
General Scientific Meeting

Otolaryngology

The 6th biennial general scientific meet
ing of the Association o f Surgeons o f
South East Asia will he held Feb. 8-13,
1987 in Bangkok, Thailand. This meet
ing will embrace all surgical disciplines by
way o f plenary sessions, scientific papers
and poster sessions, panel discussions,
workshops and exhibitions. Oncology,
organ transplantation, instrumentation
and surgical infection are some o f
the topics to be presented by invited
speakers.
For further information contact Dr. P.
Gojaseni, Scientific Chairman, Associa
tion o f Surgeons o f South East A sia, c /o
Department o f Surgery, Ramathibodi
Hospital, Bangkok 10400, Thailand.

The University o f California School of
Medicine at San Francisco will be present
ing a symposium on otolaryngology to be
held Feb. 1-8, 1986 in Grindelwald, Swit
zerland. Designed for otolaryngologists,
otologists, head and neck surgeons, and
plastic and reconstructive surgeons, this
symposium will evaluate recent develop
ments and future directions in related
areas. The co-chairmen will be Drs. Roger
Boles and Thomas O. Wildes.
For more information contact Ex
tended Programs in Medical Education,
The University of California School o f
Medicine, Rm. 569-U, San Francisco, CA
94143; or call (415) 666-4251.
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Laryngeal Chondrosarcoma: Gross Pathological, Histologic
and Electron Microscopic Characteristics
1
«

Chondrosarcoma is an uncommon car
tilaginous tumour of the upper respira
tory tract, and its morphology and clini
cal course vary widely. Few reports have
evaluated the clinicopathological findings
of this tumour in the larynx. This paper
reports on a low-grade chondrosarcoma
in a 44-year-old woman who required
laryngectomy for cure. The gross patho
logical, histologic and electron
microscopic features of the tumour are
analysed with respect to its clinical
course, using histopathological criteria.

Le chondrosarcome est une tumeur cartilagineuse peu courante des voies respiratoires superieures. Sa morphologie et son
evolution varient consid6rablement. Peu
d'articles ont evalue les observations clinicopathologiques de cette tumeur du
larynx. Cette publication decrit un chon
drosarcome devolution iente chez une
femme de 4 4 ans qui fut traite par laryngectomie a visee curative. Les caract6ristiques pathologiques macroscopiques et
histologiques, ainsi que sa presentation
au microscope electronique sont analysees a I'aide de criteres histopathologiques par rapport & revolution clinique.

scribed the first such tumour to be exa
mined using a laryngoscope. The nature
of the tumour was elaborated on at
autopsy. The first extensive literature
review was by M oore,10 in 1925, who
studied 53 cases of “ benign and malig
nant” cartilaginous lesions. In 1935,
New11 first used the term “ chondrosar
coma” to designate a malignant tumour
of laryngeal cartilages. The first published
case of metastatic chondrosarcoma of the
larynx was made by Ghalib and
associates12 in 1969. Since then, numer
ous single reports and series have been
reported,5-7'13 over half having been
reviewed by Neel and Unni6 and Ostberg
and colleagues.13
We describe a case of this rare tumour
which required laryngectomy for cure.

ing from the posterolateral wall of the cricoid.
The tumour occupied approximately half the

i

<

Case Report
A 44-year-old woman was first seen in 1980
complaining of hoarseness for 6 months.
Indirect laryngoscopy revealed a subglottic
mass, confirmed by direct laryngoscopy, which
showed a tumour in the subglottic space arisFIG. 2—Opened larynx (posterior view), e
= epiglottis, L = subglottic lumen, T = sec
tioned chondrosarcoma.

44

Malignant cartilaginous tumours of the
larynx are uncommon, accounting for less
than 1% of all laryngeal tumours.1-7 The
frequency of chondrosarcoma is 5 to 10
per 5000 cases of primary laryngeal
neoplasm s.15 Only 150 cases have been
reported in the literature since Travers
first reported on a bony growth involv
ing the cartilages of the larynx in 1816.3
M uller8 in 1836 coined the term
“ chondrom a” . In 1866, Tiirck9 de-
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FIG. 1—Laryngectomy specimen (posterior
view), e = epiglottis, t = left thyroid, T =
subglottic chondrosarcoma.

FIG. 3—Whole-mount sagittal section
through chondrosarcoma, a = arytenoid car
tilage with formed bone, m = transverse and
oblique fibres of arytenoid muscle, L = laryn
geal subglottic lumen, T = tumour mass with
bone formation, c = remaining cricoid car
tilage, t = first tracheal ring (hematoxylin and
eosin).
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airway, was covered by intact mucosa and was
quite hard. Typically, when a biopsy with cup
forceps was attempted, insufficient tissue was
harvested to arrive at a diagnosis. Through a
laryngofissure the tumour was locally resected.
Initially, there was considerable debate between
the pathologists as to whether the specimen was
a malignant tumour. The final report described
it as a grade 1 chondrosarcoma.
The patient was carefully followed up until
October 1984 when she returned with obvious
local recurrence. In view of the airway
encroachment, a total laryngectomy was per
formed.

Pathological Findings
On gross examination the mass was 4
cm in diameter and appeared well circum

scribed, with a compression capsule (Fig.
1). The tumour protruded into the lumen
of the subglottic space compromising the
airway, while laterally the tum our
encroached on, but did not invade, adja
cent structures (Figs. 2 and 3). It
infiltrated the cricoid cartilage extensively
(Figs. 3 and 4). The tumour mass was
grey-white, and composed of multiple
interconnecting lobules of varying size,
with a chondroid consistency. There was
central necrosis with areas of calcification
and ossification making the tumour gritty
on sectioning.
Histologically, small densely staining
nuclei predominated (Fig. 5) with a chon
droid intercellular background. Multiple
(two or more) nuclei within one lacuna

were frequently found. There were no
mitotic figures, but small numbers of
larger pleomorphic nuclei were present in
isolated areas (Figs. 5 and 6). Foci of cal
cification and ossification were seen (Figs.
4 and 5).
The ultrastructure of the tumour
showed well-developed chondrocytes,
varying in size, with short processes of
cytoplasm and scalloping of the cell mem
brane. The nuclei were irregular and
eccentrically placed with a thick fibrous
lamina. A prominent feature was the
presence of abundant amounts of dilated
rough endoplasmic reticulum filled with
proteinaceous material. Lipid droplets,
lysosomes and varying amounts of glyco
gen were noted. The matrix was com
posed of fine fibrillar elements with small
proteoglycan granules (Fig. 7).
Discussion

FIG. 4—Chondrosarcoma (right) invading normal cricoid cartilage (left) (hematoxylin and
eosin, original magnification x 100).

FIG. 5—Chondrosarcoma (grade 1). Lacunae containing multiple, irregular cells, occa
sionally multinucleated, in “ cluster disarray” (hematoxylin and eosin, original magnification
X 100).

Chondrosarcoma of the larynx occurs
in patients ranging in age from 40 to 60
years, in distinct contrast to malignant
cartilaginous tumours of extralaryngeal
origin which affect a much younger age
group.14 The cricoid is the most common
site (75% ), usually occupying the
posterior lamina. The thyroid cartilage is
the next most common site (20%), with
the arytenoid, epiglottis and vocal cords
being rare locations for the neoplasm.
Clinical features relate to the slow
intraluminal growth of the tumour in the
subglottic space (i.e., dyspnea, hoarseness
and dysphagia). If the tumour is in the
thyroid cartilage, it may present as a neck
mass. At laryngoscopy, the tumours show
a smooth, bulging, subglottic mass
covered with normal mucosa and possi
ble impaired movement of one or both
vocal cords. Radiologic investigations,
including soft-tissue lateral neck views,
laryngeal tomograms, laryngogram (air
way encroachment), barium swallow
(esophageal encroachment) and com
puterized tomography, all aid in the
preoperative work-up. Microscopic cal
cifications are seen radiologically in 75%
of cases.1
Chondrosarcomas have been classified
into three histologic grades on the basis
of mitotic rate, cellularity and nuclear
size.15 Grade 1 features have been eluci
dated in this case. The most striking fea
ture of a grade 2 tum our is increased cel
lularity and a low mitotic rate (less than
two mitoses per 10 high-power fields).
The nuclei are paler staining, of moder
ate size, with visible intracellular detail.
The background is more myxoid than
chondroid but this feature is variable. For
high-grade chondrosarcoma (grade 3), the
principal criterion is the presence of two
or more mitoses per 10 high-power fields.
These areas are usually located at the edge
of the mass. In addition, there is increased
nuclear size and cellularity. It is impera-
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tive to examine numerous sections of the
tumour, since many lobules will appear
of a lower grade, but the tumour is graded
according to its most active part.
The histologic grade (from 1 to 3) of
this neoplasm is based on the criteria set
out by Lichtenstein and Jaffe16 and
Spjut and colleagues:17
• Pronounced irregularity in the size of
the cells and their nuclei (Figs. 4 and 5).
• Presence of numerous cells and their
nuclei (Fig. 6).
• Pronounced hyperchromatism of the
nuclei.
• Any large or giant cells with single
or multiple nuclei or containing clumps
of chromatin (Fig. 6).
• “ Cluster disarray” 14 (Fig. 5).
There is no substantial difference
ultrastructurally between grade 1 and
grade 2 chondrosarcomas. In grade 3
neoplasms, there are more pronounced
nuclear and nucleolar abnormalities. This
high-grade tumour loses its cartilaginous
differentiation and resembles fibroblasts.
It must be emphasized that the ultrastructural abnormalities are not specific to this
tumour and cannot be used for definitive
diagnosis.
The only treatment for chondrosar
coma of the larynx is surgical excision.
There is a spectrum of surgical treat
ments, from wide local excision through
a laryngofissure approach, to total laryn
gectomy. The critical factor determining
the extent of resection is the degree of cri
coid destruction. If the tum our involves
more than half of the lamina, laryngec
tomy is the treatment of choice. It is
generally agreed that the treatment should
not be influenced by the histologic
appearance of the neoplasm.1

The long-term prognosis depends on
tumour grade, location and extent and
adequacy of initial resection. Usually,
high-grade chondrosarcomas recur locally
more often and have a greater tendency
to metastasize, to lung and bone, than
low-grade tumours, which are locally
invasive but do not metastasize. Because
laryngeal chondrosarcomas are much less
aggressive and slower growing than chon
drosarcomas of extra-laryngeal origin, the
long-term survival rates are much bet
ter.15 Specific survival rates for laryngeal
chondrosarcoma have not been compiled,
owing to the small numbers.1

FIG. 7— Laryngeal chondrosarcoma show
ing malignant chondrocyte, binucleated (N),
with abundant rough endoplasmic reticulum
(rer) with dilatations filled with proteinaceous
material. Lipid droplets (I) and glycogen (g) are
displayed. Numerous cytoplasmic processes
(m) are seen, with cells set in fibrillar chondroid
matrix (M) (original magnification x 8000).
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Pan-Pacific Surgical
Association
The 18th biennial congress of the PanPacific Surgical Association will be held
Jan. 11-17, 1986 in Honolulu, Hawaii.
The theme of the meeting will be trauma.
For more information contact: Dr.
George Bondar, Secretary, Pan-Pacific
Surgical Association, Rm. 402, 10053111th Street, Edmonton, Alta. T6K 2H8.

Trauma Management 1986
The Office of Continuing Medical Edu
cation of the University of California,
San Diego, is planning a conference on
trauma management to be held Feb. 3-5,
1986 at the U.S. Grant Hotel in San
Diego. The course director will be Dr.
Steven R. Shackford.
For further information contact the
Office of Continuing Medical Education,
M-017, University of California San
Diego School of Medicine, La Jolla, CA
92093; or phone (619) 452-3940.
continued on page 538
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Dysphagia Following Vagotomy

►
*

V
►

Dysphagia is a fairly common complica
tion of vagotomy but has received little
attention in the literature. The authors
reviewed the hospital records of 79
patients who underwent highly selective
vagotomy or truncal vagotomy with vari
ous types of drainage. Overall, 11
patients (13.9%) suffered from dyspha
gia, which was generally of short dura
tion. The incidence of dysphagia was
significantly (p <0.001) higher after
highly selective vagotomy than after
truncal vagotomy (60% versus 7.2%).
There was no significant difference
between the occurrence of dysphagia
after elective compared with emergency
truncal vagotomy. The dysphagia usually
resolves spontaneously and requires no
specific therapy.

►
I

►

V
V
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La dysphagie, une complication assez
frequente de la vagotomie, n'a obtenu
que peu d'attention de la presse medi
cate. Les auteurs ont etudie les dossiers
medicaux de 79 patients qui ont subi
une vagotomie hyper-selective ou une
vagotomie tronculaire avec divers types
de drainage. Du groupe, 11 patients
(13.9%) ont souffert de dysphagie,
generalement de courte duree. La fre
quence des cas de dysphagie apres
vagotomie hyper-selective a ete significativement plus elevee (p<0.001) qu'apres
vagotomie tronculaire (60% par rapport
a 7.2%). On n'a note aucune difference
significative entre le nombre de cas de
dysphagie apres operation differee comparativement a la vagotomie tronculaire
d'urgence. La dysphagie disparait habituellement spontanement et ne requiert
aucun traitement specifique.

Better understanding of gastric physiol
ogy over the past 20 years has led to the
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development of new operative approaches
for peptic ulcer disease. Highly selective
vagotomy has added to the surgical
armamentarium a procedure associated
with an extremely low operative mor
bidity and mortality.1 We report a com
plication of vagotomy of various types
that has not received much attention in
the literature — dysphagia. The frequency
of dysphagia with respect to emergency
or elective procedures is considered and
the relation of dysphagia to truncal vagot
omy and highly selective vagotomy is
compared.
Patients and Methods
A retrospective review was carried out
from hospital records and office notes of
all 85 patients who underwent vagotomy,
performed by one of us (S.M.), between
1972 and 1983. Six patients were
excluded: two were lost to follow-up; two
underwent concomitant fundoplication,
which may in itself cause dysphagia; and
two, previously operated on elsewhere,
underwent repeat vagotomy and may
have been subjected to excessive opera
tive manipulation at the gastroesophageal
junction. Thus, 79 patients (50 men, 29
women) form the basis of this report.
The mean age of the patients was
50 ± 16 (standard deviation) years (range
from 18 to 83 years). The procedures per
formed are listed in Table I. During the
course of surgery, seven patients under
went cholecystectomy, one an incidental
appendectomy and one a drainage gas
trostomy with feeding jejunostomy.
Follow-up ranged from 1 to 92 months
(m ean 11.7 ± 2 . 4 [standard error]
months). All patients but one were fol
Table 1-Procedures Performed in 79 Patients
With Peptic Ulcer Disease
No. of
patients
Procedure
47
Truncal vagotomy and pyloroplasty
Truncal vagotomy and
gastroenterostomy
6
10
Highly selective vagotomy
Truncal vagotomy and antrectomy
16

lowed up for at least 6 weeks and all but
four for 2 months or more.
A diagnosis of peptic ulcer disease was
established by esophagogastroduodenoscopy in 43 patients, by barium con
trast studies in 26, and by both methods
in 4. Six patients, in whom the diagnosis
was made clinically, all presented with the
picture of perforated hollow viscus.
Findings
Twenty-five patients underwent emer
gency operation and 54 elective. All
highly selective vagotomies were done
electively. Of the 47 patients who had
vagotomy and pyloroplasty alone, 19
underwent an emergency procedure and
2 patients subsequently suffered dyspha
gia; 28 underwent an elective procedure,
3 subsequently suffering from dysphagia.
This difference between elective and
emergency operation is not significant.
Of the 75 hospital survivors, 5 in the
truncal vagotomy and pyloroplasty group
and 6 in the highly selective vagotomy
group complained of dysphagia. Contin
gency table analysis yielded a p value of
less than 0.01, a highly significant differ
ence. In comparing patients with truncal
vagotomy, regardless of the type of
drainage, and all those who underwent
highly selective vagotomy, we found that
7.2% (5 of 69) of the former group and
60% (6 of 10) of the latter suffered from
dysphagia, giving an even more signifi
cant difference of p < 0.001 (Table II).
Four patients died. One patient of the
54 who underwent elective operation died
of myocardial infarction postoperatively,
while 3 of the 25 who underwent emer
gency operation died, one of myocardial
infarction and a second of pneumonia
and delirium tremens 2 weeks postoper
atively. The third patient was an
octogenarian operated on for hemor
rhagic gastritis following total hip replace
ment. She died of multiple-organ failure
1 week after operation. None of these
deaths was considered to be related to
technical problems at the time of surgery.
Dysphagia appeared at a mean 3 ± 0.4
(SEM) weeks postoperatively (range from
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1 to 6 weeks). The duration of the dys
phagia (median 1.5 months) is shown in
Table III. Only one patient needed
specific treatment. A bolus obstruction of
the esophagus required endoscopy for
relief.

Post-vagotomy dysphagia is given scant
mention in the surgical literature. Sulei
man and associates2 and Spencer3 each
reported on a single patient with severe
dysphagia requiring reoperation. Both
patients were found to have a dense mass
of fibrotic tissue around the lower end of
the esophagus. Greatorex and Thorpe4
reported a similar patient who responded
well to esophageal bougienage. Moses,5
in 1947, made the first references to post
vagotomy dysphagia although, at that
time, vagotomy was done using a trans
th o racic ap p ro ach . G rim son and
colleagues6 reported th at 21 o f 57
patients who underwent transthoracic
vagotomy experienced dysphagia, but no
patient had symptoms lasting longer than
3 months.
The overall reported incidence of post
vagotomy dysphagia ranges widely. Bruce
and Small,7 in 1958, found an incidence
of 14% after transabdominal vagotomy,
while P ostlethw ait and associates8
reported an incidence of 3.69% in 5267
patients and Wirthlin and Malt9 reported
a 1.1% incidence in 1096 patients after
transabdominal truncal vagotomy.
In a series of 829 proximal gastric
vagotomies, M oreno Gonzalez and
colleagues10 reported transient dysphagia
in 2.5%. While our incidence of dyspha
gia after transabdominal truncal vagot
omy is in agreement with that reported
in the literature, our incidence of dyspha
gia following highly selective vagotomy
is higher than that reported. However, as
is readily apparent from a study of the
literature, dysphagia is frequently not

• Denervation of the lower esophageal
sphincter (LES) mechanism which results
in incoordination of LES function or
failure of the LES to relax, or both.
• Periesophageal inflammation that
may settle down or cause more serious
fibrosis.
• Reflux with resultant dysphagia
(secondary to esophageal inflammation).
Little has been added to our under
standing of the problem since Guillory
and Clagett’s report. The first two pro
posed mechanisms would be expected to
produce transient dysphagia. Nerve-fibre
regeneration would eventually improve
LES function and the inflammation due
to operative trauma would settle down
with healing. If reflux was due to altered
LES function, reflux would be expected
to decrease as LES function returned to
normal.
These mechanisms are more applicable
to highly selective vagotomy, since an
important technical aspect of the proce
dure is a complete dissection of the lower
5 cm of distal esophagus to ensure that
all nerve fibres to the fundus of the
stomach are divided. Thus, the chance of
denervation of the LES mechanism would
be greater. More operative trauma to the
area is carried out than in simple truncal
vagotomy, so more postoperative inflam
mation may be expected.
E ndoscopic exam ination, cineesophagographic studies and manometry
may all help to determine the exact cause
of the dysphagia from the suggested
mechanism. These are planned for the
future.

T a b le I I — In c id e n c e o f D y s p h a g ia
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Conclusions
Dysphagia is a n ot infrequent compli
cation of all forms of vagotomy. It occurs
more commonly after highly selective
vagotomy. It usually follows a benign
clinical course and requires no specific
therapy.
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Canadian Orthopaedic Nurses
Association
The 9th national conference of the Cana
dian Orthopaedic Nurses Association will
be held March 24-26, 1986 at the Westin
Hotel in Winnipeg. The theme will be
education through participation.
For more information write to the
Canadian Orthopaedic Nurses Associa
tion, 43 Wellesley St. E, Toronto, Ont.
M4Y 1H1.

Postgraduate Assembly
in Surgery
The 9th annual San Diego Postgraduate
Assembly in Surgery is being presented by
the Office of Continuing Medical Educa
tion of the University of California, San
Diego, at the Hotel Intercontinental-San
Diego, Jan. 20-24, 1986. The course
director will be Dr. A.R. Moosa.
For further information contact the
Office of Continuing Medical Education,
M-017, University of California San
Diego School of Medicine, La Jolla, CA
92093; or phone (619) 452-3940.
continued on page 541
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T a b le III - D u r a t i o n

Until the pathophysiology underlying
the dysphagia is delineated, no specific
recommendations can be made to prevent
the problem.

r (

Discussion

mentioned in papers reporting results of
vagotomy. This may be due to the usually
benign and transient nature of the dys
phagia.
The exact cause of the dysphagia
rem ains enigm atic. G uillory and
Clagett11 proposed the following mech
anisms.
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Pelvic Exenteration for Advanced Primary
and Recurrent Adenocarcinoma
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The authors report on 45 patients who
have undergone pelvic exenteration for
adenocarcinoma since 1979. Three
patients underwent exenteration as the
initial treatment for their disease but all
others had had previous surgery, radi
otherapy or chemotherapy. Operating
time anti blood loss were lower in previ
ously irradiated patients. There were
seven inhospital deaths (15.5% ). The
number of complications and length of
postoperative hospital stay have
decreased significantly as experience
with pelvic exenteration has been
acquired. Symptoms have been con
trolled in a high proportion of patients.
Exenterative surgery is an effective
method of treatment in selected patients
with pelvic adenocarcinoma but should
be undertaken only by experienced sur
geons who have access to a wide range
of supportive facilities for optimal peri
operative management.

Depuis 1979, 45 malades ont subi une
exenteration pelvienne pour epithelioma
glandulaire. Chez trois malades elle a ete
faite d'embl6e; tous les autres avaient
ete prealablement operes ou traitees par
radiotherapie ou chimiotherapie. Ceux qui
ont ete irradigs saignent moins que les
autres et leurs interventions sont plus
courtes. Sept d6ces (15.5% ) surviennent
a Thopital. A la faveur de I'experience on
assiste a une diminution du nombre des
complications et de la duree du sejour
hospitalier postoperatoire. Un soulagement symptomatique est obtenu chez un
grand nombre de patients. Si I'exentGration est efficace dans certains cas choi-
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sis d'6pithelioma glandulaire de la region
pelvienne, elle ne doit etre entreprise que
par le chirurgien experiments qui a a sa
disposition tous les services de soutien
necessaires au meilleur traitement perioperatoire possible.

Pelvic exenteration has been employed
most widely for patients with locally
advanced but surgically curable squamous
cell carcinoma of the cervix. Recently,
patients with extensive adenocarcinomas
of the rectum or distal colon also have
undergone exenterative pelvic surgery.
Approximately 6% of patients with
colorectal adenocarcinom as have
advanced pelvic lesions without abdomi
nal or distant spread of disease.1’2 Fiveyear survival rates following pelvic exen
teration range from 30% to 39% in such
patients.2-4 Exenterative procedures have
also been performed for palliation in
patients with incurable disease who are
incapacitated by pelvic pain.4
Since 1979, 45 patients (22 men, 23
women) ranging in age from 31 to 78
years (median 52 years) with locally exten
sive pelvic adenocarcinomas have under
gone total, anterior or posterior exenter
ation at the Toronto General Hospital.
We report the early results of pelvic exen
teration in these patients.

Patients
All patients had deep pelvic pain that
could not be controlled by narcotic anal
gesics at the time exenteration was consi
dered (Table I). Three patients had pel
vic exenteration as the initial treatment
for their primary neoplasms. Three had
colostomy initially followed by pelvic
exenteration. The remaining 39 had their
primary lesion excised by standard sur
gical procedures; 11 underwent pelvic
exenteration as initial treatment for
tumour recurrence and the other 28 had
more conservative therapy over a further
3 to 36 months before being referred for
exenteration because of treatment failure.
Twenty-eight of the 45 patients had
received external radiotherapy (4000 to
5000 R, median 4500 R) to the pelvis

before being considered for pelvic exen
teration. Eighteen of these obtained tran
sient improvement in symptoms but the
pain subsequently worsened in every case.
The rectum was the site of origin of
adenocarcinoma in 35 patients, the sig
moid colon in 4, the cecum in 3, the
endometrium in 1 and the endocervical
canal in 1. In one patient the site of ori
gin could not be determined either at sur
gery or on gross and microscopic exami
nation of the operative specimen.
Forty-two patients underwent total pel
vic exenteration (removal of bladder,
anorectum, internal reproductive organs
and wide margins of the levator muscles
and perineum ). Two women had
posterior exenterations (anorectum and
internal genitalia), and one woman had
an anterior exenteration (bladder and
internal genitalia). The pelvic exenteration
was carried out for cure in 26 patients and
for palliation in 19.
Preoperative investigations are detailed
in Table II. Computerized transaxial
tomography was used to assess the extent
of tumour invasion into adjacent organs
or sacrum, and cystoscopy was used in 15

Table 1-Symptoms and Disease Manifestations
at the Time Exenteration Was Considered
No. of
patients
Symptom/manifestation
14
Pelvic pain only
31*
Pelvic pain and
7
large-bowel obstruction
3
small-bowel obstruction
6
rectal bleeding
1
diarrhea
4
vaginal bleeding or discharge
It
vesicovaginal fistula
1t
rectovaginal fistula
It
rectovesical fistula
6
dysuria, urgency
2
bladder outflow obstruction
1
hematuria
1
upper urinary tract obstruction
perineal breakdown, discharge
5
or bleeding
1
perineal mass
*7 had 2 and 1 had 3 symptoms or manifesta
tions in addition to pain.
tDue to tumour.
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patients to document malignant invasion
of bladder, urethra or prostate.
Exenterative surgery was necessary
because the neoplasms were densely
adherent to two or more pelvic organs,
either through microscopic invasion or by
dense fibrosis and chronic inflammation.
The tumour was adherent to sacrum and
coccyx in 21 patients and 7 patients had
malignant invasion of perianal tissues and
skin.
Involved cecum or small bowel was
resected en bloc and intestinal continuity
re-established primarily in nine patients.
One patient had a segment of involved
right external iliac artery resected; the ves
sel was reconstructed with a knitted
Dacron graft.
When necessary, urinary diversion was
performed (Table III) and, where possi
ble, the pelvic floor was reconstructed
with residual peritoneum or with
peritoneum and regional viscera as
described by Webb and Symmonds.5
In one patient, the perineal wound
could not be closed because of extensive
tissue resection, so the perineum was
reconstructed primarily using gracilis
myocutaneous flaps as described by
Palmer and associates.6 In eight patients
the pelvis was packed and the perineal
wound left open because of oozing from
raw surface areas. In six of these patients,
the perineal wound was closed over drains
when the packing was removed 48 to 72
hours postoperatively. Of the other two
patients, one underwent perineal recon
struction with gracilis flaps and in the
other, multiple split-thickness skin grafts
were applied.
The tumour was incompletely excised
in 19 of the 45 patients. Twelve had

Results
The Operation
Operative blood loss ranged from 1500
to 12 000 mL (median 4000 mL). Of the
42 patients who underwent total pelvic
exenteration, those who had received
radiotherapy previously (28 patients)
lost significantly less blood than the
14 patients who had not had radiother
apy (3660 ± 1260 mL versus 5600 ±3100
mL; p < 0.02, Student’s /-test). There was
no significant difference in blood loss
between curative and palliative total exen
terations.
The operative time ranged from 3.5 to
8.5 hours (median 5.5 hours). In patients
who had total exenteration, the duration
of surgery was significantly shorter in
those with preoperative radiotherapy
(5.8 ± 1.0 hours versus 6.4 ± 1.0 hours
for nonirradiated patients; p < 0.05).
Operative time did not differ significantly
between curative and palliative exentera
tions.
Death Rate and Survival
There were no intraoperative deaths
although two patients had cardiac arrests
during surgery due to sudden ventricular
arrhythmias. These patients were resus
citated quickly and suffered no ill effects.

T a b le II— P re o p e ra tiv e In v e s tig a tio n s C a rrie d O u t
in 4 5
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Seven patients (mean age 52.8 ± 12
years) died in hospital 15 to 181 days after
surgery (median 62 days). Two died
within 30 days, one of pelvic hemorrhage
following anticoagulation for a femoral
vein thrombosis and the other of
unknown causes following transfer to a
convalescent hospital in her home town.
Three inhospital deaths were directly
attributable to surgical complications (uri
nary sepsis, external iliac graft infection,
recurrent hemorrhage, sepsis and renal
failure). One hospital death resulted from
hemorrhage from an unsuspected cerebral
metastasis and another patient died of
unknown causes 140 days after operation,
following transfer to a convalescent
hospital. There was no difference in oper
ative blood loss or duration of operation
between the 38 who survived the
postoperative hospital stay and the 7 who
did not.
Of 16 patients who had palliative exen
teration and survived the postoperative
hospital stay 9 died, 7 of tumour progres
sion (median 5 months), 1 of urinary sep
sis at 4 months and another of unknown
causes at 4 months. Those currently alive
have been followed up for 2 to 26 months
(median 7.5 months).
Twenty-two patients left hospital after
curative exenteration. Six of these later
died of tumour recurrence and progres
sion (median time 15.5 months). Median
disease-free survival was 8 months. Four
patients are alive with recurrent or
metastatic disease 11, 17, 21 and 23
months after operation, having been
disease-free for 5, 14, 17 and 20 weeks.
The remaining 12 patients are alive and
disease free 4 to 41 months after opera
tion (median 10.5 months).

microscopic disease at resection margins,
3 had liver metastases and 4 had sacral
invasion, which computerized tomogra
phy failed to detect preoperatively. The
exenteration specimen had to be “ cracked
off” the sacrum, leaving gross disease in
situ.
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to m o g ra p h y (a b d o m e n an d pelvis)
L y m p h a n g io g r a p h y
U ltra s o n o g ra p h y (a b d o m e n a n d pelvis)

28
1

T a b le IV — R e s u lts o f E x e n t e r a tio n W it h R e s p e c t t o

15

R e lie f o f P r e o p e r a tiv e P e lv ic P a in

R a d io n u c lid e s tu d ie s
L iv e r s c a n n in g

7

B o n e s c a n n in g

10

p a in

E ndoscopy
S ig m o id o s c o p y

5

C o m p le t e

C o lo n o s c o p y

3

C y s to s c o p y
E x a m in a tio n u n d e r a n e s th e s ia

540

15
5

E x e n t e r a t io n , n o . ( % ) *

C o n tro l of
C u r a t iv e

P a llia t iv e

1 6 (7 2 .7 )

5 (3 1 .2 )

P a r t ia l

4 (1 8 .2 )

6 (3 7 .5 )

Poor

2 (9 .1 )

5 (3 1 .3 )

*3

p e r io p e r a t iv e o r h o s p it a l d e a th s e x c lu d e d f r o m p a llia tiv e g ro u p a n d 4 f r o m c u ra tiv e g ro u p .
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The median hospital stay was 21.5 days
(range from 9 to 181 days) for the 26
patients who had curative pelvic exenter
ation and 23.5 days (range from 13 to 165
days) for the 19 having a palliative proce
dure. The length of hospital stay was not
affected by previous radiotherapy. Hospi
tal stay has decreased significantly as
experience with total exenteration has
accrued (Spearman correlation; rs =
-0 .3 6 , p = 0.0162).

►

►

b

S

►

Complications
The frequency of early complications
was similar in irradiated and nonirradiated patients. There was no difference
with respect to age, duration of operation
or operative blood loss between patients
who had early complications and those
who did not. However, postoperative
recovery was free of complications in only
5 of the initial 22 patients operated upon,
as compared with 14 of the latter 23
patients in this series (x2 = 6.74,
p < 0 .0 1 ).

Relief o f Pelvic Pain
and Other Symptoms
►
►

*

t
p

►
>

t

All patients presented preoperatively
with disabling pelvic pain. Partial control
of pain (requiring analgesics once or twice
per week) or complete control of pain (no
analgesics) was obtained in 90.9% of
patients who left hospital after curative
resection and in 68.7% of those who were
discharged following palliative exentera
tion (Table IV).
Of the seven patients who died in
hospital, four had complete relief of pel
vic pain after exenteration until they died.
Symptoms or disease manifestations
other than pain were completely relieved
in all of the 38 patients who were dis
charged from hospital.
Discussion
Our findings show that operative
procedures were shorter and associated
with less blood loss in patients who had
undergone radiotherapy before opera
tion. Previous radiotherapy did not have
any significant effects on the overall inci
dence of complications or hospital mor
tality. These findings differ somewhat
from those of other larger series.7,8
In most other respects, our early results
with pelvic exenteration are similar to
those reported elsewhere. Perioperative
and hospital mortality associated with
these procedures ranged from 5.6% to
23% .1-4,7' 10 Our overall mortality was
15.5%; four patients died in hospital
from 62 to 181 days postoperatively. The
longer survival in our patients was prob
ably due to the major advances made in
supportive and intensive care in the past
15 years, but these late hospital deaths are

distressing. We now pay particular atten
tion to patient selection and preoperative
nutritional and medical status in an effort
to prevent these unfortunate deaths.
In five series of pelvic exenteration
published since 1976, 377 postoperative
complications were reported in 405
patients.2‘4,9,11 Our patients had 66 early
complications (31 occurred in the seven
patients who died in hospital) and 11 late
complications. The postoperative hospi
tal stay was free of complications in a
much larger proportion of our patients
recently than earlier in this series. Further
more, there was a significant trend
towards shorter postoperative hospital
stay in our series. As experience with
exenteration is gained, there are fewer
complications. Our results underscore the
belief of various authors that this proce
dure should only be undertaken by sur
geons who have experience with it. These
surgeons should be located in centres
equipped with the full range of suppor
tive facilities for optimal postoperative
care. We have been impressed by the sub
stantial improvement in the quality of life
afforded by exenteration. Pain was
relieved in both irradiated and nonirradiated patients. Furthermore, exenteration
provides good palliation for patients
whose tumours cannot be completely
removed. We support the view of Deckers
and colleagues4 that, when used selec
tively, pelvic exenteration is superior to
simple narcotic analgesia or multipleagent chemotherapy for patients with
incurable pelvic adenocarcinoma. The
procedure is of particular value in patients
whose tumours are complicated by dis
charge or bleeding from malignant
masses, sinuses or fistulas involving pel
vic organs or the perineum. We concur
with Vera,12 that patients who undergo
pelvic exenteration generally regard them
selves as better off postoperatively despite
the radical nature of this operation.
In conclusion, we believe that pelvic
exenteration has a place in the manage
ment of extensive, recurrent pelvic
adenocarcinomas. It is of particular value
in patients whose tumours can be com
pletely removed, but can also provide
effective palliation of symptoms in
selected patients with incurable disease.
We acknowledge the cheerful assistance of
Lana Bryant in preparing this manuscript.

4. Deckers P J, O lsso n C, W illiam s LA, M o zden PJ:
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Decisions in Surgery
The University of California School of
Medicine at San Francisco is presenting
the 2nd annual conference on Decisions
in Surgery to be held Mar. 1-8, 1986 in
Snowmass, Colo., just a few miles from
Aspen.
Designed for general surgeons, this
program will address problems encoun
tered in daily practice. It will offer the op
portunity to discuss various approaches
and to formulate a rational basis for sur
gical decision-making. There will be time
available following each formal presen
tation for discussion and interaction with
the faculty. Topics to be covered include
gastrointestinal surgery, pediatric and fe
tal surgery, thoracic surgery, trauma,
obesity surgery, sepsis and breast cancer.
This conference meets the criteria for 20
hours in Category 1 of the Physician’s
Recognition Award of the American
Medical Association.
For more information contact Ex
tended Programs in Medical Education,
Rm. 569-U, University of California
School of Medicine, San Francisco, CA
94143; or call (415) 666-4251.

World Congress on Pain
References
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The Vth World Congress on Pain, spon
sored by the International Association for
the Study of Pain, will be held Aug. 2-7,
1987 in Hamburg, West Germany.
For more inform ation write: The Vth
World Congress on Pain, c/o Hamburg
Messe und Congress GmbH. Congress
Organization, Postfach 30 24 80, 2000
Hamburg 36, West Germany.
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Chylopericardium Following Cardiac Surgery
Chylopericardium is one of the rarest
complications of cardiac surgery. The
authors report only the 19th case, that
of a 12-year-old boy. The
chylopericardium developed after an
aortic valvotomy, even though the
retropericardial portion of the mediasti
num was entered only to pass a tape
around the ascending aorta. Etiologic
factors are directly or indirectly related
to injury to the thoracic duct or its tribu
taries. Treatment initially is conservative,
consisting of adequate pericardial
drainage and a low-fat, medium-chain
triglyceride diet. If this fails, the
appropriate operative procedure is carried
out.

Le chylopericarde est I'une des plus rares
complications de la chirurgie cardiaque.
Les auteurs signalent ce qui n'est que le
19e cas; il est survenu chez un garcon
de 12 ans. Le chylopericarde est apparu
apres valvotomie aortique meme si on
n'avait penetre la partie retropericardique
du mediastin que pour entourer I'aorte
ascendante d'un ruban adhesif. Les facteurs etiologiques sont directement ou
indirectement relies d une blessure du
canal thoracique ou d'un des vaisseaux
qui lui sont tributaires. Au depart, le traitement est conservateur se limitant a
assurer un drainage pericardique adequat
et a fournir un regime hypo-lipidique de
triglycerides a chatne moyenne. En cas
d'echec, on procddera a ('intervention
chirurgicale appropriee.

one encountered at our institution in 2500
cardiac operations.

Case Report
A 12-year-old boy with congenital aortic ste
nosis underwent aortic valvotomy with cardio
pulmonary bypass and cardioplegic arrest. The
operation was performed through a median
sternotomy and vertical pericardiotomy.
Venous drainage was accomplished with a sin
gle atrial cannula and caval tapes were not
used. The boy’s postoperative course was
smooth and he was discharged home 6 days
after operation.
On a routine follow-up visit 4 weeks later,
he was found to have distended neck veins, an
enlarged liver and a pulsus paradoxus. He had
gained 2.7 kg in weight since discharge. A chest
film showed an enlarged cardiopericardial sil
houette. Echocardiography revealed a very
large pericardial effusion (Fig. 1).
On pericardiocentesis a large amount of
milky fluid was obtained. A pericardial
catheter was left in place for 24 hours and a
total of 1100 mL of chylous fluid drained.
Analysis of the fluid revealed electrolyte com

position similar to that of plasma, protein con
tent of 48 g/L , cholesterol of 1.6 mmol/L and
triglyceride level of 8.4 mmol/L. Gram’s stain
ing and cultures were all negative for bacteria.
A Sudan III fat stain of the fluid revealed the
presence of numerous fat globules, establish
ing the diagnosis of chylopericardium.
The patient was placed on a medium-chain
triglyceride diet, low in fat. There was no evi
dence of reaccumulation of chyle and an
echocardiogram 10 days after admission rev
ealed no pericardial effusion. Two months
later, the boy was on a normal diet, was com
pletely asymptomatic and had no evidence of
recurrent pericardial effusion.

Discussion
Chylopericardium is a rare complica
tion of cardiac surgery. Its incidence must
be extremely low since most patients
reported represent isolated case reports.
Our case is the only one encountered at
our institution in approximately 2500
cardiac operations. The first case of iso
lated chylopericardium following a

Chylopericardium is one o f the rarest
complications o f cardiac surgery. We
report a case of this condition, the first
From the Division o f Cardiovascular Sur
gery, The Montreal Children’s Hospital,
Montreal, PQ
Accepted fo r publication June 12, 1985
Reprint requests to: Dr. Anthony R.C.
Dobell, Rm. C-827, The Montreal
Children’s Hospital, 2300 Tupper St.,
Montreal, PQ H3H 1P3
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FIG. 1—Echocardiogram shows large pericardial effusion (E) in long axis parasternal view.
AO = aorta, RV = right ventricle, LV = left ventricle.
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cardiac procedure was reported by Louhimo and associates,1 in a 21-month-old
boy after a left Blalock shunt for tetral
ogy of Fallot. The first case after openheart surgery was reported by Thomas
and McGoon2 in 1971 in a 31-year-old
woman following repair of pulmonary
atresia and ventricular septal defect. Since
then, 16 other cases have been
reported.3' 15 The age of the 19 reported
patients ranged from 11 days to 57 years.
There were 14 males and 5 females. Oper
ations for congenital heart disease were
performed on 15 of them and for
acquired heart disease on 4.
In the congenital group, there were 4
extrapericardial procedures and 11 in
which the pericardium was intentionally
opened. The extrapericardial procedures
included three Blalock-Taussig shunts
and one repair of an interrupted
aortic arch.1’5'7,10 The pericardiotomies
included eight open -h eart proce
dures,^2 ,8,9,12,14 two Waterston shunts,3,4
and one cavopulmonary (Glenn) shunt.5
It is interesting that chylopericardium
occurred after extrapericardial procedures
and it is hard to explain its etiology in this
setting. However, in one of these cases,
reported by Hargus and colleagues,7 a
5-mm defect in the pericardium was noted
at re-exploration through which chyle was
diverted into the pericardial cavity. The
time of presentation was in the early
postoperative period in five patients and
was evidenced by the onset of copious
milky drainage from the pericardial tubes.
This usually coincided with the onset of
oral feeding. In the others, the clinical
presentation was between 1 week and 2
months postoperatively. Of these, nine
presented with cardiac tamponade,2'5,7'10
one patient had chest pain,6 and one had
dyspnea.11 In two patients, the mode of
presentation was not noted. Our patient
was asymptomatic, although, on physi
cal examination, he had all the signs of
a pericardial effusion.
The diagnosis of chylopericardium is
strongly suggested by the milky appear
ance of the fluid and the elevated
triglyceride level. It is confirmed by the
presence of fat globules under the micro
scope after staining for fat. Bacterial cul
tures in all reported cases were negative,
supporting the fact that the chylous fluid
is bacteriostatic.
Since chylopericardium complicating
cardiac surgery follows a surgical inter
vention, one must assume that its occur
rence is directly or indirectly related to
injury of the thoracic duct or its lym
phatic tributaries. A review o f the anat
omy of the thoracic duct reveals that it
is in close relation to the aorta in the lower
thorax, running between the aorta and
azygos vein. At the level of T4-5, it
crosses from right to left immediately
posterior to the aortic arch. Then it passes
cephalad, posteromedial to the left sub

clavian artery and left recurrent laryngeal
nerve. We suspect that in our patient the
duct or a tributary was injured when the
ascending aorta was encircled before
cross-clamping.
The lymphatic vessels draining the mid
dle and upper lobes of the right lung run
along the anterior surface of the right
bronchus or along the right pulmonary
artery, or both. Therefore, retrocaval
mobilization of the right pulmonary
artery could injure lymphatic tributaries
from the right lung. The elevation in
superior vena caval pressure that follows
a Glenn shunt may predispose to a lym
phatic fistula if the lymphatic system is
injured. Glenn and colleagues15 reported
that three of five patients with chylothorax had a moderate superior vena caval
syndrome following a Glenn shunt. This
could have played a role in the develop
ment of chylopericardium in the patient
following a Glenn shunt reported by
Delaney and associates.5 Another impor
tant factor that may lead to lymphatic
obstruction is venous thrombosis around
the left jugulosubclavian junction secon
dary to the use of left subclavian or left
internal jugular catheters. This factor
could be identified in four cases that we
reviewed.2,6,9,11
Another possibility is a lymphatic leak
occurring from anterior mediastinal dis
section and an opening in the
p ericardium . As adhesions form
postoperatively, the chylous leak could be
diverted into the pericardium. This was
observed in the patient reported by
Hargus and colleagues.7 It is possible
that in a number of cases the lymphatic
leak occurs in the anterior mediastinum
from dissection around the thymus. If the
pericardium is incompletely closed after
the procedure, the leak could be diverted
into the pericardium. This concept is also
supported by a case reported by Wong
and associates,16 of a 42-year-old woman
who had chylomediastinum but not
chylopericardium following mitral valve
replacement. The authors report that in
this patient, the pericardium was com
pletely closed.
Treatment of postoperative chyloperi
cardium is initially conservative, consis
ting of adequate pericardial drainage and
a low-fat, medium-chain triglyceride diet.
This regimen was successful in our case
and in half of the cases reported. O f the
reported cases treated operatively, partial
pericardiectomy was performed in three
patients, a pericardioperitoneal fistula
was established in one, mediastinal lym
phatics were ligated in one and the tho
racic duct was ligated in three patients.
One patient with tamponade suffered a
fatal cardiac arrest during emergency
thoracotomy.5 This was the only death
directly attributable to the chylo
pericardium (5.3%).

Recommendations
On the basis of our limited experience
and review of the literature, we make the
following suggestions.
• Avoid unnecessary dissection, since
a basic prerequisite for chylopericardium
is injury to the thoracic duct or its lym
phatic tributaries.
• Be especially aware of the danger
areas: the retrocaval right pulmonary
artery, behind the aortic arch and the left
subclavian artery.
• Avoid placing catheters in the left
subclavian and left internal jugular veins
if possible since venous thrombosis at the
jugulosubclavian junction will result in
lymphatic obstruction and favour a lym
phatic leak.
• Initial treatment should be conserva
tive involving adequate pericardial
drainage to relieve symptoms and a
medium-chain triglyceride diet high in
protein and low in fat to prevent reac
cumulation and allow healing o f the
injured lymphatics. This was successful
in our case and in more than half of the
cases reported.
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BOOK REVIEWS

continued from page 489
As the title suggests, anatomy is emphasized
and the book provides an impressive, concise
description of the structure of the hand as well
as its function, so important to the hand sur
geon. The text is divided into three parts: the
first is short and defines the hand as an organ.
The second and major portion discusses struc
ture and function. Only one chapter is devoted
to kinesiology, which perhaps indicates the lack
of understanding in this area, which has yet
to be studied and elucidated. Finally, part three
deals with surgical anatomy in three chapters
which discuss surgical anatomy, surgical
approaches, and concepts and treatment in
amputations.
Some o f the remarks relating to compara
tive anatom y would be of more interest to the
student o f anatomy than to the clinician.
Kaplan was a scholar and the text generally
reflects his influence and interest. On the other
hand, it is interesting that so many clinicians
have particpated in revising the section on anat
omy which covers well over half the book.
I recommend this book as a worthy addition
to the library of any hand surgeon. It would
also be of interest to the student of anatomy.

P. G a r e a u ,

m d , fr csc

830A Pembroke St.,
Victoria, BC
V8T 1H9

THE PLANNING OF LOCAL PLASTIC
OPERATIONS ON THE BODY SUR
FACE: Theory and Practice. A .A . Limberg. Translated by S. Anthony Wolfe. 635
pp. Illust. D.C. Heath and Company, Lex
ington, Mass.; D.C. Heath Canada Ltd.,
Toronto, 1984. $77.95. ISBN 0-669-04646-9.

At first glance, Professor Limberg’s analy
sis of plastic surgical operations seems unneces
sarily confusing and complex. However, with
more-detailed study, his stereometric analyses
make it much easier to understand the changes
that occur following tissue-shifting techniques,
which are used daily by plastic surgeons. I had
the pleasure of visiting with Professor Limberg
in Leningrad in the early 1960s and reviewed
with him his various models for planning a
large number of plastic surgical operations on
the face, trunk and extremities. This
.monumental book, translated by Anthony
Wolfe, is a valuable addition to the medical
libraries of the English-speaking world.
The material contained in this textbook
needs careful study. It is really directed towards
students of plastic surgery, particularly those
with an interest in geometric design and sur
face anatom y. Its contents can best be under
stood by constructing the models personally,
using soft cardboard or a silence cloth and then
allowing the rotation, transposition and
advancement of the various components as
meticulously outlined by Professor Limberg.
He has made a very important contribution to
the specialty of plastic surgery in his native
Russia and a study of his textbook gives a clear
indication of his analytical thinking which will
be of value to plastic surgeons in the West.
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I find it difficult to recommend this book
for individual purchase except to those with a
keen interest in surface planning, but I highly
recommend it as a reference book for hospi
tal and medical libraries.

H. Bruce W illiams, md , frcsc
Director, Division of Plastic
and Reconstructive Surgery,
The Montreal General Hospital,
1650 Cedar Ave.,
Montreal, PQ
H3G 1A4

PROGRESS IN CRITICAL CARE MEDI
CINE. Vol 1. Multiple Trauma. Edited by
R.J. Wilder. 826 pp. Illust. S. Karger AG,
B asel,
1984.
$57.
(U S ).
ISBN
3-8055-3823-5.

This multiauthored text deals with care of the
traumatized patient with multiple injuries. It
is not proposed as a definitive text on the treat
ment of such patients, but it does provide upto-date knowledge in specific areas related to
multiple trauma.
The book begins with a review of the ration
ale and role o f trauma centres, followed by a
discussion of the initial management of the
patient with multiple injuries. The remainder
of the book is devoted to updating knowledge
on isolated topics concerning these patients.
Each section is well referenced.
The value of computerized tomography is
discussed under the sections on intracranial
injuries, craniofacial trauma, abdominal
trauma and spinal trauma. Monitoring the
traumatized patient, the endocrine response to
injury, post-traumatic respiratory failure,
cerebral resuscitation, fluid therapy and nutri
tion in the perioperative period, and anesthe
sia are all covered. The therapy and preven
tion of infections in traumatized patients are
also outlined as well as more specialized areas
such as trauma in the child and during preg
nancy.
This book is easy to read and I recommend
it to all physicians who treat traumatized
patients with multiple injuries.

L.B. CONOCHIE, MD, CM, FRCSC
Department o f Orthopedic Surgery,
The Montreal General Hospital,
1650 Cedar Ave.,
Montreal, PQ
H3G 1A4

SILVERGIRL’S SURGERY: THE BREAST.
Edited by Guy F. Robbins. 257 pp. Illust.
Silvergirl, Inc., Austin, Tex., 1984. Price
not stated. ISBN 0-941432-13-0.

This is the initial volume in a series that
addresses specialty areas by presenting papers
that were important in developing ideas in the
particular field. This volume on breast cancer
begins with a section on primitive treatment.
In addition to an Egyptian papyrus written
approximately 5000 years ago, this section con
tains papers o f Latin, Greek and Talmudic
origins.

The next part marks the beginning of a more
scientific approach with contributions from the
18th and 19th centuries. This is followed by
segments devoted to the development and tech
nique of radical mastectomy, containing the
classic papers of Heidenhain and Halsted. Two
other sections deal with radical mastectomy.
One reviews more radical extensions of the
standard operation and another describes some
of the classic moderating variations such as
those of Keynes and McWhirter. The incom
pleteness of this section is one of the volume’s
weaknesses. The reports of Vera Peters and
Mustakalio, who are mentioned in the
introduction, should have been included here
as landmarks in the march toward conserva
tive surgery.
The concluding segments on historical
aspects of cystic disease of the breast and
Paget’s disease reproduce the original papers
of Paget and Schimmelbusch.
Each section is preceded by a brief comment
from the editor that puts it into perspective.
The book is generously illustrated with many
reproductions of artistic works related to the
breast. On the whole it offers a rich source of
fundamental material on early thinking in the
field of breast cancer.
This volume will be of interest to surgeons
wanting a greater perspective on the historical
aspects of breast cancer surgery. Many of these
papers are cited in more modern reports, espe
cially review articles, but seldom does the stu
dent have an opportunity to read the original
material. Thus, this volume represents a use
ful look back on our heritage. The paper by
Mitchell Banks written in 1882 provides a vivid
and provocative description o f surgery using
Listerian antiseptics.
A poignant account of breast surgery in the
19th century from the patients’ perspective is
provided by John Brown’s description of his
experience as a clinical clerk. It provides a fit
ting counterpoint to some of the more dispas
sionate discourses in the other chapters.
The only disturbing element in this book is
the subtle editorial slant. There is an attempt
in the introduction to continue the long
standing debate on the optimal surgical
approach to the management of primary breast
cancer. Although the papers presented are
selected for their historic importance, the
introduction mentions the works of Peters,
Crile, Mustakalio and others, and criticizes
them for inadequate statistical methodology.
These papers, however, are not published in
this volume nor is other evidence that would
be useful in the context of this debate. The
unwary reader would conclude that the ana
tomic and lymphatic considerations that domi
nated the 19th and early 20th centuries are still
the most important and continue to represent
the only rational basis for planning treatment.
The alternative hypothesis of Fisher and the
evidence supporting it are not mentioned.
While this volume is obviously not intended to
be an overview of controversial or contending
hypotheses, the insertion of several paragraphs
criticizing breast-conserving operations can
mislead an inexperienced reader. The editor
would have served his readers better if he had
refrained from argumentative views in the
introduction and stipulated that this collection
gives a historical perspective, not an overview,
of breast cancer.
While the book does not present the entire
spectrum of views on breast cancer, it succeeds
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in collecting into one volume some of the clas
sic, historical contributions that will enrich any
one studying cancer surgery.
*

R ichard Margolese, md , frcsc

►

Director, Division of Oncology,
The Sir Mortimer B. Davis-Jewish
General Hospital,
3755 Cote Ste-Catherine,
Montreal, P.Q.
H3T 1E2
TEXTBOOK OF SURGERY. 5th ed. Edited
by David A. Macfarlane and Lewis P.
Thomas. 468 pp. Illust. Academic Press
Canada, Don Mills, Ont., 1984. $45, paperbound. ISBN 0-443-02768-4.

The authors of this British textbook of surgery
state in the preface to this new edition that their
intent is “ to provide surgical information in
a concise and didactic form...to enable the stu
dent to retain the essentials” . One of the
problems with this approach is that the effort
to be concise may lead to a superficial review.
By comparison with North American textbooks
of surgery, this is undoubtedly the major criti
cism of this book.
It strikes a satisfactory balance between the
general knowledge that undergraduate medi
cal students need to know about surgical topics
and the requirement for specialist information
relating to these topics. The book is well laid
out, written with the economy of style that is
characteristic of British writing. It was a par
ticular pleasure to see clear definitions at the
start of chapters and subsections. While there
are no photographs, the text is liberally inter
spersed with line drawings, the groupings of
which clearly define some of the classifications.
For example, the diagrams showing the types
of herniation in the groin accurately delineate

the sites where the student may expect to find
indirect and direct inguinal and femoral her
nias. Similarly, the diagrams showing gastric
and duodenal ulcers and their complications
will help the student to remember them.
The chapters on surgical aspects of infection,
injury and repair are extremely basic, and the
immunologic aspects of infection are not
referred to at all. The table of appropriate
antibiotic usage is useful, although the
cephalosporins are given scant coverage. Many
of the other chapters fail to define for the stu
dent how frequently a specific disease entity
is likely to be encountered. Thus, in the dis
cussion of deep venous thrombosis and pulmo
nary embolism, little attention is paid to the
frequency of this complication postoperatively,
so that such statements as “ the majority of
cases improve spontaneously” in reference to
the management of deep venous thrombosis are
more than open to doubt. One can also dis
agree with the statement “ although the regime
of low dose heparin is now widely used, its
value is still in doubt” . If this referred to pul
monary embolism the statement would prob
ably be true, but the evidence supporting the
reduction of isotopically detected deep venous
thrombosis now seems unequivocal in many
studies. It is also unfortunate to see ligation
o f the femoral veins still being recommended
for venous thrombosis as well as plication of
the inferior vena cava being recommended
without mention of more recent transvenous
techniques. In addition, the pros and cons of
caval ligation are not considered at all.
There are numerous instances of dogmatic
statements which are, by the very nature of the
book, unsupported by appropriate discussion.
Frequently these give the wrong impression and
do not relate to contemporary practice. Thus,
the statement that “ gangrene of the foot not
responding to arterial reconstruction will, in
most cases, necessitate mid-thigh amputation”

is misleading when below-knee am putation is
being performed with greater frequency and
success. In general, the indications for surgi
cal treatment are inadequately covered in terms
of discussion of the natural history o f the
treated versus the untreated disease. Repair of
aneurysms is recommended dogmatically for
those greater than 7 cm in size without any dis
cussion of the risks of rupture in asymptomatic
aneurysms smaller than this.
This book is at its best when reviewing the
underlying principles that pertain to surgical
care and surgical disease. The chapter on the
principles of managing malignant disease is
excellent, with clear accounts o f tum our clas
sification, the treatment o f the premalignant
lesion and of methods available for the
management of malignant disease. Operative
management, radiotherapy and chemotherapy
are all covered and an adequate background
is provided for-the student in these areas.
In conclusion, this book sets out to do what
it intended to by providing inform ation in a
concise and didactic form. It suffers, however,
in that, being didactic, it cannot discuss the
areas where pragmatism overcomes dogma. It
provides easy reading and may be useful for
students receiving their first exposure to sur
gery. However, most teachers will expect a
deeper understanding of the nature of surgi
cal disease and therefore I cannot recommend
it highly. With its competitive price, this book
provides an inexpensive overview of a complex
subject and thus may be attractive to some stu
dents.

J ohn L. P rovan, ms, frcs , frcsc , facs
Professor of Surgery,
University of Toronto,
Surgeon-in-Chief,
The Wellesley Hospital,
Toronto, Ont.
M4Y 1J3

SESAP IV Critique
ITEM 255

►

♦

Adjuvant chemotherapy is given at or near the time of attempted regional eradication of cancer, with the aim of eliminat
ing systemic microscopic metastases. The current theories are based largely on experimental work in animals, but are in
creasingly being confirmed by prospective clinical trials in patients. These hold that if the number of remaining viable
cancer cells can be reduced below a certain level, the patient can then control the disease indefinitely and thereby achieve
a “ clinical cure.” Treatment must be planned to achieve the lowest possible number of viable cancer cells. Chemotherapy
is given as close as possible to the time of eradication of local and regional disease, using multiple drugs with different
modes of action to eliminate cells that would otherwise escape the action o f the other drugs in the combination. Continu
ous administration of these toxic drugs is not wise and does not increase the chance of achieving the desired effect. Multi
ple drugs are given soon after treatment of the primary tumor, in maximal tolerated doses but for a limited period. The
results to date have been encouraging in patients with cancer of the breast who have nodal but not detectable systemic
metastases.
D

t
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U N IV ER S IT Y O F O T T A W A
CHAIR OF G E N E R A L S U R G ER Y

U N IV ER S IT E D 'O T T A W A
C HAIRE D E C H IRU RG IE G E N E R A L E

A p p lica tio n s are invited fo r the position o f Chairman
o f th e Division o f General Surgery. The appointee m ust
have th e leadership qualities, the q u a lifica tio n s and the
experience to undertake the re sponsibility fo r research,
undergraduate and postgraduate medical education and
th e coordination of educational a ctivitie s in the major a f
filia te d teaching hospitals, nam ely, th e O ttaw a Civic
H ospital, the O ttaw a General Hospital and the Children's
H ospital of Eastern O ntario. Suitable candidates should
be eligible fo r ce rtifica tio n by the Royal College o f Phy
sicians and Surgeons o f Canada and fo r licensure by the
C ollege of Physicians and Surgeons o f Ontario.

L'Universite d 'O tta w a ouvre un concours pour le poste
de Titulaire et D ire cte u r/d ire ctrice de la division de chirurgie generale. Le/la candidat(e) choisi(e) aura la responsabilite de voir au developpem ent du programme de
recherche. Il/elle devra en plus vo ir a la surveillance des
programmes de fo rm a tio n au niveau prediplome et p o s t
doctoral, et a la co -ordination des programmes d'enseignem ent integr6s dans les hopitaux affilies, soit I'H opital
General d 'O tta w a , I'H opital Civique d 'O tta w a et I'H opital pour enfants de I'E s t de I'O ntario.

In accordance w ith Canadian Im m igration require
m ents, priority w ill be given to Canadian citizens and per
m a n e n t residents o f Canada.
A n application, including curriculum vitae and appropri
ate references should be fo rw a rd e d PRIOR to NOVEM
BER 3 0 , 1985.
W .J. Keon, MD
Chairm an, S election C om m ittee
Faculty o f Health Sciences
U niversity o f O ttaw a
O ttaw a, Ontario
K1H 8M 5

Les candidats q u a lifie s devront etre eligibles au certific a t du College royal des medecins et chirurgiens du
Canada et au perm is d 'e xe rce r du College des medecins
et chirurgiens de I'O ntario.
Selon les exigences d 'lm m ig ra tio n Canada, la prefe
rence sera donnee aux candidats qui sont citoyens canadiens ou im m igrants recus.
Priere de faire parvenir votre curriculum vitae et la liste
des references A V A N T le 30 novem bre 1985 a I'a tte n tion de:
W .J. Keon, MD
President, com ite de selection
Faculte des Sciences de la sante
U niversite d 'O tta w a
O tta w a , O ntario K1H 8 M 5
—S 85-35

S U N N Y B R O O K M ED IC A L C EN T R E
C H IEF OF N EU R O S U R G ER Y
This University of Toronto Division has 28 beds,
a 12-bed neuro-ICU plus traum a beds. Excellent
associated services include, neuroradiology, neu
ropathology, psychology and neurology (Depart
m en t o f Neurosciences).
S tre n g th s include a regional spinal cord injury
unit, regional traum a unit, neuro-oncology (w ith
Toronto-B ayview Cancer Clinic), and cardiovas
cular surgery. As w ell, research facilities are
available w ith in the hospital.
Interested parties m ay apply w ith th e ir curricu
lum vita e by December 15, 1985 to :
Dr. Marvin Tile,
Surgeon-in-Chief
Sunnybrook Medical Centre
2 0 7 5 Bayview Avenue, A -3
Toronto, Ontario
M 4N 3M 5
546
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TRAUMA
DIRECTOR
The Calgary General Hospital is seeking a Direc
tor of Trauma. This position will be a joint
appointment with The University of Calgary
Faculty of Medicine.
The successful candidate will be a physician
who will direct the trauma service at the Calgary
General Hospital to include academic and
research programs. Candidates should be
specialists in Surgery, Intensive Care or
Emergency Medicine with interest, training and
experience in trauma.
A high priority will be to develop a Regional
Trauma Referral Service for Southern Alberta at
the Calgary General Hospital.
All qualified individuals are encouraged to
apply, but preference will be given to Canadian
citizens, and permanent residents.
Applicants are requested to submit a statement
of interest, and a current curriculum vitae in
cluding the names of three referees by
December 30, 1985 addressed to:
Dr. Roger West, Chairman,
Search Committee
d o Calgary General Hospital
841 Centre Avenue, East
Calgary, Alberta T2E 0A1
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